ECKERD CORP
10-K, 1996-04-30
DRUG STORES AND PROPRIETARY STORES
Previous: EASTMAN KODAK CO, 10-K/A, 1996-04-30
Next: VAN KAMPEN AMERICAN CAPITAL ENTERPRISE FUND/, 497J, 1996-04-30



                                                           

                                                            
                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-K

              [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED)
                   For the fiscal year ended February 3, 1996
                                       OR
            [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
              THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED)
                        For the transition period from to

                          Commission File Number 1-4844

                               ECKERD CORPORATION
             (Exact name of registrant as specified in its charter
                    
         DELAWARE                                       13-3302437
(State of incorporation)                  (I.R.S. Employer Identification No.)

                              8333 Bryan Dairy Road
                                 Largo, FL 34647
              (Address and zip code of principal executive offices)
                                 (813) 399-6000
               (Registrant's telephone number including area code)

           Securities registered pursuant to Section 12(b) of the Act:
                                
                                                          Name of each
      Title of each class                        exchange on which registered 
      -------------------                        ---------------------------- 
  Common Stock, par value $.01                       New York Stock Exchange
  9 1/4% Senior Subordinated Notes Due 2004          New York Stock Exchange

        Securities registered pursuant to Section 12(g) of the Act: None

        Indicate by check mark whether the  registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such  reports),  and (2) has been subject to the
filing requirements for the past 90 days. Yes X No .

        Indicate by check mark if disclosure of  delinquent  filers  pursuant to
Item 405 of Regulation S-K is not contained  herein,  and will not be contained,
to the best of  registrant's  knowledge,  in  definitive  proxy  or  information
statements  incorporated  by  reference  in Part  III of this  Form  10-K or any
amendment to this Form 10-K. [ ]

        The aggregate market value of the voting stock held by non-affiliates of
the  Company  as of  March  29,  1996  was  $1,548,335,443  (Calculated  on  the
assumption  that all directors,  all executive  officers,  and certain  entities
affiliated with Merrill Lynch & Co. are affiliates).

        As of March 29, 1996, 69,966,834 shares of common stock, par value $.01,
were outstanding  (adjusted to give effect to a two-for-one  stock split payable
in the form of a stock  dividend  declared April 1, 1996 and payable on or about
May 13, 1996).

                       DOCUMENTS INCORPORATED BY REFERENCE

(1) Certain  portions of the Annual Report to  Stockholders 
    for the fiscal year ended February 3, 1996                    Parts II & IV
(2  Certain portions of the Definitive  Proxy Statement for 
    Stockholder Meeting to be held on May 23, 1996                Part III

<PAGE>



                               ECKERD CORPORATION
                    FEBRUARY 3, 1996 FORM 10-K ANNUAL REPORT
                                Table of Contents


                                                       
Item                                                                       Page
- ----                                 PART I                                ----
 1.    Business                                                               3
 2.    Properties                                                             9
 3.    Legal Proceedings                                                     10
 4.    Submission of Matters to a Vote of Security Holders                   10
       Executive Officers of the Registrant                                  10

                                     PART II

 5.    Market for the Registrant's Common Equity and Related
         Stockholder Matters                                                 12
 6.    Selected Financial Data                                               12
 7.    Management's Discussion and Analysis of Financial Condition
         and Results of Operations                                           13
 8.    Financial Statements and Supplementary Data                           13
 9.    Changes in and Disagreements with Accountants on Accounting and
         Financial Disclosure                                                13

                                    PART III

10.    Directors and Executive Officers of the Registrant                    13
11.    Executive Compensation                                                13
12.    Security Ownership of Certain Beneficial Owners and Management        14
13.    Certain Relationships and Related Transactions                        14

                                     PART IV

14.    Exhibits, Financial Statement Schedules, and Reports on Form 8-K      14

                                       2
<PAGE>

                                     PART I

Item 1.       Business

General

        Eckerd  Corporation (the "Company" or "Eckerd") operates the Eckerd drug
store chain, which is one of the largest drug store chains in the United States.
At February 3, 1996,  the Eckerd  chain  consisted  of 1,715 stores in 13 states
located  primarily in the  Sunbelt.  Over its 43-year  history,  the Eckerd drug
store  chain has  built a strong  market  position  in areas  where  demographic
characteristics  are  favorable to drug store growth.  The Company's  stores are
concentrated  in 10 of the 12  metropolitan  statistical  areas with the largest
percentage  growth in population from 1980 to 1990,  and,  according to industry
sources, the Company ranks first or second in terms of drug store sales in 12 of
the major metropolitan markets in which it operates.

        The  primary  focus of  Eckerd  stores is the sale of  prescription  and
over-the-counter  drugs, which, during fiscal 1995, generated  approximately 62%
of the  Company's  sales.  Eckerd  stores  sell a wide  variety  of  nonpharmacy
merchandise, including health and beauty aids, convenience foods, greeting cards
and numerous other  convenience  products.  Another  significant focus of Eckerd
stores is photofinishing.  The Company offers overnight  photofinishing services
in all Eckerd  stores and at  February 3, 1996  operated  Eckerd  Express  Photo
one-hour photofinishing mini-labs in 515 stores.

        The Company  believes that customer service and convenience are critical
in positioning itself as the alternative to mass merchandisers, supermarkets and
other  large  format  retailing  channels.  The Company  emphasizes  service and
convenience  through  pharmacy  support  services,  store  location  and design,
merchandising programs and operating hours geared to the needs of the particular
market.

        The Company was formed in 1985 for the purpose of  acquiring  the former
Jack Eckerd Corporation ("Old Eckerd"), in a leveraged buyout in April 1986 (the
"Acquisition").  On August 12, 1993,  the Company  completed  an initial  public
offering  (the  "IPO") in which it issued and sold  10,350,000  shares of Common
Stock for $7.00 per share  (adjusted for the  two-for-one  stock split  declared
April 1, 1996 and payable on or about May 13, 1996).  In connection with the IPO
the  Company's  name was  changed  from  "Jack  Eckerd  Corporation"  to "Eckerd
Corporation."

The Drug Store Industry

        Prescription and  over-the-counter  medications have  traditionally been
sold by  independent  drug stores as well as drug store chains,  such as Eckerd.
The drug store industry has recently undergone  significant  changes as a result
of the following important trends: (i) the increase in third-party  payments for
prescription drugs, (ii) the consolidation within the drug store industry, (iii)
the aging of the United States  population  and (iv) the increase in competition
from non-traditional retailers of prescription and over-the-counter drugs.

        During the last several years, a growing percentage of prescription drug
volume  throughout the industry has been accounted for by sales to customers who
are covered by third-party payment programs ("managed care sales"). In a typical
managed care sale, the drug store has a contract with a managed care payor, such
as an insurance company,  health  maintenance  organization  ("HMO"),  preferred
provider organization ("PPO"), other managed care provider, government agency or

                                       3
<PAGE>

private employer, which agrees to pay for part or all of the customer's eligible
prescription  purchases.  Although  these  managed  care sales  contracts  often
provide a high volume of prescription sales, such sales typically generate lower
gross  margins  than  non-managed  care  sales  due  principally  to the  highly
competitive  nature of this business and the high level of  competition  between
managed care firms and the resulting efforts to reduce costs.  Larger drug store
chains,  such as Eckerd,  are better able to service the  growing  managed  care
segment  than  independent  drug  stores and  smaller  chains as a result of the
larger chains' more sophisticated  technology  systems,  larger number of stores
and greater penetration within their markets.

        As a result of the  economies  of scale  from  which  larger  drug store
chains  benefit  as well as the  managed  care  payment  trend,  the  number  of
independent  drug stores and smaller drug store chains has  decreased as many of
such  retailers  have been acquired by larger drug store  chains.  This trend is
expected to continue  because larger chains are better  positioned to handle the
increased managed care sales,  purchase inventory on more advantageous terms and
achieve other economies of scale with respect to their  marketing,  advertising,
distribution  and other  expenditures.  The Company  believes that the number of
independent drug stores and smaller drug store chains remaining in operation may
provide significant acquisition opportunities for larger drug store chains, such
as the Company.

        Strong  demographic  trends have also contributed to changes in the drug
store  industry,  as the group of  persons  over age 50 is the  fastest  growing
segment of the United States population.  This trend has had, and is expected to
continue to have, a marked effect on the pharmacy  business in the United States
because  consumer   prescription  and  over-the-counter   drug  usage  generally
increases with age. The Company's markets have large  concentrations of, and are
continuing to experience  significant  growth in, the number of persons over age
65.

Eckerd Drug Stores

        As of February 3, 1996, the Company operated the number of Eckerd stores
and  Eckerd  Express  Photo  centers  indicated  below in each of the  following
states:

                                                         Drug Stores
                                         Eckerd          With Eckerd
                                          Drug          Express Photo
                                         Stores            Centers
                                         ------            -------
                Florida                     575                247
                Texas                       475                138
                North Carolina              178                 46
                Georgia                     163                 46
                Louisiana                    95                 20
                South Carolin                76                 13
                New Jersey                   38                  1
                Tennessee                    35                  1
                Mississippi                  26                  -
                Oklahoma                     26                  -
                Alabama                      16                  3
                Delaware                     11                  -
                Maryland                      1                  -
                                          -----                ---           
                   Total                  1,715                515
                                          =====                ===

                                       4
<PAGE>

        Over the past five years the Company has implemented several initiatives
designed to improve the quality and operating performance of the Company's store
base.  Among such  initiatives  are the opening,  relocation and  acquisition of
additional stores,  the closure or divestiture of underperforming  stores and an
extensive  remodeling  program.  Since the beginning of fiscal 1990,  390 Eckerd
drug stores have been opened or acquired within the Company's  existing markets,
more than 300 underperforming stores have been closed or divested, and more than
50% of the Company's  remaining  stores have been  remodeled.  In addition,  the
Company  opened  more than 300  Express  Photo  centers.  The  Company  has also
increased  the degree to which  merchandise  is tailored  to  specific  markets,
instituted  a  chainwide  shrinkage  reduction  program  and made a  significant
investment in its management information systems.

        The following table summarizes the number of Eckerd drug stores operated
by the  Company and the sales on an  aggregate  and per store basis for the last
five years.
<TABLE>
<CAPTION>

                                                                                   Fiscal Years
                                                                                   ------------
                                                          1995               1994           1993          1992         1991
                                                          ----               ----           ----          ----         ----
<S>                                                      <C>                <C>            <C>           <C>          <C>
Number of Eckerd drug stores at
    beginning of period                                  1,735              1,718          1,696         1,675        1,673
Stores opened or acquired (1)                               88  (2)            39             52            50           22
Stores sold or closed                                     (108) (3)           (22)           (30)          (29)         (20)
                                                         -----               ----           ----          ----         ----
Number of Eckerd drug stores
    at end of period                                     1,715              1,735          1,718         1,696        1,675
                                                         =====              =====          =====         =====        =====

Number with Express Photo centers                          515                481            413           378          321
Sales of Eckerd drug stores (in thousands)          $4,986,804          4,436,926      4,052,302     3,759,246    3,629,037
Average annual sales per Eckerd drug
    store (in thousands)                                $2,925              2,584          2,388         2,244        2,163

</TABLE>

(1)    Excludes relocations.
(2)    Includes 40 Florida stores acquired from Rite Aid of Florida, Inc.
(3)    Consists of (i) 84 stores  that were closed as a result of the  Company's
       decision in the fourth  quarter of fiscal 1994 to accelerate  the closing
       of approximately 90 geographically  dispersed,  under-performing  stores,
       and (ii) 24 stores closed in the normal course of business.

        The  Company  intends to continue to expand its  business  through  both
internal  expansion and  acquisitions of drug store chains and independent  drug
stores.  Although the Company  currently  plans to expand  within the  Company's
existing  markets,  the Company also considers  strategic  acquisitions in other
markets. The Company opened or acquired 120 drug stores including 32 relocations
in fiscal 1995 and has a goal of opening (including relocations) 100 drug stores
in fiscal 1996 and expects the rate of new store development to accelerate about
20% each year  thereafter,  through  fiscal  2000.  The  majority of the new and
relocated stores are expected to be freestanding  locations. In addition to such
openings and  acquisitions,  the Company expects to sell or close a small number
of drug stores per year in fiscal 1996 and  thereafter  through fiscal 2000. The
cash  costs   associated   with  opening  a  drug  store  are  estimated  to  be
approximately $545,000,  which includes initial inventory costs of approximately
$315,000.  The Company  intends to use cash flow from  operations to finance the
cash costs of this growth,  although borrowings may also be available to finance
such  growth.  See "Item 7.  Management's  Discussion  and Analysis of Financial
Condition and Results of Operations-Liquidity and Capital Resources."

        In  determining  the areas in which to open or acquire drug stores,  the
Company  evaluates a number of demographic  considerations,  including the size,
growth  pattern  and  per  capita  income  of the  population,  as  well  as the
competitive environment and the accessibility of a proposed site to the customer
and to the Company's  warehouse and  distribution  facilities.  The Company also
continually  reviews these factors and the  performance of individual  stores in
determining whether to close or relocate certain stores.

                                       5
<PAGE>

Products and Services

Pharmacy

        The primary focus of Eckerd drug stores is the sale of prescription  and
over-the-counter drugs. The Company seeks to position pharmacists as health-care
professionals  who build  relationships  with their  customers.  Over the years,
marketing  and  advertising  campaigns  have been  focused  on  reinforcing  the
professionalism  of the  Company's  pharmacists  and  positioning  them as a key
factor in high quality pharmacy service. The Company has also instituted several
health-related  programs  such as  health  screenings,  education  and  outreach
programs.

        Eckerd pharmacy  departments are modern, clean and clearly identified by
attractive signs. The pharmacy areas in the Company's newer and remodeled stores
provide  a  consultation  area and a  waiting  area  with  comfortable  seating,
informational  brochures and free blood pressure testing. The pharmacy areas are
designed to be conducive to customer service and counseling by the pharmacists.

        The Company has devoted  substantial  resources  to marketing to managed
care payors,  such as insurance  companies,  HMO's, PPO's and other managed care
providers and government  agencies.  This effort has produced managed care sales
of  approximately  71%  of  prescription   sales  in  fiscal  1995  compared  to
approximately 36% in fiscal 1990. The Company's computer systems provide on-line
adjudication  which  permits the Company and the managed care payor to determine
electronically,  at the time of sale,  eligibility of the customer,  coverage of
the   prescription  and  pricing  and  co-payment   requirement,   if  any,  and
automatically  bills the respective plan.  On-line  adjudication  reduces losses
from rejected  claims and  eliminates a portion of the  Company's  paperwork for
billing and collection of receivables and costs associated therewith.

Nonpharmacy Merchandise

        In addition to prescription and  over-the-counter  drugs,  Eckerd stores
sell a wide  variety of  nonpharmacy  merchandise,  including  health and beauty
aids, convenience foods, greeting cards and numerous other convenience products.
Eckerd-brand products,  which are attractively priced and provide higher margins
than similar  national brand  products,  represent a growing segment of products
offered.  Items such as Eckerd Award soft drinks,  bottled water and cookies are
recent additions to the Eckerd brand products offered by Eckerd stores.

        Health  merchandise  offerings  include a broad  assortment  of  popular
national  brands  as well as  private  label  over-the-counter  drugs  and other
products   related  to  dental  care,   foot  care,   vitamins  and  nutritional
supplements,  feminine  hygiene,  family  planning and baby care.  Eckerd stores
offer an assortment of popular brand name cosmetics, fragrances and other beauty
products.  Skin care  products are an  increasingly  important  component of the
beauty  category  due to the aging  population  and  growing  concern  about the
effects of the  environment on the skin. The greeting card  department in Eckerd
stores offers a wide selection of contemporary and traditional cards, gift wrap,
bows and  novelties.  This wide selection and the locations of its stores should
enable customers to satisfy their card and gift needs more  conveniently than at
traditional card stores. The convenience  products merchandise category consists
of an assortment of items, including candy, soft drinks, cookies, bottled water,
tobacco products, books and magazines,  household products, seasonal merchandise
and toys. The Company also seeks to serve its customers'  needs by  specifically
tailoring  items in this category to meet the needs of its customers in specific
store locations.

                                       6
<PAGE>


Photofinishing

        The Company believes that it is the leading source of  photofinishing in
all of the major  markets in which it operates.  The Company  believes  that its
branded processing  programs,  which emphasize quality and service,  have helped
position  the  Company  as a  leader  in  photofinishing.  The  Company's  photo
departments  also  offer  camera  and  photo  accessories,   small  electronics,
batteries and audio and video tapes.

Store Operations

        The  Company  will  continue  to remodel and reset its stores to provide
modern,  well-identified  stores,  which are easily  accessible to customers and
will seek to open new stores in easily  accessible high traffic  locations.  The
Company also tailors its  merchandising to provide the product mix and selection
to best serve the  customers of each  particular  store.  The Company  typically
provides  several  conveniently  located,  modern  stores  in a  community.  The
Company's  stores range in size from 8,200 to 11,000 square feet and are located
primarily in neighborhood strip centers or freestanding  locations.  Such stores
are typically open every day of the year except Christmas,  with some open until
midnight or 24 hours a day.

Purchasing and Distribution

        Merchandising, buying and supplier payments are generally centralized at
Company  headquarters to assure consistency and efficiency.  The Company uses an
electronic  buying system to aid in inventory and gross profit  management which
enables the Company to take better  advantage of quantity  discounts and forward
buying opportunities,  which the Company believes will lower the average cost of
inventory.

        Approximately  85% of  store  merchandise  is  purchased  centrally  and
distributed,  principally by Company-operated trucks, through the Company's five
centrally located distribution  facilities located in or near Orlando,  Florida;
Atlanta, Georgia;  Charlotte, North Carolina; and Dallas and Houston, Texas. The
remainder of store merchandise is shipped directly to the stores,  some of which
is purchased at the store level.

Advertising and Marketing

        A combination of newspaper  advertising and TV and radio  commercials is
used throughout the year to promote sales. The Company's concentration of stores
within its markets  enables it to achieve  economies of scale in its advertising
and marketing  expenditures and also enables the Company to negotiate  favorable
rates for advertising time and print  production.  The Company believes that its
current level of advertising expenditures is appropriate to support its existing
marketing strategies.

Information and Technology

        The  Company  intends to continue  to invest in  information  systems to
improve customer service,  reduce operating costs, provide information needed to
support management decisions and enhance the Company's competitive position with
managed  care  payors.  In  fiscal  1994  and  1995 the  Company  completed  the
installation of a satellite  communications network,  enhanced the point of sale
("POS")  reporting  system and enhanced the  merchandise  and store  information
management  systems. In fiscal 1996 the Company will complete the rollout of POS
scanning  equipment to all stores and also complete the  installation of a state
of the art pharmacy system for the stores.

                                       7
<PAGE>

        In 1993,  the  Company  and  Integrated  Systems  Solutions  Corporation
("ISSC"),  a wholly-owned  subsidiary of IBM, entered into a Systems  Operations
Service  Agreement.  Under the  Company's  supervision,  ISSC manages the entire
information  systems  operation  and is  responsible  for  providing  technology
services to the Company. The Systems Operations Services Agreement has a 10-year
term, and the total  payments to be made by the Company  thereunder are expected
to be $480.0 million over such term,  based on currently  anticipated  services.
The Company  believes that this  arrangement has and will continue to enable the
Company to further  improve  customer  service,  replace the Company's  existing
systems,  reduce operating costs and capital  expenditures for hardware,  obtain
information  needed to support  management  decisions  on an improved  basis and
increase the Company's focus on its core business.

Competition

        The  Company's  retail  drug  stores  operate  in a  highly  competitive
industry.  The Company's drug stores compete  primarily on the basis of customer
service,  convenience  of location and store  design,  price and product mix and
selection.

        In addition to traditional  competition from independent drug stores and
other drug store chains,  the Company faces  competition  from discount  stores,
supermarkets,  combination  food  and  drug  stores,  mail  order  distributors,
hospitals and HMOs. These other formats have experienced  significant  growth in
their market share of the prescription and over-the-counter drug business.

        The  Company's  Express  Photo  centers  compete with a variety of photo
processors including other mini-labs,  retail stores and photo specialty stores.
The Company's Express Photo business competes  primarily on the basis of quality
of processing, quality and speed of service and value.

Seasonality

        The Company's  sales and earnings are higher during peak holiday periods
and from  Christmas  through  Easter  in  selected  geographic  areas.  Sales of
health-related  products  peak during  seasonal  outbreaks of cough and cold/flu
virus, typically during the winter and spring.  Accordingly,  sales and earnings
are typically highest in the fourth quarter followed by the first quarter.

Regulation

        All of the Company's  pharmacists and stores are required to be licensed
by the  appropriate  state boards of  pharmacy.  The  Company's  drug stores and
distribution  centers  are also  registered  with the Federal  Drug  Enforcement
Administration. Most of the stores sell beer and wine and are subject to various
state and local liquor  licensing  requirements.  By virtue of these license and
registration requirements, the Company is obligated to observe certain rules and
regulations,  and a violation  of such rules and  regulations  could result in a
suspension or revocation of a license or registration.

        The Company  has a number of managed  care payor  contracts  pursuant to
which the Company is a provider of prescription drugs. "Freedom of choice" state
statutes,  pursuant to which all  pharmacies  would be entitled to be a provider
under such a contract,  have been enacted in certain states,  including Alabama,
Delaware, Georgia, Louisiana, Maryland, Mississippi, New Jersey, North Carolina,
South Carolina, Tennessee and Texas, and may be enacted in others. Although such
 
                                      8
<PAGE>

statutes may adversely  affect certain of the Company's  managed care contracts,
they may also  provide  the  Company  with  opportunities  regarding  additional
managed care contracts.

        In recent years, an increasing number of legislative proposals have been
introduced  or proposed in Congress  and in some state  legislatures  that would
effect major  changes in the health care  system,  either  nationally  or at the
state level. The Company cannot predict whether any federal or state health care
reform  legislation will eventually be passed,  and if so, the impact thereof on
the Company's  financial position or results of operations.  Health care reform,
if implemented,  could adversely affect the pricing of prescription drugs or the
amount of reimbursement from governmental  agencies and managed care payors, and
consequently could be adverse to the Company. However, to the extent health care
reform expands the number of persons receiving health care benefits covering the
purchase of  prescription  drugs,  it may also result in increased  purchases of
such drugs and could thereby have a favorable impact on both the Company and the
retail drug industry in general.  Nevertheless,  there can be no assurance  that
any future  federal or state health care reform  legislation  will not adversely
affect the Company or the retail drug store industry generally.

Employees

        As of February 3, 1996, the Company had approximately  44,600 employees,
of which 23,300 were  full-time  employees.  The Company  believes  that overall
employee relations are good. None of the Company's  employees are represented by
unions.

Patents, Trademarks and Tradenames

        No patent, trademark,  license, franchise or concession is considered to
be of material  importance  to the business of the Company  other than the trade
names under which the Company  operates  its retail  businesses,  including  the
Eckerd  name.  The  Company  also  holds  servicemarks  for  its  photofinishing
products, private label products and information systems.

Item 2. Properties

        The Company  conducts  substantially  all of its retail  businesses from
stores located in leased premises. Substantially all of these leases will expire
within the next twenty years. In the normal course of business,  however,  it is
expected that leases will be renewed through the exercise of existing options or
amendments,  or replaced by leases on other  properties.  Most of the  Company's
store  leases  provide for a fixed  minimum  rental  together  with a percentage
rental based on sales.

        The material office and distribution  center  properties owned or leased
by the Company at February 3, 1996 are as follows:
                                                              Owned or
    Location                                  Square Feet      Leased
    --------                                  -----------     --------
    Largo, Flor                                  488,000        Owned (1)
    Charlotte, North                             587,000        Owned
    Garland, Texas                               270,000        Owned
    Conroe, Texas                                345,000        Owned
    Orlando, Florida                             587,000       Leased (2)
    Newnan, Georg                                244,000        Owned (3)
    Hammond, Louisia                             185,000        Owned (3)(4)

                                       9
<PAGE>

 ------------------------------
 (1)   Includes the Company headquarters.
 (2)   In  January  1993  the  Company   assumed  a  lease  for  an  office  and
       distribution facility of approximately 587,000 square feet (lease expires
       2005).  The  Company's   existing   Orlando   facilities  and  the  Largo
       distribution  center  facility  were  consolidated  into the new facility
       during 1993.
 (3)   Construction was financed pursuant to revenue bond issues.  Because these
       properties are currently  leased subject to nominal purchase options with
       development  authorities which the Company  anticipates it will exercise,
       they are listed as owned by the Company.
 (4)   The  Company  closed  the  Hammond  distribution  center  and  previously
       subleased the former Hammond,  Louisiana office and distribution  center.
       The property has been listed for sale.

        The  Company  considers  that  all  property  owned  or  leased  is well
maintained and in good condition.

Item 3. Legal Proceedings

        In the ordinary course of its business, the Company and its subsidiaries
are parties to various legal  actions which the Company  believes are routine in
nature and  incidental  to the  operation of the business of the Company and its
subsidiaries.  The Company believes that the outcome of the proceedings to which
the Company and its subsidiaries  currently are parties will not have a material
adverse effect upon its operations or financial condition.

Item 4. Submission of Matters to a Vote of Security Holders

        No matters were submitted to a vote of security  holders during the last
quarter of the fiscal year ended February 3, 1996.

Executive Officers of the Registrant

        The name, age and office of the executive  officers of the Company as of
February 3, 1996 and certain  information  relating to their business experience
are set forth below:

Name                    Age      Position
- ----                    ---      --------    
Stewart Turley           61      Director, Chairman of the Board
Francis A. Newman        47      Director, President and Chief Executive Officer
James M. Santo           54      Executive Vice President/Administration and 
                                 Secretary
Samuel G. Wright         45      Executive Vice President and Chief Financial 
                                 Officer
Kenneth L. Flynn         51      Senior Vice President/Store Operations
Edward W. Kelly          50      Senior Vice President/Merchandising
Richard R. Powis         48      Senior Vice President/Pharmacy Services
Martin W. Gladysz        43      Vice President/Treasurer
Robert E. Lewis          35      Vice President/General Counsel and Assistant 
                                 Secretary
Thomas M. Nash           48      Vice President/Real Estate
N. John Simmons, Jr.     40      Vice President/Controller

        Mr.  Turley has served as  Chairman  of the Board of the  Company  since
1986.  He served as Chief  Executive  Officer  of the  Company  from 1986  until
February  1996 and as  President  of the Company  from 1986 until July 1993.  He
joined Old Eckerd in 1966 and served as Senior Vice  President  (1971-1974)  and
President  and Chief  Executive  Officer  (1974-1975)  prior to being elected to
Chairman  of the Board,  President  and Chief  Executive  Officer.  He is also a

                                       10
<PAGE>

director of Barnett Banks, Inc., Sprint Corporation and Springs Industries, Inc.
He has been a director  of the  Company  since  1986,  and was a director of Old
Eckerd between 1971 and 1986.

        Mr.  Newman  has been  Chief  Executive  Officer  of the  Company  since
February 1996. He is also President,  Chief Operating  Officer and a director of
the  Company,  positions  he has held  since July  1993.  Prior to  joining  the
Company, Mr. Newman served as President,  Chief Executive Officer and a director
of F&M  Distributors,  Inc. ("F&M"),  a drug store chain,  since 1986. F&M filed
bankruptcy  under  Chapter 11 of the United States  Bankruptcy  Code in December
1994.  Prior to joining F&M, he was the  Executive  Vice  President of Household
Merchandising,  Inc.,  a retail  firm,  from  1984 to 1986 and the  Senior  Vice
President of Merchandising for F.W. Woolworth, a retail firm, from 1980 to 1984.
Mr. Newman is also a director of FabriCenters of America, a retail firm.

        Mr. Santo was appointed Executive Vice  President/Administration  of the
Company   in   May   1995.    Prior   thereto   he   served   as   Senior   Vice
President/Administration  (February  1993)  and was  also  Vice  President/Legal
Affairs of the  Company,  a  position  he held for more than the past five years
prior to 1993.  In addition,  Mr. Santo was  appointed  Secretary of the Company
effective January 1, 1992.

        Mr.  Wright  was  appointed  Executive  Vice  President/Chief  Financial
Officer of the Company in May 1995.  Prior thereto he was appointed  Senior Vice
President and Chief  Financial  Officer in February 1995. Mr. Wright also served
as Senior Vice President/Finance from February 1993 until February 1995 and Vice
President and  Controller of the Company,  from  September  1988 until  February
1993.  Mr.  Wright  became a Vice  President  of the  Company in June  1986.  In
addition, Mr. Wright served as Vice President of Finance of Eckerd Drug Company,
formerly Old Eckerd's principal  subsidiary  ("Eckerd Drug Company") and now the
Company's principal division, since May 1985.

        Mr. Flynn was appointed  Senior Vice  President/Store  Operations of the
Company in December 1994. Prior to joining the Company,  Mr. Flynn was Executive
Vice President with the Thrifty/Payless drug chain in Portland, Oregon. Prior to
joining  Thrifty/Payless in August 1993, Mr. Flynn was employed by Lucky Stores,
Inc. for over 30 years, most recently as Senior Vice President/Store Operations.

        Mr.  Kelly was  appointed  Senior  Vice  President/Merchandising  of the
Company  in  February  1993.  Prior  thereto  he  served  as Vice  President  of
Merchandising of Eckerd Drug Company for more than the preceding five years.

        Mr. Powis was appointed Senior Vice  President/Pharmacy  Services of the
Company  in April  1995.  Prior to  joining  the  Company,  he was  Senior  Vice
President  Pharmacy Services for the American Board of Retired Persons ("AARP").
Prior to joining  AARP in  September  1994,  Mr.  Powis was employed for over 19
years by Hooks SupRx,  Inc.,  most  recently as Senior Vice  President  Pharmacy
Services.

        Mr. Gladysz was appointed Vice President/Treasurer of the Company in May
1994.   Prior  to  joining  the  Company,   Mr.   Gladysz  was  Executive   Vice
President/Treasurer  for Fortune  Bancorp,  a Florida  banking  organization,  a
position he held for more than the five years prior to 1994.

        Mr. Lewis was  appointed  Vice  President/General  Counsel and Assistant
Secretary of the Company in August 1994. He was a shareholder in the law firm of
Shackleford,  Farrior,  Stallings & Evans, P.A. in Tampa,  Florida, from January
1992 to August 1994 and was an  associate  at that firm for more than five years
prior thereto.

                                       11
<PAGE>

        Mr.  Nash was  appointed  Vice  President/Real  Estate of the Company in
August 1995.  Prior to joining the  Company,  he served as Vice  President  Real
Estate at  Checkers  Drive-In  Restaurants,  Inc.  from 1993  until  1995 and at
Morrison Restaurants, Inc. from 1990 until 1993.

        Mr.  Simmons was appointed Vice  President/Controller  of the Company in
August 1995. Prior to joining the Company,  Mr. Simmons served as Vice President
of Finance and Chief Financial  Officer of Checkers Drive-In  Restaurants,  Inc.
from January 1993 until August  1995.  Prior  thereto,  he was a partner at KPMG
Peat Marwick LLP for more than the preceding five years.

        Officers  are elected for a one-year  term by the Board of  Directors at
its  annual  meeting.  There  is no  family  relationship  between  any  of  the
aforementioned officers or directors of the Company.


                                    PART II

Item 5.Market for the Registrant's Common Equity and Related Stockholder Matters

        The  Company's  common  stock is listed on the New York  Stock  Exchange
(Symbol:  ECK). The  approximate  number of  shareholders of record on March 29,
1996 was 965. All market price per share  information below has been restated to
reflect a  two-for-one  stock  split  effected  in the form of a stock  dividend
declared April 1, 1996 (payable on or about May 13, 1996).

                                              Fiscal 1995
                                             Quarter Ended
    Market Price                             ------------- 
Per Share Information     4/29/95        7/29/95       10/28/95        2/3/96
- ---------------------     -------        -------       --------        ------
        High               15.12          17.31          21.00         22.37
        Low                12.25          14.19          16.31         19.06
                                             
                                              Fiscal 1994
                                             Quarter Ended       
    Market Price                             -------------
Per Share Information     4/30/94        7/30/94       10/29/94       1/28/95
- ---------------------     -------        -------       --------       -------
        High               12.00          12.62          15.75         16.00
        Low                 9.25           9.06          11.62         12.69


        The  Company  is  subject  to  restrictive  covenants  under its  Credit
Agreement and the 9 1/4% Senior Subordinated Notes which restrict the payment of
dividends.  The  Company has not paid or declared  any  dividends  on its common
stock.

Item 6. Selected Financial Data

        The selected financial  information required by this item is included in
the Company's  1995 annual report to  stockholders  on page 11 under the heading
"Five Year Financial Operating Summary." Such information is incorporated herein
by reference.  The ratio of earnings to fixed charges was 2.1X, 1.7X and 1.0X in
fiscal 1995, 1994 and 1991, respectively.  In fiscal 1993 and 1992 earnings were
inadequate to cover fixed charges,  and the Company had a deficiency in earnings
to fixed  charges  of  $2,941,000  and  $4,123,000  in  fiscal  1993  and  1992,
respectively.

                                       12
<PAGE>

Item 7. Management's   Discussion  and  Analysis  of  Financial  Condition   and
        Results of Operations

        The information  required by this item is included in the Company's 1995
annual  report  to  stockholders  on  pages 12  through  15  under  the  heading
"Management's  Discussion  and Analysis of Results of  Operations  and Financial
Condition." Such information is incorporated herein by reference.


Item 8. Financial Statements and Supplementary Data

        The following  consolidated  financial statements as of February 3, 1996
and January  28,  1995 and for each of the years in the three year period  ended
February 3, 1996 included in the Company's 1995 annual report to stockholders on
pages 16 through 27 are incorporated herein by reference:

        Consolidated Statements of Operations
        Consolidated Balance Sheets
        Consolidated Statements of Stockholders' Equity (Deficit)
        Consolidated Statements of Cash Flows
        Notes to Consolidated Financial Statements

        Information on selected  quarterly  financial data also required by this
item is included in the Company's 1995 annual report to  stockholders on page 30
under the heading  "Quarterly  Information  (Unaudited)."  Such  information  is
incorporated herein by reference.

Item 9. Changes  in  and  Disagreements  with   Accountants  on  Accounting  and
        Financial Disclosure

        Not applicable.
                                    PART III

Item 10. Directors and Executive Officers of the Registrant

        Information required by this item regarding the directors of the Company
is included in the Company's definitive proxy statement dated April 23, 1996 for
the 1996 annual meeting of  stockholders on pages 2 through 4 under the headings
"Nominees  For Election of Directors In Class III With Terms  Expiring in 1999";
"Directors  in Class I With Terms  Expiring in 1997" and  "Directors in Class II
With  Terms  Expiring  in 1998."  Such  information  is  incorporated  herein by
reference. Information required by this item regarding executive officers of the
Company  is  contained  in Part I of this  Form  10-K  under  the item  entitled
"Executive  Officers  of the  Registrant."  Information  required  by this  item
regarding  compliance  with Section 16(a) of the Exchange Act is included in the
Company's  definitive  proxy  statement dated April 23, 1996 for the 1996 annual
meeting of  stockholders  on page 5 under the  heading  "Security  Ownership  of
Certain Persons." Such information is incorporated herein by reference.

Item 11. Executive Compensation

        Information  regarding  management   remuneration  is  included  in  the
Company's  definitive  proxy  statement dated April 23, 1996 for the 1996 annual
meeting of  stockholders  on pages 1 and 2, and 7 through 13 under the  headings

                                       13
<PAGE>

"Nomination  and  Election of  Directors"  and  "Executive  Compensation."  Such
information is incorporated herein by reference.


Item 12. Security Ownership of Certain Beneficial Owners and Management

        Information  regarding  security  ownership of certain beneficial owners
and of management is included in the Company's  definitive proxy statement dated
April 23,  1996 for the 1996  annual  meeting of  stockholders  on pages 5 and 6
under the heading  "Security  Ownership Of Certain Persons." Such information is
incorporated herein by reference.


Item 13. Certain Relationships and Related Transactions

        Information  regarding certain relationships and related transactions is
included in the Company's  definitive  proxy  statement dated April 23, 1996 for
the 1996 annual  meeting of  stockholders  on pages 12 and 16 under the headings
"Executive   Compensation  -  Compensation   Committee  Interlocks  and  Insider
Participation"  and "Certain  Transactions."  Such  information is  incorporated
herein by reference.


                                     PART IV

Item 14. Exhibits, Financial Statement Schedules,  and Reports on Form 8-K

        Listed  below  are  all  financial  statements,  notes,  schedules,  and
exhibits filed as part of this Form 10-K annual report:

         (a)   Financial Statements and Schedules

         1. The  following  financial  statements  and  schedules of the Company
         together with the Report of Independent  Certified  Public  Accountants
         dated March 26, 1996 in this Form 10-K are filed herewith:

         Eckerd Corporation and Subsidiaries

         Financial Statements:
                 Independent Auditors' Report
                 Consolidated  Balance Sheets as of February 3, 1996 and January
                           28, 1995
                 Consolidated  Statements  of  Operations  for the  Years  Ended
                           February  3, 1996,  January  28, 1995 and January 29,
                           1994
                 Consolidated Statements of  Stockholders'  Equity (Deficit) for
                           the Years Ended  February  3, 1996,  January 28, 1995
                           and January 29, 1994
                 Consolidated  Statements  of Cash  Flows  for the  Years  Ended
                           February  3, 1996,  January  28, 1995 and January 29,
                           1994
                 Notes to Consolidated Financial Statements

          Schedules:
                 II - Reserves
                 Independent Auditors' Report

                                       14
<PAGE>

                 All other schedules for the Company are omitted as the required
          information  is  inapplicable  or the  information is presented in the
          respective consolidated financial statements or related notes.

                 Also  filed  in this  Form  10-K is the  consent  of KPMG  Peat
          Marwick  LLP to the  incorporation  by  reference  of their  auditors'
          report dated March 26, 1996,  relating to the  consolidated  financial
          statements  appearing in the Form 10-K,  into  Registration  Statement
          Numbers  33-49977,  33-50755 and 33-60175 on Form S-8 and Registration
          Statement Numbers 33-50223 and 33-56261 on Form S-3.

          2.  Exhibits:

          Exhibits previously filed or filed by incorporation by reference:

  3.1     Restated  Certificate  of  Incorporation  of Eckerd  Corporation  (the
          "Company")  (incorporated  by  reference  to  Exhibit  3.1(i)  to  the
          Registration Statement on Form S-3 of the Company (No. 33-50223)).

  4.1     Form of certificate for the Company's Common Stock, par value $.01 per
          share  (incorporated  by reference to Exhibit 4.1 to the  Registration
          Statement on Form S-2 of the Company (No. 33-64906)).

  4.2     Form of  9-1/4%  Senior  Subordinated  Notes  Due 2004 of the  Company
          (incorporated  by reference  to Exhibit 4.01 to the Current  Report on
          Form 8-K dated October 26, 1993 of the Company (File No. 1-4844)).

  4.3     Indenture  dated as of November 1, 1993  between the Company and State
          Street Bank and Trust Company of Connecticut, National Association, as
          Trustee relating to the Company's 9-1/4% Senior Subordinated Notes Due
          2004  (incorporated by reference to Exhibit 4.02 to the Current Report
          on Form 8-K dated October 26, 1993 of the Company (File No. 1-4844)).

  4.4     Amendment  Agreement  dated  as of  November  29,  1995 to the  Credit
          Agreement  dated as of June 14,  1993,  as amended and  restated as of
          August 3, 1994, among the Company, the lenders named therein, Chemical
          Bank  and  NationsBank  of  Florida,  N.A.,  as  managing  agents  and
          swingline  lenders,  and  Chemical  Bank as  administrative  agent and
          NationsBank of Florida,  N.A. as documentation  agent (incorporated by
          reference to Exhibit 4.4 to the Registration  Statement on Form S-3 of
          the Company (No. 33-64409)).

 10.1     Commercial  Paper  Placement  Agency  Agreement  dated  July 17,  1989
          between   the  Company  and   Merrill   Lynch  Money   Markets,   Inc.
          (incorporated  by  reference  to  Exhibit  10.15  of Form  10-K of the
          Company for the period ended February 3, 1990).

 10.2     Registration  Rights Agreement dated as of April 30, 1986 by and among
          the Company,  the Merrill Lynch Investors,  Morgan Capital Corporation
          and the other bank affiliates  listed therein,  the  institutional and
          corporate  investors  listed therein and certain members of management
          of the Company  (incorporated  by  reference  to Exhibit  10.19 to the
          Registration Statement on Form S-2 of the Company (No. 33-64906)).

                                       15
<PAGE>

 10.3     First  Amendment to Registration  Rights  Agreement among the Company,
          EDS Holdings Inc., the Merrill Lynch  Investors,  the Bank Affiliates,
          the Institutional Investors and the Management Investors (incorporated
          by reference to Exhibit 10.20 to Amendment  No. 1 to the  Registration
          Statement on Form S-2 of the Company (No.
          33-64906)).

 10.4     Master Lease  Agreement I dated as of May 18, 1993 between the Company
          and Imaging  Financial  Services d/b/a EKCC ("IFS")  (incorporated  by
          reference  to Exhibit  10.28 to  Amendment  No. 1 to the  Registration
          Statement on Form S-2 of the Company (No. 33-64906)).

 10.5     Master  Lease  Agreement  II  dated as of June 15,  1993  between  the
          Company  and IFS  (incorporated  by  reference  to  Exhibit  10.29  to
          Amendment  No.  1 to the  Registration  Statement  on Form  S-2 of the
          Company (No. 33-64906)).

 10.6     Systems Operations Service Agreement dated as of July 14, 1993 between
          the Company and Integrated Systems Solutions Corporation (incorporated
          by reference to Exhibit 10.30 to Amendment  No. 1 to the  Registration
          Statement on Form S-2 of the Company (No. 33-64906))

 10.7     Letter  dated March 16, 1993  between IFS and the Company  relating to
          IFS Sale and Leaseback  (incorporated by reference to Exhibit 10.31 to
          Amendment  No.  2 of the  Registration  Statement  on Form  S-2 of the
          Company (No. 33-64906)).

 10.8     1993 Stock Option and Incentive Plan of the Company  (incorporated  by
          reference to Exhibit 99.1 to the Registration Statement on Form S-8 of
          the Company (No. 33-49977)).

 10.9     1995 Stock Option and Incentive Plan of the Company  (incorporated  by
          reference to Exhibit 99.1 to the Registration Statement on Form S-8 of
          the Company (No. 33-60175)).

 10.10    Receivables  Purchase  Agreement  dated as of January 26, 1995 between
          the Company and Three  Rivers  Funding  Corporation  (incorporated  by
          reference to Exhibit  10.18 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No. 1-4844)).

 10.11    First  Amendment to Receivables  Purchase  Agreement dated as of March
          31, 1995  between the Company  and Three  Rivers  Funding  Corporation
          (incorporated  by reference  to Exhibit  10.19 to Form 10-K405 for the
          year ended January 28, 1995 of the Company (File No. 1-4844)).

 10.12    Registration  Rights  Agreement  dated as of December  31, 1994 by and
          among the  Company  and the Eckerd  Corporation  Profit  Sharing  Plan
          (incorporated  by reference  to Exhibit  10.20 to Form 10-K405 for the
          year ended January 28, 1995 of the Company (File No. 1-4844)).

 10.13    Guarantee  Agreement dated as of June 14, 1993 as amended and restated
          as  of  August  3,  1994  (the   "Guarantee   Agreement")   among  the
          subsidiaries  of the Company  listed  therein and  Chemical  Bank,  as
          collateral  agent  (incorporated by reference to Exhibit 10.21 to Form
          10-K405 for the year ended  January 28, 1995 of the Company  (File No.
          1-4844)).

 10.14    Indemnity, Subrogation and Contribution Agreement dated as of June 14,
          1993 as amended  and  restated  as of August 3, 1994 (the  "Indemnity,
          Subrogation  and  Contribution  Agreement"),  among the Company,  each
          subsidiary  of the  Company  listed  therein  and  Chemical  Bank,  as
          collateral  agent  (incorporated by reference to Exhibit 10.22 to Form
          10-K405 for the year ended  January 28, 1995 of the Company  (File No.
          1-4844)).

                                       16
<PAGE>

 10.15    Pledge  Agreement dated as of June 14, 1993 as amended and restated as
          of August 3, 1994 among the Company, each subsidiary of the Registrant
          listed therein and Chemical Bank, as collateral agent (incorporated by
          reference to Exhibit  10.23 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No.
          1-4844)).

 10.16    Security  Agreement  dated as of June 14, 1993 as amended and restated
          as of August 3, 1994 among the Company, each subsidiary of the Company
          listed therein and Chemical Bank, as collateral agent (incorporated by
          reference to Exhibit  10.24 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No.
          1-4844)).

 10.17    Trademark  Security Agreement dated as of June 14, 1993 as amended and
          restated as of August 3, 1994 among the Company,  each  subsidiary  of
          the Company  listed  therein and Chemical  Bank, as  collateral  agent
          (incorporated  by reference  to Exhibit  10.25 to Form 10-K405 for the
          year ended January 28, 1995 of the Company (File No.
          1-4844)).

 10.18    Revolving  Note,  dated as of August 3, 1994,  made by the  Company in
          favor  of  Chemical  Bank  issued  pursuant  to the  Credit  Agreement
          (incorporated  by reference  to Exhibit  10.26 to Form 10-K405 for the
          year ended January 28, 1995 of the Company (File No. 1-4844)).

 10.19    Term Note, dated as of August 3, 1994, made by the Company in favor of
          Chemical Bank issued pursuant to the Credit Agreement (incorporated by
          reference to Exhibit  10.27 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No. 1-4844)).

 10.20    Swingline  Note,  dated as of August 3, 1994,  made by the  Company in
          favor  of  Chemical  Bank  issued  pursuant  to the  Credit  Agreement
          (incorporated  by reference  to Exhibit  10.28 to Form 10-K405 for the
          year ended January 28, 1995 of the Company (File No. 1-4844)).

 10.21    Deed of Trust,  Security  Agreement and Assignment of Leases and Rents
          dated as of June 14,  1993,  as amended  and  restated as of August 3,
          1994, by the Company in favor of Kenneth Plifka,  as trustee,  for the
          benefit of Chemical  Bank,  as collateral  agent,  relating to certain
          real  property  located  in  Dallas  County,  Texas  (incorporated  by
          reference to Exhibit  10.29 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No. 1-4844)).

 10.22    Deed of Trust,  Security  Agreement and Assignment of Leases and Rents
          dated as of June 14,  1993,  as amended  and  restated as of August 3,
          1994, by the Company in favor of Kenneth Plifka,  as trustee,  for the
          benefit of Chemical  Bank,  as collateral  agent,  relating to certain
          real property  located in Montgomery  County,  Texas  (incorporated by
          reference to Exhibit  10.30 to Form 10-K405 for the year ended January
          28, 1995 of the Company (File No. 1-4844)).

 10.23    Amendment,  Consent  and Waiver  dated as of October  31,  1994 to the
          Credit Agreement, the Guarantee Agreement, the Indemnity,  Subrogation
          and Contribution Agreement (incorporated by reference to Exhibit 10.31
          to Form  10-K405  for the year ended  January  28, 1995 of the Company
          (File No. 1-4844)).

 10.24    Amended and Restated  Mortgage,  Security  Agreement and Assignment of
          Leases and Rents dated as of August 3, 1994, as mortgagor and Chemical
          Bank, as mortgagee (incorporated by reference to Exhibit 10.32 to Form
          10-K405 for the year ended  January 28, 1995 of the Company  (File No.
          1-4844)).

                                       17
<PAGE>

 12.1     Statement regarding  computation of ratio of earnings to fixed charges
          of the  Company  (incorporated  by  reference  to Exhibit  12.1 to the
          Registration Statement on Form S-3 of the Company (No. 33-50223)).

          Exhibits filed herewith:

  3.2     Amended and Restated By-Laws of the Company.

 10.25    Employment and Consulting Agreement dated February 4, 1996 between the
          Company and Stewart Turley.

 10.26    Employment  Agreement  dated  February 4, 1996 between the Company and
          Francis A. Newman.

 10.27    Employment  Agreement  dated  February 4, 1996 between the Company and
          James M. Santo.

 10.28    Employment  Agreement  dated  February 4, 1996 between the Company and
          Samuel G. Wright.

 10.29    Employment  Agreement  dated  February 4, 1996 between the Company and
          Kenneth L. Flynn.

 10.30    The Executive  Excess Benefit Plan of Jack Eckerd  Corporation and Its
          Subsidiaries.

 10.31    Eckerd Corporation Executive Three (3) Year Bonus Plan.

 12.2     Statement regarding  computation of ratio of earnings to fixed charges
          of the Company.

 13       The following  sections of the 1995 annual report to  stockholders  of
          the Company  incorporated by reference and included in Parts II and IV
          of this Form 10-K:


          Five Year Financial Operating Summary.
          Management's  Discussion  and  Analysis of Results of  Operations  and
          Financial Condition.
          Consolidated Financial Statements and Independent Auditors' Report.
          Quarterly Information (Unaudited).

 21.1     Subsidiaries of the Company.

 23.1     Consent of Independent Certified Public Accountants.

 27       Financial data schedules.

         (b) Reports on Form 8-K

        The  Company  did not file any  reports on Form 8-K during the  fourteen
weeks ended February 3, 1996.

                                       18
<PAGE>


                                   SIGNATURES

        Pursuant to the  requirements  of Section 13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this Form 10-K report to be
signed on its behalf by the undersigned, thereunto duly authorized.

April 30, 1996                      ECKERD CORPORATION


                                    By:/s/Samuel G. Wright
                                    ----------------------------------------
                                                Samuel G. Wright
                                            Executive Vice President
                                     Chief Financial and Accounting Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following  persons on behalf of the  Registrant and
in the capacities indicated on the date indicated.

       Signature                              Titles                  Date
       ---------                              ------                  ----
/s/Stewart Turley
- ----------------------------------
       Stewart Turley                 Chairman of the Board       April 30, 1996

/s/Francis A. Newman
- ----------------------------------
       Francis A. Newman              President, Chief Executive 
                                      Officer and Director        April 30, 1996
/s/John W. Boyle
- ----------------------------------
       John W. Boyle                  Director                    April 30, 1996

/s/James T. Doluisio
- ----------------------------------
       James T. Doluisio              Director                    April 30, 1996

/s/Donald F. Dunn
- ----------------------------------
       Donald F. Dunn                 Director                    April 30, 1996

/s/Albert J. Fitzgibbons, III
- ----------------------------------
       Albert J. Fitzgibbons, III     Director                    April 30, 1996

/s/Margaret H. Jordan
- ----------------------------------
       Margaret H. Jordan             Director                    April 30, 1996

/s/Lewis W. Lehr
- ----------------------------------
       Lewis W. Lehr                  Director                    April 30, 1996

/s/Alexis P. Michas
- ----------------------------------
       Alexis P. Michas               Director                    April 30, 1996

/s/Rupinder S. Sidhu
- ----------------------------------
       Rupinder S. Sidhu              Director                    April 30, 1996

                                       19
<PAGE>
 

<TABLE>
<CAPTION>
                                                                                           
                                                                                              Schedule II


                                           ECKERD CORPORATION AND SUBSIDIARIES
                                                         RESERVES
                           Years ended February 3, 1996, January 28, 1995 and January 29, 1994
                                                      (In Thousands)



                                             Balance at     Charged                              Balance at
                                              Beginning       to                                     End
    Description                               of Period    earnings     Deductions     Other      of Period

    <S>                                        <C>          <C>           <C>        <C>           <C>
    Allowance for doubtful receivables (a)
      Year ended February 3, 1996              $3,000       $4,564        $4,564         -         $3,000
                                               ======       ======        ======     ==========    ======
                                                                                         
      Year ended January 28, 1995              $5,000       $7,148        $4,924       ($4,224)    $3,000
                                               ======       ======        ======     ==========    ======
      Year ended January 29, 1994              $5,000       $7,000        $7,000         -         $5,000
                                               ======       ======        ======     ==========    ======
</TABLE>

- --------------
Notes:
(a)  This reserve is deducted from receivables in the balance sheets.



                         Independent Auditors' Report
                         ----------------------------


The Board of Directors
Eckerd Corporation and Subsidiaries

Under date of March 26, 1996, we reported on the consolidated  balance sheets of
Eckerd Corporation and subsidiaries as of February 3, 1996 and January 28, 1995,
and the related  consolidated  statements of  operations,  stockholders'  equity
(deficit),  and cash flows for each of the years in the three-year  period ended
February 3, 1996,  which are  incorporated  by  reference  in the Form 10-K.  In
connection  with  our  audits  of  the  aforementioned   consolidated  financial
statements,  we  also  audited  the  related  consolidated  financial  statement
schedule  in  the  Form  10-K.   This  financial   statement   schedule  is  the
responsibility of the Company's management.  Our responsibility is to express an
opinion on this financial statement schedule based on our audits.

In our opinion,  such financial statement schedule,  when considered in relation
to the  basic  consolidated  financial  statements  taken as a  whole,  presents
fairly, in all material respects, the information set forth therein.

As discussed in note 9 to the  consolidated  financial  statements,  the Company
changed its  accounting  policy in fiscal year 1994 related to the timing of the
recognition of closed store obligations.




                                             KPMG PEAT MARWICK LLP

Tampa, Florida
March 26, 1996

<PAGE>


                             Exhibit Index
                     Eckerd Corporation Form 10-K
              for the Fiscal Year Ended February 3, 1996

Exhibit                                                                  Page
 Index                  Description of Exhibit                          Number
- -------                 ----------------------                          ------
3.1    Restated  Certificate of  Incorporation  of Eckerd  Corporation     *
       (the "Company")  (incorporated by * reference to Exhibit 3.1(i)
       to the  Registration  Statement on Form S-3 of the Company (No.
       33-50223)).

3.2    Amended and Restated By-laws of the Company.

4.1    Form of certificate for the Company's  Common Stock,  par value     *
       $.01 per share  (incorporated  by * reference to Exhibit 4.1 to
       the  Registration  Statement  on Form S-2 of the  Company  (No.
       33-64906)).

4.2    Form  of 9 1/4%  Senior  Subordinated  Notes  Due  2004  of the     * 
       Company  (incorporated  by  reference * to Exhibit  4.01 to the
       Current  Report  on Form  8-K  dated  October  26,  1993 of the
       Company (File No. 1-4844)).

4.3    Indenture  dated as of November 1, 1993 between the Company and     *
       State Street Bank and Trust * Company of Connecticut,  National
       Association, as Trustee relating to the Company's 9 1/4% Senior
       Subordinated  Notes  Due 2004  (incorporated  by  reference  to
       Exhibit  4.02 to the Current  Report on Form 8-K dated  October
       26, 1993 of the Company (File No. 1-4844)).

4.4    Amendment Agreement dated as of November 29, 1995 to the Credit     *
       Agreement  dated as of June * 14, 1993, as amended and restated
       as of August 3, 1994,  among the  Company,  the  lenders  named
       therein,  Chemical Bank and  NationsBank  of Florida,  N.A., as
       managing  agents and  swingline  lenders,  and Chemical Bank as
       administrative  agent  and  NationsBank  of  Florida,  N.A.  as
       documentation  agent  (incorporated by reference to Exhibit 4.4
       to the  Registration  Statement on Form S-3 of the Company (No.
       33-64409)).

10.1   Commercial Paper Placement Agency Agreement dated July 17, 1989     *
       between  the Company and * Merrill  Lynch Money  Markets,  Inc.
       (incorporated by reference to Exhibit 10.15 of Form 10-K of the
       Company for the period ended February 3, 1990).

10.2   Registration Rights Agreement dated as of April 30, 1986 by and     *
       among  the  Company,  the *  Merrill  Lynch  Investors,  Morgan
       Capital  Corporation  and  the  other  bank  affiliates  listed
       therein,  the  institutional  and  corporate  investors  listed
       therein  and  certain  members  of  management  of the  Company
       (incorporated by reference to Exhibit 10.19 to the Registration
       Statement on Form S-2 of the Company (No. 33-64906)).

10.3   First  Amendment to  Registration  Rights  Agreement  among the     *
       Company, EDS Holdings Inc., the * Merrill Lynch Investors,  the
       Bank Affiliates, the Institutional Investors and the Management
       Investors  (incorporated  by  reference  to  Exhibit  10.20  to
       Amendment  No. 1 to the  Registration  Statement on Form S-2 of
       the Company (No. 33-64906)).

10.4   Master  Lease  Agreement I dated as of May 18, 1993 between the     *
       Company and Imaging  Financial  * Services  d/b/a EKCC  ("IFS")
       (incorporated  by reference to Exhibit 10.28 to Amendment No. 1
       to the  Registration  Statement on Form S-2 of the Company (No.
       33-64906)).
<PAGE>

10.5   Master Lease Agreement II dated as of June 15, 1993 between the     *
       Company and IFS  (incorporated  * by reference to Exhibit 10.29
       to Amendment No. 1 to the Registration Statement on Form S-2 of
       the Company (No. 33-64906)).

10.6   Systems  Operations Service Agreement dated as of July 14, 1993     *
       between  the  Company  and  *  Integrated   Systems   Solutions
       Corporation  (incorporated  by  reference  to Exhibit  10.30 to
       Amendment  No. 1 to the  Registration  Statement on Form S-2 of
       the Company (No. 33-64906)).

10.7   Letter  dated  March  16,  1993  between  IFS and  the  Company     *
       relating to IFS Sale and Leaseback * (incorporated by reference
       to  Exhibit  10.31  to  Amendment  No.  2 of  the  Registration
       Statement on Form S-2 of the Company (No. 33-64906)).

10.8   1993  Stock   Option  and   Incentive   Plan  of  the   Company     *
       (incorporated   by   reference   to   Exhibit  *  99.1  to  the
       Registration   Statement  on  Form  S-8  of  the  Company  (No.
       33-49977)).

10.9   1995  Stock   Option  and   Incentive   Plan  of  the   Company     *
       (incorporated   by   reference   to   Exhibit  *  99.1  to  the
       Registration   Statement  on  Form  S-8  of  the  Company  (No.
       33-60175)).

10.10  Receivables  Purchase  Agreement  dated as of January  26, 1995     *
       between  the  Company  and Three * Rivers  Funding  Corporation
       (incorporated by reference to Exhibit 10.18 to Form 10-K405 for
       the year  ended  January  28,  1995 of the  Company  (File  No.
       1-4844)).

10.11  First Amendment to Receivables  Purchase  Agreement dated as of     *
       March 31, 1995 between the * Company and Three  Rivers  Funding
       Corporation (incorporated by reference to Exhibit 10.19 to Form
       10-K405  for the year ended  January  28,  1995 of the  Company
       (File No. 1-4844)).

10.12  Registration  Rights Agreement dated as of December 31, 1994 by     *
       and  among  the  Company  and the * Eckerd  Corporation  Profit
       Sharing Plan  (incorporated  by  reference to Exhibit  10.20 to
       Form 10-K405 for the year ended January 28, 1995 of the Company
       (File No. 1-4844)).

10.13  Guarantee  Agreement  dated as of June 14,  1993 as amended and     *
       restated  as of August 3,  1994 * (the  "Guarantee  Agreement")
       among  the  subsidiaries  of the  Company  listed  therein  and
       Chemical Bank, as collateral  agent  (incorporated by reference
       to Exhibit 10.21 to Form 10-K405 for the year ended January 28,
       1995 of the Company (File No. 1-4844)).

10.14  Indemnity,  Subrogation and Contribution  Agreement dated as of     *
       June 14,  1993 as amended  and * restated  as of August 3, 1994
       (the  "Indemnity,  Subrogation  and  Contribution  Agreement"),
       among  the  Company,  each  subsidiary  of the  Company  listed
       therein and Chemical Bank, as collateral agent (incorporated by
       reference  to Exhibit  10.22 to Form 10-K405 for the year ended
       January 28, 1995 of the Company (File No. 1-4844)).

10.15  Pledge  Agreement  dated as of June  14,  1993 as  amended  and     *
       restated  as of  August  3,  1994  among  * the  Company,  each
       subsidiary of the Registrant  listed therein and Chemical Bank,
       as collateral agent (incorporated by reference to Exhibit 10.23
       to Form  10-K405  for the year ended  January  28,  1995 of the
       Company (File No. 1-4844)).
<PAGE>

10.16  Security  Agreement  dated as of June 14,  1993 as amended  and     *
       restated  as of  August  3,  1994 *  among  the  Company,  each
       subsidiary of the Company  listed therein and Chemical Bank, as
       collateral agent (incorporated by reference to Exhibit 10.24 to
       Form 10-K405 for the year ended January 28, 1995 of the Company
       (File No. 1-4844)).

10.17  Trademark  Security  Agreement  dated  as of June  14,  1993 as     *
       amended and  restated as of August * 3, 1994 among the Company,
       each  subsidiary  of the Company  listed  therein and  Chemical
       Bank, as collateral agent (incorporated by reference to Exhibit
       10.25 to Form  10-K405  for the year ended  January 28, 1995 of
       the Company (File No. 1-4844)).

10.18  Revolving Note, dated as of August 3, 1994, made by the Company     *
       in  favor of  Chemical  Bank * issued  pursuant  to the  Credit
       Agreement  (incorporated  by reference to Exhibit 10.26 to Form
       10-K405  for the year ended  January  28,  1995 of the  Company
       (File No. 1-4844)).

10.19  Term Note,  dated as of August 3, 1994,  made by the Company in     *
       favor  of  Chemical  Bank  issued  *  pursuant  to  the  Credit
       Agreement  (incorporated  by reference to Exhibit 10.27 to Form
       10-K405  for the year ended  January  28,  1995 of the  Company
       (File No. 1-4844)).

10.20  Swingline Note, dated as of August 3, 1994, made by the Company     *
       in  favor of  Chemical  Bank * issued  pursuant  to the  Credit
       Agreement  (incorporated  by reference to Exhibit 10.28 to Form
       10-K405  for the year ended  January  28,  1995 of the  Company
       (File No. 1-4844)).

10.21  Deed of Trust,  Security Agreement and Assignment of Leases and     *
       Rents dated as of June 14, * 1993,  as amended and  restated as
       of August 3, 1994,  by the Company in favor of Kenneth  Plifka,
       as trustee,  for the benefit of Chemical  Bank,  as  collateral
       agent,  relating  to certain  real  property  located in Dallas
       County,  Texas  (incorporated  by reference to Exhibit 10.29 to
       Form 10-K405 for the year ended January 28, 1995 of the Company
       (File No. 1-4844)).

10.22  Deed of Trust,  Security Agreement and Assignment of Leases and     *
       Rents dated as of June 14, * 1993,  as amended and  restated as
       of August 3, 1994,  by the Company in favor of Kenneth  Plifka,
       as trustee,  for the benefit of Chemical  Bank,  as  collateral
       agent,  relating to certain real property located in Montgomery
       County,  Texas  (incorporated  by reference to Exhibit 10.30 to
       Form 10-K405 for the year ended January 28, 1995 of the Company
       (File No. 1-4844)).

10.23  Amendment,  Consent and Waiver  dated as of October 31, 1994 to     *
       the Credit Agreement, the * Guarantee Agreement, the Indemnity,
       Subrogation  and   Contribution   Agreement   (incorporated  by
       reference  to Exhibit  10.31 to Form 10-K405 for the year ended
       January 28, 1995 of the Company (File 1-4844)).

10.24  Amended  and  Restated   Mortgage,   Security   Agreement   and     *
       Assignment of Leases and Rents dated as * of August 3, 1994, as
       mortgagor  and Chemical  Bank,  as mortgagee  (incorporated  by
       reference  to Exhibit  10.32 to Form 10-K405 for the year ended
       January 28, 1995 of the Company (File 1-4844)).

10.25  Employment  and  Consulting  Agreement  dated  February 4, 1996
       between the Company and Stewart Turley.

10.26  Employment Agreement dated February 4, 1996 between the Company
       and Francis A. Newman.
<PAGE>

10.27  Employment Agreement dated February 4, 1996 between the Company
       and James M. Santo.

10.28  Employment Agreement dated February 4, 1996 between the Company
       and Samuel G. Wright.

10.29  Employment Agreement dated February 4, 1996 between the Company
       and Kenneth L. Flynn.

10.30  The Executive  Excess  Benefit Plan of Jack Eckerd  Corporation
       and Its Subsidiaries.

10.31  Eckerd Corporation Executive Three (3) Year Bonus Plan.

12.1   Statement  regarding  computation of ratio of earnings to fixed     *
       charges of the Company * (incorporated  by reference to Exhibit
       12.1 to the  Registration  Statement on Form S-3 of the Company
       (No. 33-50223).

12.2   Statement  regarding  computation of ratio of earnings to fixed
       charges of the Company.

13     The   following   sections  of  the  1995   annual   report  to     *
       stockholders  of the Company  incorporated  * by reference  and
       included in Parts II and IV of this Form 10-K:

       Five Year Financial Operating Summary.
       Management's  Discussion  and Analysis of Results of Operations
       and Financial Condition.
       Consolidated  Financial  Statements and  Independent  Auditors'
       Report.
       Quarterly Information (Unaudited).

21.1   Subsidiaries of the Company.

23.1   Consent of Independent Certified Public Accountants.

27     Financial data schedules.
- ------------------------------
*  Filed by incorporation by reference.









                                                                   EXHIBIT 3.2


                              AMENDED AND RESTATED
                                     BY-LAWS
                                       OF
                               ECKERD CORPORATION
                     (hereinafter called the "Corporation")
                            (As of February 8, 1996)

                                    ARTICLE I
                                     OFFICES

          Section 1. Registered Office. The registered office of the Corporation
shall be in the City of Wilmington,  County of New Castle, State of Delaware.
          Section 2. Other  Offices.  The  Corporation  may also have offices at
such other  places both within and without the State of Delaware as the Board of
Directors may from time to time determine.

                                   ARTICLE II
                            MEETINGS OF STOCKHOLDERS

          Section 1. Place of  Meetings.  Meetings of the  stockholders  for the
election of  directors or for any other  purpose  shall be held at such time and
place,  either  within or without the State of  Delaware as shall be  designated
from  time to time by the Board of  Directors  and  stated in the  notice of the
meeting or in a duly executed waiver of notice thereof.
          Section 2. Annual Meetings.  The Annual Meetings of Stockholders shall
be held on such date and at such time as shall be  designated  from time to time
by the Board of  Directors  and  stated in the notice of the  meeting,  at which
meetings the stockholders  shall elect by a plurality vote a Board of Directors,
and transact such other  business as may properly be brought before the meeting.
Written  notice of the Annual  meeting  stating the place,  date and hour of the
meeting shall be given to each stockholder  entitled to vote at such meeting not
less than ten nor more than sixty days before the date of the meeting.
          Section 3. Special Meetings.  Unless otherwise prescribed by law or by
the Certificate of  Incorporation,  Special  Meetings of  Stockholders,  for any
purpose or purposes,  may be called by either the Chairman, if there be one, the
President  or the  Secretary  and shall be called by either such  officer at the
request in writing of a majority of the Board of  Directors or at the request in
writing  of  stockholders  owning  a  majority  of  the  capital  stock  of  the
Corporation  issued and  outstanding  and entitled to vote.  Such request  shall
state the purpose or  purposes  of the  proposed  meeting.  Written  notice of a
Special Meeting stating the place,  date and hour of the meeting and the purpose
or purposes for which the meeting is called shall be given not less than ten nor
more than sixty days before the date of the meeting to each stockholder entitled
to vote at such meeting and only such business as is stated in such notice shall
be acted thereat.
           Section 4. Quorum.  Except  as  otherwise  provided  by law or by the
Certificate  of  Incorporation,  the holders of a majority of the capital  stock
issued  and  outstanding  and  entitled  to vote  thereat,  present in person or
represented  by  proxy,  shall  constitute  a  quorum  at  all  meetings  of the
stockholders for the transaction of business. If, however, such quorum shall not
be present or represented at any meeting of the  stockholders,  the stockholders
entitled to vote thereat,  present in person or represented by proxy, shall have
power to  adjourn  the  meeting  from time to time,  without  notice  other than
announcement at the meeting, until a quorum shall be present or represented.  At
such adjourned  meeting at which a quorum shall be present or  represented,  any
business may be  transacted  which might have been  transacted at the meeting as
originally noticed. If the adjournment is for more than thirty days, or if after
the adjournment a new record date is fixed for the adjourned  meeting,  a notice
of the adjourned meeting shall be given to each stockholder  entitled to vote at
the meeting.
          Section 5. Voting.  Unless otherwise  required by law, the Certificate
of  Incorporation  or these Amended and Restated  By-Laws,  any question brought
before any meeting of  stockholders  shall be decided by the vote of the holders
of a majority  of the stock  represented  and  entitled  to vote  thereat.  Each
stockholder  represented at a meeting of stockholders  shall be entitled to cast
one vote for each share of the capital  stock  entitled to vote  thereat held by
such  stockholder.  Such  votes  may be cast in  person or by proxy but no proxy
shall be voted on or after three years from its date, unless such proxy provides
for a longer period. The Board of Directors,  in its discretion,  or the officer
of the Corporation  presiding at a meeting of  stockholders,  in his discretion,
may require that any votes cast at such meeting shall be cast by written ballot.
          Section 6. List of  Stockholders  Entitled to Vote. The officer of the
Corporation who has charge of the stock ledger of the Corporation  shall prepare
and make,  at least ten days before every  meeting of  stockholders,  a complete
list  of  the  stockholders  entitled  to  vote  at  the  meeting,  arranged  in
alphabetical  order,  and showing the address of each stockholder and the number
of shares registered in the name of each stockholder. Such list shall be open to
the  examination  of any  stockholder,  for any purpose  germane to the meeting,
during ordinary  business hours,  for a period of at least ten days prior to the
meeting,  either at a place  within  the city  where the  meeting is to be held,
which  place  shall be  specified  in the notice of the  meeting,  or, if not so
specified,  at the place where the meeting is to be held. The list shall also be
produced  and kept at the time and place of the  meeting  during  the whole time
thereof,  and may be  inspected by any  stockholder  of the  Corporation  who is
present.
          Section 7. Stock Ledger.  The stock ledger of the Corporation shall be
the only evidence as to who are the  stockholders  entitled to examine the stock
ledger,  the list  required by Section 6 of this  Article II or the books of the
Corporation, or to vote in person or by proxy at any meeting of stockholders.
          Section 8. Nomination of Directors.  Only persons who are nominated in
accordance  with the  following  procedures  shall be eligible  for  election as
directors of the  Corporation.  Nominations of persons for election to the Board
of  Directors  may be made at any  annual  meeting  of  stockholders,  or at any
special  meeting of stockholders  called for the purpose of electing  directors,
(a) by or at the  direction  of the Board of Directors  (or any duly  authorized
committee  thereof) or (b) by any  stockholder of the  Corporation  (i) who is a
stockholder  of record on the date of the giving of the notice  provided  for in
this  Section 8 and on the record  date for the  determination  of  stockholders
entitled  to vote at  such  meeting  and  (ii)  who  complies  with  the  notice
procedures set forth in this Section 8.
                   In  addition  to any  other  applicable  requirements,  for a
nomination to be made by a stockholder,  such stockholder must have given timely
notice thereof in proper written form to the Secretary of the Corporation.
                   To be timely, a stockholder's notice to the Secretary must be
delivered to or mailed and received at the  principal  executive  offices of the
Corporation (a) in the case of an annual meeting,  not less than sixty (60) days
nor more than ninety (90) days prior to the anniversary  date of the immediately
preceding annual meeting of stockholders;  provided,  however, that in the event
that the annual meeting is called for a date that is not within thirty (30) days
before or after such  anniversary  date,  notice by the stockholder to be timely
must be so received not later than the close of business on the tenth (10th) day
following  the day on which such  notice of the date of the annual  meeting  was
mailed or such  public  disclosure  of the date of the annual  meeting was made,
whichever  first  occurs;  and  provided,  further,  that  with  respect  to the
Corporation's first annual meeting of stockholders held subsequent to August 12,
1993, to be timely, a stockholder's notice to the Secretary must be delivered to
or mailed and received at the principal executive offices of the Corporation not
less than  sixty (60) days nor more than  ninety  (90) days prior to the date of
the annual  meeting,  unless less than seventy (70) days' notice or prior public
disclosure of the date of the annual  meeting is given or made to  stockholders,
in which  case  notice  by the  stockholder  in order  to be  timely  must be so
received not later than the close of business on the tenth (10th) day  following
the day on which  such  notice of the date of the annual  meeting  was mailed or
such public  disclosure  of the date of the annual  meeting was made,  whichever
first occurs;  and (b) in the case of a special meeting of  stockholders  called
for the purpose of electing  directors,  not later than the close of business on
the  tenth  (10th)  day  following  the day on which  notice  of the date of the
special  meeting  was  mailed or public  disclosure  of the date of the  special
meeting was made, whichever first occurs.
                   To be in proper written form, a  stockholder's  notice to the
Secretary must set forth (a) as to each person whom the stockholder  proposes to
nominate  for  election as a director (i) the name,  age,  business  address and
residence address of the person, (ii) the principal  occupation or employment of
the person,  (iii) the class or series and number of shares of capital  stock of
the Corporation that are owned  beneficially or of record by the person and (iv)
any other  information  relating  to the  person  that would be  required  to be
disclosed  in a  proxy  statement  or  other  filings  required  to be  made  in
connection with  solicitations of proxies for election of directors  pursuant to
Section 14 of the  Securities  Exchange Act of 1934,  as amended (the  "Exchange
Act"), and the rules and regulations promulgated  thereunder;  and (b) as to the
stockholder  giving  the  notice  (i)  the  name  and  record  address  of  such
stockholder,  (ii) the class or series and number of shares of capital  stock of
the Corporation  that are owned  beneficially or of record by such  stockholder,
(iii)  a  description  of  all  arrangements  or  understandings   between  such
stockholder and each proposed nominee and any other person or persons (including
their  names)  pursuant  to  which  the  nomination(s)  are to be  made  by such
stockholder,  (iv) a representation  that such stockholder  intends to appear in
person or by proxy at the  meeting to nominate  the persons  named in its notice
and (v) any  other  information  relating  to such  stockholder  that  would  be
required to be disclosed in a proxy  statement or other  filings  required to be
made in  connection  with  solicitations  of proxies for  election of  directors
pursuant  to  Section  14 of the  Exchange  Act and the  rules  and  regulations
promulgated thereunder.  Such notice must be accompanied by a written consent of
each proposed  nominee to being named as a nominee and to serve as a director if
elected.
                   No person shall be eligible for election as a director of the
Corporation unless nominated in accordance with the procedures set forth in this
Section 8. If the Chairman of the meeting  determines  that a nomination was not
made in accordance with the foregoing procedures,  the Chairman shall declare to
the meeting that the  nomination  was  defective and such  defective  nomination
shall be disregarded.
          Section 9. Business at Annual Meetings.  No business may be transacted
at an annual  meeting of  stockholders,  other than  business that is either (a)
specified in the notice of meeting (or any  supplement  thereto)  given by or at
the  direction  of the  Board of  Directors  (or any duly  authorized  committee
thereof),  (b) otherwise properly brought before the annual meeting by or at the
direction of the Board of Directors (or any duly authorized  committee  thereof)
or (c) otherwise  properly  brought before the annual meeting by any stockholder
of the  Corporation (i) who is a stockholder of record on the date of the giving
of the notice  provided  for in this  Section 9 and on the  record  date for the
determination  of stockholders  entitled to vote at such annual meeting and (ii)
who complies with the notice procedures set forth in this Section 9.
         In addition to any other  applicable  requirements,  for business to be
properly  brought before an annual meeting by a  stockholder,  such  stockholder
must have given timely notice thereof in proper written form to the Secretary of
the Corporation.
         To be timely, a stockholder's notice to the Secretary must be delivered
to or mailed and received at the principal  executive offices of the Corporation
not less  than  sixty  (60)  days nor more than  ninety  (90) days  prior to the
anniversary  date of the immediately  preceding  annual meeting of stockholders;
provided,  however,  that in the event that the  annual  meeting is called for a
date that is not within thirty (30) days before or after such anniversary  date,
notice by the  stockholder  to be timely must be so received  not later than the
close of business on the tenth (10th) day following the day on which such notice
of the date of the annual  meeting was mailed or such public  disclosure  of the
date of the annual  meeting was made,  whichever  first  occurs;  and  provided,
further,  that  with  respect  to the  Corporation's  first  annual  meeting  of
stockholders  held subsequent to August 12, 1993, to be timely,  a stockholder's
notice to the  Secretary  must be  delivered  to or mailed and  received  at the
principal executive offices of the Corporation not less than sixty (60) days nor
more than ninety (90) days prior to the date of the annual meeting,  unless less
than seventy (70) days'  notice or prior  public  disclosure  of the date of the
annual  meeting is given or made to  stockholders,  in which case  notice by the
stockholder  in order to be timely must be so received  not later than the close
of business on the tenth  (10th) day  following  the day on which such notice of
the date of the annual meeting was mailed or such public  disclosure of the date
of the annual meeting was made, whichever first occurs.
         To be in proper written form, a  stockholder's  notice to the Secretary
must set forth as to each matter such  stockholder  proposes to bring before the
annual  meeting (i) a brief  description  of the business  desired to be brought
before the annual  meeting and the reasons for  conducting  such business at the
annual meeting, (ii) the name and record address of such stockholder,  (iii) the
class or series and number of shares of capital  stock of the  Corporation  that
are owned  beneficially or of record by such stockholder,  (iv) a description of
all arrangements or understandings between such stockholder and any other person
or persons  (including  their  names) in  connection  with the  proposal of such
business by such  stockholder and any material  interest of such  stockholder in
such business and (v) a representation  that such stockholder  intends to appear
in person or by proxy at the annual  meeting to bring such  business  before the
meeting.
         No business  shall be conducted at the annual  meeting of  stockholders
except  business  brought  before the  annual  meeting  in  accordance  with the
procedures set forth in this Section 9, provided,  however,  that, once business
has been properly  brought  before the annual  meeting in  accordance  with such
procedures,  nothing in this Section 9 shall be deemed to preclude discussion by
any  stockholder  of any such  business.  If the  Chairman of an annual  meeting
determines  that business was not properly  brought before the annual meeting in
accordance  with the  foregoing  procedures,  the Chairman  shall declare to the
meeting that the business was not properly  brought  before the meeting and such
business shall not be transacted.

                                   ARTICLE III
                                    DIRECTORS

          Section 1. Election of  Directors.  Except as provided in Section 2 of
this Article III, Directors shall be elected by a plurality of the votes cast at
Annual Meetings of Stockholders,  and each director so elected shall hold office
as  provided  by  Article  FIFTH,  Section  3 of  the  Restated  Certificate  of
Incorporation.  Any  director  may  resign  at  any  time  upon  notice  to  the
Corporation. Directors need not be stockholders.
          Section 2.  Vacancies.   Vacancies  and  newly  created  directorships
resulting from any increase in the authorized  number of directors may be filled
by a majority of the directors then in office,  though less than a quorum, or by
a sole remaining  director,  and the directors so chosen shall hold office until
the next  annual  election  and until  their  successors  are duly  elected  and
qualified, or until their earlier resignation or removal.
          Section 3. Duties and Powers. The business of the Corporation shall be
managed by or under the  direction of the Board of Directors  which may exercise
all such powers of the Corporation and do all such lawful acts and things as are
not by statute or by the  Certificate of  Incorporation  or by these Amended and
Restated   By-Laws  directed  or  required  to  be  exercised  or  done  by  the
stockholders.
          Section 4.  Meetings.  The Board of Directors of the  Corporation  may
hold meetings,  both regular and special,  either within or without the State of
Delaware.  Regular meetings of the Board of Directors may be held without notice
at such  time and at such  place as may from time to time be  determined  by the
Board of Directors.  Special meetings of the Board of Directors may be called by
the  Chairman,  if  there  be one,  or the  President  or by a  majority  of the
directors then in office. Notice thereof stating the place, date and hour of the
meeting shall be given to each director either by mail not less than forty-eight
(48)  hours  before  the  date of the  meeting,  by  telephone  or  telegram  on
twenty-four  (24)  hours'  notice,  or on such  shorter  notice as the person or
persons   calling  such  meeting  may  deem  necessary  or  appropriate  in  the
circumstances.
          Section 5. Quorum. Except as may be otherwise specifically provided by
law, the Restated  Certificate  of  Incorporation  or these Amended and Restated
By-Laws,  at all  meetings of the Board of  Directors,  a majority of the entire
Board of Directors shall constitute a quorum for the transaction of business and
the act of a majority of the directors  present at any meeting at which there is
a quorum  shall be the act of the Board of  Directors.  If a quorum shall not be
present at any meeting of the Board of Directors,  the directors present thereat
may  adjourn  the  meeting  from  time  to  time,   without  notice  other  than
announcement at the meeting, until a quorum shall be present.
          Section 6. Action by Written Consent. Unless otherwise provided by the
Certificate of Incorporation or these Amended and Restated  By-Laws,  any action
required or permitted to be taken at any meeting of the Board of Directors or of
any committee thereof may be taken without a meeting,  if all the members of the
Board of Directors or of any committee,  as the case may be, consent  thereto in
writing,  and the writing or writings are filed with the minutes of  proceedings
of the Board of Directors or committee.
          Section 7. Meetings by Means of Conference Telephone. Unless otherwise
provided by the  Restated  Certificate  of  Incorporation  or these  Amended and
Restated By-Laws,  members of the Board of Directors of the Corporation,  or any
committee designated by the Board of Directors,  may participate in a meeting of
the Board of Directors or such  committee by means of a conference  telephone or
similar communications  equipment by means of which all persons participating in
the meeting can hear each other, and participation in a meeting pursuant to this
Section 7 shall constitute presence in person at such meeting.
          Section 8.  Committees.  The Board of  Directors  may,  by  resolution
passed by a majority of the entire  Board of  Directors,  designate  one or more
committees,  each  committee  to consist of one or more of the  directors of the
Corporation.  The Board of  Directors  may  designate  one or more  directors as
alternate  members of any committee,  who may replace any absent or disqualified
member at any meeting of any such committee.  In the absence or disqualification
of a member of a committee,  and in the absence of a designation by the Board of
Directors of an alternate  member to replace the absent or disqualified  member,
the member or members thereof present at any meeting and not  disqualified  from
voting,  whether or not he or they constitute a quorum, may unanimously  appoint
another  member of the Board of  Directors to act at the meeting in the place of
any absent or disqualified  member. Any committee,  to the extent allowed by law
and provided in the resolution  establishing such committee,  shall have and may
exercise  all  the  powers  and  authority  of the  Board  of  Directors  in the
management of the business and affairs of the Corporation.  Each committee shall
keep regular minutes and report to the Board of Directors when required.
          Section 9. Compensation.  The directors may be paid their expenses, if
any, of  attendance  at each meeting of the Board of Directors and may be paid a
fixed sum for  attendance  at each meeting of the Board of Directors or a stated
salary as director,  or both. No such payment  shall  preclude any director from
serving  the  Corporation  in any  other  capacity  and  receiving  compensation
therefor.  Members  of  special  or  standing  committees  may be  allowed  like
compensation for attending committee meetings.
          Section 10. Interested  Directors.  No contract or transaction between
the  Corporation  and one or more of its  directors or officers,  or between the
Corporation  and any  other  corporation,  partnership,  association,  or  other
organization  in which one or more of its directors or officers are directors or
officers,  or have a financial  interest,  shall be void or voidable  solely for
this  reason,  or solely  because  the  director  or  officer  is  present at or
participates in the meeting of the Board of Directors or committee thereof which
authorizes the contract or transaction, or solely because his or their votes are
counted  for  such  purpose  if (i)  the  material  facts  as to  his  or  their
relationship  or interest and as to the contract or transaction are disclosed or
are known to the Board of Directors or the committee, and the Board of Directors
or  committee  in good faith  authorizes  the  contract  or  transaction  by the
affirmative votes of a majority of the disinterested directors,  even though the
disinterested  directors be less than a quorum; or (ii) the material facts as to
his or their  relationship or interest and as to the contract or transaction are
disclosed or are known to the  stockholders  entitled to vote  thereon,  and the
contract or  transaction is  specifically  approved in good faith by vote of the
stockholders; or (iii) the contract or transaction is fair as to the Corporation
as of  the  time  it is  authorized,  approved  or  ratified,  by the  Board  of
Directors,  a  committee  thereof  or the  stockholders.  Common  or  interested
directors may be counted in determining the presence of a quorum at a meeting of
the Board of  Directors  or of a  committee  which  authorizes  the  contract or
transaction.

                                   ARTICLE IV
                                    OFFICERS

          Section 1. General. The officers of the Corporation shall be chosen by
the Board of Directors  and shall be a President,  a Secretary  and a Treasurer.
The Board of  Directors,  in its  discretion,  may also choose a Chairman of the
Board of Directors (who must be a director), a Vice Chairman (who also must be a
director)  and one or more Vice  Presidents,  Assistant  Secretaries,  Assistant
Treasurers  and other  officers.  Any number of offices  may be held by the same
person,  unless  otherwise  prohibited  by  law,  the  Restated  Certificate  of
Incorporation  or these  Amended  and  Restated  By-Laws.  The  officers  of the
Corporation  need not be stockholders of the Corporation nor, except in the case
of the Chairman of the Board of  Directors,  need such  officers be directors of
the Corporation.
          Section 2. Election.  The Board of Directors at its first meeting held
after each  Annual  Meeting of  Stockholders  shall  elect the  officers  of the
Corporation  who shall hold their offices for such terms and shall exercise such
powers and perform such duties as shall be  determined  from time to time by the
Board of Directors;  and all officers of the Corporation shall hold office until
their successors are chosen and qualified, or until their earlier resignation or
removal.  Any officer  elected by the Board of  Directors  may be removed at any
time by the  affirmative  vote of a  majority  of the  Board of  Directors.  Any
vacancy  occurring in any office of the Corporation shall be filled by the Board
of Directors.  The salaries of all officers of the Corporation shall be fixed by
the Board of Directors.
          Section 3.  Voting  Securities  Owned by the  Corporation.  Powers  of
attorney,  proxies, waivers of notice of meeting, consents and other instruments
relating to securities  owned by the  Corporation may be executed in the name of
and on behalf of the  Corporation by the President or any Vice President and any
such officer may, in the name of and on behalf of the Corporation, take all such
action as any such  officer may deem  advisable to vote in person or by proxy at
any meeting of security  holders of any corporation in which the Corporation may
own  securities  and at any such meeting  shall possess and may exercise any and
all rights and power incident to the ownership of such  securities and which, as
the owner  thereof,  the  Corporation  might have  exercised  and  possessed  if
present.  The Board of Directors  may, by  resolution,  from time to time confer
like powers upon any other person or persons.
          Section 4.  Chairman of the Board of  Directors.  The  Chairman of the
Board of  Directors,  if there be one,  shall  preside  at all  meetings  of the
stockholders and of the Board of Directors. Except where by law the signature of
the President is required,  the Chairman of the Board of Directors shall possess
the same power as the President to sign all  contracts,  certificates  and other
instruments  of  the  Corporation  which  may be  authorized  by  the  Board  of
Directors.  During the absence or disability of the  President,  the Chairman of
the Board of  Directors  shall  exercise  all the powers and  discharge  all the
duties of the  President.  The  Chairman  of the Board of  Directors  shall also
perform  such other  duties and may  exercise  such other powers as from time to
time may be assigned  to him by these  Amended  and  Restated  By-Laws or by the
Board of Directors.
          Section 5.  President.  The  President  shall be the  Chief  Executive
Officer of the Corporation.  The President shall,  subject to the control of the
Board of Directors and, if there be one, the Chairman of the Board of Directors,
have general  supervision of the business of the  Corporation and shall see that
all orders and resolutions of the Board of Directors are carried into effect. He
shall  execute all bonds,  mortgages,  contracts  and other  instruments  of the
Corporation  requiring a seal, under the seal of the  Corporation,  except where
required or permitted by law to be otherwise signed and executed and except that
the other  officers of the  Corporation  may sign and execute  documents when so
authorized by these Amended and Restated By-Laws,  the Board of Directors or the
President.  In the  absence  or  disability  of the  Chairman  of the  Board  of
Directors,  or if there be none, the President  shall preside at all meetings of
the  stockholders  and the Board of Directors.  The President shall also perform
such other duties and may exercise such other powers as from time to time may be
assigned  to him by  these  Amended  and  Restated  By-Laws  or by the  Board of
Directors.
          Section 6. Vice Presidents.  At the request of the President or in his
absence or in the event of his  inability  or refusal to act (and if there be no
Chairman of the Board of Directors),  the Vice President or the Vice  Presidents
if there is more than one (in the order  designated  by the Board of  Directors)
shall perform the duties of the  President,  and when so acting,  shall have all
the powers of and be subject to all the  restrictions  upon the President.  Each
Vice President shall perform such other duties and have such other powers as the
Board of Directors from time to time may  prescribe.  If there be no Chairman of
the Board of  Directors  and no Vice  President,  the Board of  Directors  shall
designate the officer of the Corporation who, in the absence of the President or
in the event of the inability or refusal of the President to act,  shall perform
the duties of the  President,  and when so acting,  shall have all the powers of
and be subject to all the restrictions upon the President.
          Section 7.  Secretary.  The Secretary shall attend all meetings of the
Board  of  Directors  and  all  meetings  of  stockholders  and  record  all the
proceedings  thereat  in a book  or  books  to be kept  for  that  purpose;  the
Secretary  shall also  perform  like  duties for the  standing  committees  when
required. The Secretary shall give, or cause to be given, notice of all meetings
of the stockholders  and special  meetings of the Board of Directors,  and shall
perform  such other  duties as may be  prescribed  by the Board of  Directors or
President, under whose supervision he shall be. If the Secretary shall be unable
or shall refuse to cause to be given notice of all meetings of the  stockholders
and special  meetings of the Board of  Directors,  and if there be no  Assistant
Secretary,  then  either  the Board of  Directors  or the  President  may choose
another  officer  to cause such  notice to be given.  The  Secretary  shall have
custody  of the  seal of the  Corporation  and the  Secretary  or any  Assistant
Secretary,  if there  be one,  shall  have  authority  to affix  the same to any
instrument requiring it and when so affixed, it may be attested by the signature
of the Secretary or by the signature of any such Assistant Secretary.  The Board
of Directors  may give general  authority to any other officer to affix the seal
of the  Corporation  and to attest the affixing by his signature.  The Secretary
shall see that all books, reports, statements,  certificates and other documents
and records  required by law to be kept or filed are properly kept or filed,  as
the case may be.
          Section 8.  Treasurer.  The  Treasurer  shall have the  custody of the
corporate  funds and  securities  and shall keep full and  accurate  accounts of
receipts  and  disbursements  in books  belonging to the  Corporation  and shall
deposit all moneys and other  valuable  effects in the name and to the credit of
the  Corporation  in such  depositories  as may be  designated  by the  Board of
Directors.  The Treasurer  shall disburse the funds of the Corporation as may be
ordered  by  the  Board  of   Directors,   taking   proper   vouchers  for  such
disbursements,  and shall render to the President and the Board of Directors, at
its regular meetings,  or when the Board of Directors so requires, an account of
all  his  transactions  as  Treasurer  and of  the  financial  condition  of the
Corporation. If required by the Board of Directors, the Treasurer shall give the
Corporation  a bond in such sum and with  such  surety or  sureties  as shall be
satisfactory  to the Board of  Directors  for the  faithful  performance  of the
duties of his office and for the restoration to the Corporation,  in case of his
death,  resignation,  retirement or removal from office,  of all books,  papers,
vouchers,  money and other  property of whatever kind in his possession or under
his control belonging to the Corporation.
          Section 9. Assistant Secretaries.  Except as may be otherwise provided
in these Amended and Restated By-Laws,  Assistant Secretaries,  if there be any,
shall  perform  such  duties  and have  such  powers as from time to time may be
assigned to them by the Board of Directors,  the President,  any Vice President,
if there be one, or the Secretary, and in the absence of the Secretary or in the
event of his  disability  or refusal  to act,  shall  perform  the duties of the
Secretary,  and when so  acting,  shall have all the powers of and be subject to
all the restrictions upon the Secretary.
          Section 10. Assistant Treasurers.  Assistant  Treasurers,  if there be
any,  shall perform such duties and have such powers as from time to time may be
assigned to them by the Board of Directors,  the President,  any Vice President,
if there be one, or the Treasurer, and in the absence of the Treasurer or in the
event of his  disability  or refusal  to act,  shall  perform  the duties of the
Treasurer,  and when so  acting,  shall have all the powers of and be subject to
all the restrictions upon the Treasurer.  If required by the Board of Directors,
an Assistant  Treasurer  shall give the  Corporation a bond in such sum and with
such surety or sureties as shall be  satisfactory  to the Board of Directors for
the faithful  performance of the duties of his office and for the restoration to
the Corporation,  in case of his death, resignation,  retirement or removal from
office,  of all books,  papers,  vouchers,  money and other property of whatever
kind in his possession or under his control belonging to the Corporation.
          Section 11.  Other  Officers.  Such  other  officers  as the  Board of
Directors may choose shall perform such duties and have such powers as from time
to time  may be  assigned  to them by the  Board  of  Directors.  The  Board  of
Directors  may  delegate to any other  officer of the  Corporation  the power to
choose such other officers and to prescribe their respective duties and powers.

                                    ARTICLE V
                                      STOCK

          Section 1.  Form  of  Certificates.  Every  holder  of  stock  in  the
Corporation  shall be entitled to have a certificate  signed, in the name of the
Corporation  (i) by the Chairman of the Board of  Directors,  the President or a
Vice  President  and (ii) by the  Treasurer  or an Assistant  Treasurer,  or the
Secretary or an Assistant Secretary of the Corporation, certifying the number of
shares owned by him in the Corporation.
          Section 2.  Signatures.  Where a certificate is countersigned by (i) a
transfer agent other than the  Corporation or its employee,  or (ii) a registrar
other  than  the  Corporation  or  its  employee,  any  other  signature  on the
certificate may be a facsimile. In case any officer, transfer agent or registrar
who has signed or whose  facsimile  signature has been placed upon a certificate
shall have ceased to be such officer,  transfer  agent or registrar  before such
certificate is issued,  it may be issued by the Corporation with the same effect
as if he were such officer, transfer agent or registrar at the date of issue.
          Section 3. Lost Certificates.  The Board of Directors may direct a new
certificate to be issued in place of any certificate  theretofore  issued by the
Corporation  alleged to have been lost, stolen or destroyed,  upon the making of
an affidavit of that fact by the person  claiming the certificate of stock to be
lost, stolen or destroyed. When authorizing such issue of a new certificate, the
Board of Directors may, in its  discretion  and as a condition  precedent to the
issuance  thereof,   require  the  owner  of  such  lost,  stolen  or  destroyed
certificate,  or his legal representative,  to advertise the same in such manner
as the Board of Directors shall require and/or to give the Corporation a bond in
such sum as it may  direct  as  indemnity  against  any  claim  that may be made
against the  Corporation  with respect to the  certificate  alleged to have been
lost, stolen or destroyed.
          Section 4. Transfers.  Stock of the Corporation  shall be transferable
in the manner  prescribed  by law and in these  Amended  and  Restated  By-Laws.
Transfers  of stock  shall be made on the books of the  Corporation  only by the
person named in the  certificate  or by his  attorney  lawfully  constituted  in
writing  and upon the  surrender  of the  certificate  therefor,  which shall be
cancelled before a new certificate shall be issued.
          Section 5. Record Date.  In order that the  Corporation  may determine
the stockholders entitled to notice of or to vote at any meeting of stockholders
or any adjournment  thereof,  or entitled to express consent to corporate action
in writing without a meeting,  or entitled to receive payment of any dividend or
other  distribution  or  allotment  of any rights,  or entitled to exercise  any
rights in respect of any change,  conversion  or  exchange of stock,  or for the
purpose of any other lawful action,  the Board of Directors may fix, in advance,
a record  date,  which  shall not be more than sixty days nor less than ten days
before  the date of such  meeting,  nor more than  sixty days prior to any other
action.  A  determination  of stockholders of record entitled to notice of or to
vote at a meeting of stockholders shall apply to any adjournment of the meeting;
provided, however, that the Board of Directors may fix a new record date for the
adjourned meeting.
          Section 6. Beneficial  Owners.  The  Corporation  shall be entitled to
recognize the exclusive  right of a person  registered on its books as the owner
of shares to receive  dividends,  and to vote as such owner,  and to hold liable
for  calls  and  assessments  a person  registered  on its books as the owner of
shares,  and shall not be bound to recognize  any equitable or other claim to or
interest in such share or shares on the part of any other person, whether or not
it shall have express or other notice thereof,  except as otherwise  provided by
law.

                                   ARTICLE VI
                                     NOTICES

          Section 1. Notices.  Whenever  written  notice is required by law, the
Restated  Certificate of Incorporation or these Amended and Restated By-Laws, to
be given to any director, member of a committee or stockholder,  such notice may
be  given  by  mail,  addressed  to such  director,  member  of a  committee  or
stockholder,  at his  address as it appears on the  records of the  Corporation,
with postage thereon prepaid, and such notice shall be deemed to be given at the
time when the same shall be deposited in the United States mail.  Written notice
may also be given personally or by telegram, telex or cable.
          Section 2. Waivers of Notice.  Whenever any notice is required by law,
the Restated Certificate of Incorporation or these Amended and Restated By-Laws,
to be given to any  director,  member of a committee  or  stockholder,  a waiver
thereof in writing,  signed,  by the person or persons  entitled to said notice,
whether  before or after the time  stated  therein,  shall be deemed  equivalent
thereto.

                                   ARTICLE VII
                               GENERAL PROVISIONS

          Section 1.  Dividends.   Dividends  upon  the  capital  stock  of  the
Corporation,   subject  to  the  provisions  of  the  Restated   Certificate  of
Incorporation,  if any, may be declared by the Board of Directors at any regular
or special  meeting,  and may be paid in cash, in property,  or in shares of the
capital stock. Before payment of any dividend, there may be set aside out of any
funds of the  Corporation  available for dividends such sum or sums as the Board
of Directors  from time to time, in its absolute  discretion,  deems proper as a
reserve or reserves to meet contingencies,  or for equalizing dividends,  or for
repairing  or  maintaining  any property of the  Corporation,  or for any proper
purpose, and the Board of Directors may modify or abolish any such reserve.
          Section 2. Disbursements. All checks or demands for money and notes of
the Corporation shall be signed by such officer or officers or such other person
or persons as the Board of Directors may from time to time designate.
          Section 3. Fiscal Year.  The fiscal year of the  Corporation  shall be
fixed by resolution of the Board of Directors.
          Section 4.  Corporate  Seal.  The corporate  seal shall have inscribed
thereon the name of the Corporation,  the year of its organization and the words
"Corporate  Seal,  Delaware".  The seal may be used by causing it or a facsimile
thereof to be impressed or affixed or reproduced or otherwise.

                                  ARTICLE VIII
                                 INDEMNIFICATION

          Section 1. Power to Indemnify in Actions,  Suits or Proceedings  other
Than Those by or in the Right of the  Corporation.  Subject to Section 3 of this
Article VIII, the  Corporation  shall indemnify any person who was or is a party
or is  threatened  to be made a party to any  threatened,  pending or  completed
action,  suit  or  proceeding,   whether  civil,  criminal,   administrative  or
investigative  (other than an action by or in the right of the  Corporation)  by
reason of the fact that he is or was a director  or officer of the  Corporation,
or is or was a director or officer of the Corporation  serving at the request of
the  Corporation  as a  director  or  officer,  employee  or  agent  of  another
corporation,  partnership,  joint venture, trust, employee benefit plan or other
enterprise,  against expenses (including attorneys' fees), judgments,  fines and
amounts paid in settlement actually and reasonably incurred by him in connection
with such action,  suit or  proceeding if he acted in good faith and in a manner
he  reasonably  believed  to be in or not opposed to the best  interests  of the
Corporation,  and,  with respect to any criminal  action or  proceeding,  had no
reasonable  cause to believe his conduct was unlawful.  The  termination  of any
action, suit or proceeding by judgment, order, settlement, conviction, or upon a
plea of nolo  contendere  or its  equivalent,  shall not,  of  itself,  create a
presumption  that the person did not act in good faith and in a manner  which he
reasonably  believed  to be in or not  opposed  to  the  best  interests  of the
Corporation,  and,  with  respect  to any  criminal  action or  proceeding,  had
reasonable cause to believe that his conduct was unlawful.
          Section 2. Power to Indemnify in Actions,  Suits or  Proceedings by or
in the Right of the Corporation.  Subject to Section 3 of this Article VIII, the
Corporation shall indemnify any person who was or is a party or is threatened to
be made a party to any threatened,  pending or completed action or suit by or in
the right of the Corporation to procure a judgment in its favor by reason of the
fact that he is or was a director or officer of the Corporation,  or is or was a
director or officer of the Corporation serving at the request of the Corporation
as a director,  officer, employee or agent of another corporation,  partnership,
joint venture, trust, employee benefit plan or other enterprise against expenses
(including   attorneys'  fees)  actually  and  reasonably  incurred  by  him  in
connection  with the defense or settlement of such action or suit if he acted in
good faith and in a manner he reasonably believed to be in or not opposed to the
best interests of the Corporation;  except that no indemnification shall be made
in respect of any claim, issue or matter as to which such person shall have been
adjudged to be liable to the Corporation  unless and only to the extent that the
Court of Chancery  or the court in which such  action or suit was brought  shall
determine upon  application  that,  despite the adjudication of liability but in
view of all the  circumstances of the case, such person is fairly and reasonably
entitled  to  indemnity  for such  expenses  which the Court of Chancery or such
other court shall deem proper.
          Section 3. Authorization of Indemnification. Any indemnification under
this Article VIII (unless  ordered by a court) shall be made by the  Corporation
only  as   authorized   in  the  specific   case  upon  a   determination   that
indemnification  of the  director  or  officer  is proper  in the  circumstances
because he has met the applicable  standard of conduct set forth in Section 1 or
Section 2 of this Article VIII, as the case may be. Such determination  shall be
made (i) by the Board of Directors by a majority vote of a quorum  consisting of
directors who were not parties to such action,  suit or  proceeding,  or (ii) if
such  a  quorum  is  not  obtainable,   or,  even  if  obtainable  a  quorum  of
disinterested  directors so directs,  by independent  legal counsel in a written
opinion, or (iii) by the stockholders.  To the extent,  however, that a director
or officer of the  Corporation has been successful on the merits or otherwise in
defense of any action, suit or proceeding  described above, or in defense of any
claim,  issue  or  matter  therein,  he shall be  indemnified  against  expenses
(including   attorneys'  fees)  actually  and  reasonably  incurred  by  him  in
connection  therewith,  without the necessity of  authorization  in the specific
case.
          Section 4. Good Faith Defined. For purposes of any determination under
Section 3 of this  Article  VIII, a person shall be deemed to have acted in good
faith and in a manner he reasonably believed to be in or not opposed to the best
interests  of the  Corporation,  or,  with  respect  to any  criminal  action or
proceeding, to have had no reasonable cause to believe his conduct was unlawful,
if his action is based on the records or books of account of the  Corporation or
another  enterprise,  or on  information  supplied to him by the officers of the
Corporation  or  another  enterprise  in the course of their  duties,  or on the
advice  of  legal  counsel  for the  Corporation  or  another  enterprise  or on
information  or records  given or  reports  made to the  Corporation  or another
enterprise by an independent  certified public  accountant or by an appraiser or
other  expert  selected  with  reasonable  care by the  Corporation  or  another
enterprise.  The term "another  enterprise" as used in this Section 4 shall mean
any other corporation or any partnership, joint venture, trust, employee benefit
plan or other  enterprise  of which such person is or was serving at the request
of the Corporation as a director,  officer, employee or agent. The provisions of
this  Section 4 shall not be deemed to be  exclusive  or to limit in any way the
circumstances  in  which a  person  may be  deemed  to have  met the  applicable
standard of conduct set forth in Sections 1 or 2 of this  Article  VIII,  as the
case may be.
          Section 5.  Indemnification by a Court.  Notwithstanding  any contrary
determination  in the specific case under  Section 3 of this Article  VIII,  and
notwithstanding  the absence of any  determination  thereunder,  any director or
officer  may  apply  to any  court of  competent  jurisdiction  in the  State of
Delaware for indemnification to the extent otherwise  permissible under Sections
1 and 2 of this Article VIII. The basis of such indemnification by a court shall
be a determination by such court that indemnification of the director or officer
is proper in the  circumstances  because he has met the applicable  standards of
conduct set forth in Sections 1 or 2 of this Article  VIII,  as the case may be.
Neither a contrary  determination  in the specific  case under Section 3 of this
Article VIII nor the absence of any determination  thereunder shall be a defense
to such application or create a presumption that the director or officer seeking
indemnification  has not met any applicable  standard of conduct.  Notice of any
application for indemnification pursuant to this Section 5 shall be given to the
Corporation  promptly upon the filing of such  application.  If  successful,  in
whole or in part, the director or officer seeking  indemnification shall also be
entitled to be paid the expense of prosecuting such application.
          Section 6.  Expenses  Payable  in  Advance.  Expenses  incurred  by  a
director  or officer in  defending  or  investigating  a  threatened  or pending
action,  suit or proceeding  shall be paid by the  Corporation in advance of the
final  disposition  of  such  action,  suit or  proceeding  upon  receipt  of an
undertaking  by or on behalf of such director or officer to repay such amount if
it shall  ultimately be determined  that he is not entitled to be indemnified by
the Corporation as authorized in this Article VIII.
          Section 7.  Nonexclusivity  of  Indemnification  and  Advancement   of
Expenses. The indemnification and advancement of expenses provided by or granted
pursuant to this Article VIII shall not be deemed  exclusive of any other rights
to which  those  seeking  indemnification  or  advancement  of  expenses  may be
entitled  under  any  By-Law,  agreement,  contract,  vote  of  stockholders  or
disinterested directors or pursuant to the direction (howsoever embodied) of any
court of competent jurisdiction or otherwise,  both as to action in his official
capacity and as to action in another  capacity  while  holding  such office,  it
being  the  policy  of the  Corporation  that  indemnification  of  the  persons
specified  in Sections 1 and 2 of this Article VIII shall be made to the fullest
extent permitted by law. The provisions of this Article VIII shall not be deemed
to preclude the indemnification of any person who is not specified in Sections 1
or 2 of this Article VIII but whom the  Corporation  has the power or obligation
to indemnify under the provisions of the General Corporation Law of the State of
Delaware, or otherwise.
          Section 8.  Insurance.  The  Corporation  may  purchase  and  maintain
insurance  on behalf of any person  who is or was a  director  or officer of the
Corporation,  or is or was a director or officer of the  Corporation  serving at
the  request of the  Corporation  as a director,  officer,  employee or agent of
another corporation, partnership, joint venture, trust, employee benefit plan or
other enterprise  against any liability asserted against him and incurred by him
in any such capacity,  or arising out of his status as such,  whether or not the
Corporation would have the power or the obligation to indemnify him against such
liability under the provisions of this Article VIII.
          Section 9. Certain  Definitions.  For  purposes of this Article  VIII,
references  to "the  Corporation"  shall  include,  in addition to the resulting
corporation,  any  constituent  corporation  (including  any  constituent  of  a
constituent)  absorbed  in a  consolidation  or merger  which,  if its  separate
existence  had  continued,  would have had power and  authority to indemnify its
directors or officers, so that any person who is or was a director or officer of
such  constituent  corporation,  or is or was a  director  or  officer  of  such
constituent  corporation serving at the request of such constituent  corporation
as a director,  officer, employee or agent of another corporation,  partnership,
joint venture, trust, employee benefit plan or other enterprise,  shall stand in
the same position  under the provisions of this Article VIII with respect to the
resulting  or  surviving  corporation  as he would  have  with  respect  to such
constituent corporation if its separate existence had continued. For purposes of
this Article VIII, references to "fines" shall include any excise taxes assessed
on a person with respect to an employee benefit plan; and references to "serving
at the  request of the  Corporation"  shall  include  any service as a director,
officer,  employee  or agent of the  Corporation  which  imposes  duties  on, or
involves  services  by,  such  director or officer  with  respect to an employee
benefit plan, its participants or beneficiaries;  and a person who acted in good
faith  and in a manner  he  reasonably  believed  to be in the  interest  of the
participants  and  beneficiaries  of an employee benefit plan shall be deemed to
have acted in a manner "not opposed to the best interests of the Corporation" as
referred to in this Article VIII.
          Section 10. Survival of  Indemnification  and Advancement of Expenses.
The indemnification and advancement of expenses provided by, or granted pursuant
to, this  Article VIII shall,  unless  otherwise  provided  when  authorized  or
ratified, continue as to a person who has ceased to be a director or officer and
shall inure to the benefit of the heirs,  executors and administrators of such a
person.
          Section 11. Limitation on  Indemnification.  Notwithstanding  anything
contained  in this  Article  VIII to the  contrary,  except for  proceedings  to
enforce rights to indemnification (which shall be governed by Section 5 hereof),
the  Corporation  shall not be obligated to indemnify any director or officer in
connection  with a proceeding (or part thereof)  initiated by such person unless
such proceeding (or part thereof) was authorized or consented to by the Board of
Directors of the Corporation.
          Section 12.  Indemnification  of Employees and Agents. The Corporation
may,  to the  extent  authorized  from time to time by the  Board of  Directors,
provide  rights  to  indemnification  and  to the  advancement  of  expenses  to
employees  and  agents of the  Corporation  similar to those  conferred  in this
Article VIII to directors and officers of the Corporation.

                                   ARTICLE IX
                                   AMENDMENTS

          Section 1. These Amended and Restated By-Laws may be altered,  amended
or  repealed,  in  whole  or in  part,  or new  By-Laws  may be  adopted  by the
stockholders  or by the Board of Directors,  provided,  however,  that notice of
such  alteration,  amendment,  repeal or adoption of new By-Laws be contained in
the notice of such meeting of stockholders or Board of Directors as the case may
be. All such  amendments must be approved by either the holders of a majority of
the  outstanding  capital stock entitled to vote thereon or by a majority of the
entire Board of Directors then in office.
          Section 2. Entire Board of  Directors.  As used in this Article IX and
in these  Amended and Restated  By-Laws  generally,  the term  "entire  Board of
Directors" means the total number of directors which the Corporation  would have
if there were no vacancies.


                                                              EXHIBIT 10.25


                       EMPLOYMENT AND CONSULTING AGREEMENT



         AGREEMENT   made  as  of  February  4,  1996  by  and  between   ECKERD
CORPORATION, a Delaware corporation (the "Company") and STEWART TURLEY, residing
at 401 St. Andrews Drive, Belleair, Florida 34616 ("Turley").

         WHEREAS,  upon  the  terms  and  subject  to  the  conditions  of  this
Agreement,  the  Company  desires  to  employ  Turley  and  to  engage  him as a
consultant  to the  Company  and Turley is willing to accept  employment  by the
Company and to render consulting services to the Company.

         NOW,  THEREFORE,  in  consideration  of the mutual  covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto agree as follows:

                                  I. EMPLOYMENT

         1.       Employment.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,   the  Company  hereby  employs  Turley  and  Turley  hereby  accepts
employment by the Company in the capacity hereinafter set forth.

         2.       Term of Employment.

                  The term of  Turley's  employment  by the  Company  under this
Agreement shall commence on February 4, 1996 and shall continue  through January
31,  1998,  subject  to  termination  as  provided  in  Section  14 hereof  (the
"Employment Period").

         3.       Duties; Extent of Services.

                  (a) During the  Employment  Period,  Turley shall serve as the
Chairman  of the Board of the  Company or in such other  executive  capacity  as
shall be determined from time to time by agreement  between Turley and the Board
of  Directors  of the  Company  and shall  perform  the  duties,  undertake  the
responsibilities and exercise the authority  customarily  performed,  undertaken
and  exercised by a person in such position in the business in which the Company
is engaged.

                  (b)  Except  as  otherwise  provided  herein  and  except  for
illness,  permitted  vacation periods and permitted leaves of absence during the
Employment Period, Turley shall (i) devote such time and attention during normal
business hours to the business of the Company and its subsidiaries as Turley and
the Company shall agree; (ii) use his efforts to


promote the Company's and its subsidiaries'  interest;  and (iii) discharge such
other and  further  executive  and  administrative  duties as may be  reasonably
assigned to him by the Board of Directors of the Company and its subsidiaries.

         4.       Compensation.

                  (a) In consideration of the services  rendered by Turley as an
employee under this Agreement, the Company shall pay Turley a base annual salary
(the  "Base  Salary")  in the  amount  of Six  Hundred  Fifty  Thousand  Dollars
($650,000)  payable  monthly on the  fifteenth  (15th) of each month  during the
Employment Period.

                  (b) During the Employment  Period, as additional  compensation
for his services and as a further  incentive and  inducement to Turley to accept
employment  by the Company and to devote his efforts to the business and affairs
of the Company and its subsidiaries,  Turley shall be entitled to participate in
the Company's  Executive Three Year Bonus Plan (or any bonus plan replacing such
plan).  Turley's  participation in the Company's Key Management Bonus Plan shall
terminate  on  February 3, 1996,  although  the Board of  Directors  may, in its
discretion, pay additional bonuses to Turley during the Employment Period.

                  (c) The Company  agrees that Turley shall be entitled to defer
some portion or all of his Base Salary for any calendar year in accordance  with
the provisions of the Company's Executive Deferred  Compensation Plan as adopted
by the Board of Directors.

         5.       Fringe Benefits.

                  In addition to the  compensation  provided in Section 4 above,
during the Employment Period Turley shall be entitled to the following benefits:

                  (a) Turley shall be entitled to paid vacation time annually in
accordance with the Company policy as determined by the Board of Directors.

                  (b) Turley  shall be entitled to  participate  in all employee
benefit  programs  now or  hereafter  maintained  by the Company  for  executive
personnel for which he is eligible,  including,  without limitation,  group life
insurance, short and long-term disability,  profit sharing, pension,  automobile
allowance  or  leasing,  stock  option  (subject  to  approval  by the  Board of
Directors),  supplemental retirement income (subject to approval by the Board of
Directors),  hospitalization  and  medical  and  dental  reimbursement  plan  or
program,  his  participation  in such  programs to be based upon the  applicable
provisions of such programs as they may exist from time to time.


                                 II. CONSULTING

         6.       Consultant.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,  the Company hereby agrees to retain Turley, and Turley hereby agrees
to serve the Company, as a consultant.

         7.       Term of Consultant Relationship.

                  The term of Turley's  retention as a consultant to the Company
shall commence on February 1, 1998 and shall continue  through February 3, 2001,
subject  to  termination  as  provided  in Section  13 hereof  (the  "Consulting
Period")  (the  Employment  Period and the  Consulting  Period are  collectively
referred to herein as the "Contract Period").

         8.       Duties; Extent of Service.

                  During  the  Consulting  Period,   Turley  shall  serve  as  a
consultant to the Company and its  subsidiaries  to act in an advisory  capacity
thereto.  Turley shall  furnish such  consulting  services as may be  reasonably
requested  of him  from  time  to  time  during  the  Consulting  Period  as are
commensurate with his knowledge, ability and experience,  provided that he shall
not be called upon to render such  services more than fifty (50) days during any
fiscal  year of the  Company  during  the  Consulting  Period.  Turley  shall be
available  to advise  and  counsel  the  Company  and its  subsidiaries  at such
reasonable times and locations as may be agreed upon from time to time by Turley
and the Board of Directors or Chief Executive Officer of the Company.

         9.       Compensation.

                  In consideration of the consulting services rendered by Turley
under this Agreement, the Company shall pay Turley an annual consulting fee (the
"Consulting  Fee") in the amount of Three Hundred  Twenty-Five  Thousand Dollars
($325,000)  payable  monthly on the  fifteenth  (15th) of each month  during the
Consulting Period.

         10.      Fringe Benefits.

                  In addition to the  compensation  provided in Section 9 above,
during the Consulting Period Turley shall be entitled to participate in the same
life insurance and hospitalization and medical and dental  reimbursement plan or
programs that he participates in during the Employment Period.


         11.      Consultant Relationship.

                  During the Consulting  Period,  Turley shall be an independent
contractor and, except as provided in Section 10 above or as otherwise  provided
by the Board of Directors,  shall not be entitled to participate in any pension,
profit sharing,  stock purchase or option plan, or any plan of life,  disability
or heath insurance or incentive  compensation plan or any other employee benefit
plan or program of the Company.  During the Consulting  Period,  Turley shall be
responsible for payment of all taxes,  including Federal,  state and local taxes
arising out of activities engaged in during the Consulting Period, including but
not  limited  to  all  federal  and  state  income  tax,  social  security  tax,
unemployment insurance taxes and any other applicable taxes.

                                  III. GENERAL

         12.      Expenses.

                  The Company shall pay or reimburse  Turley for all  reasonable
expenses  reasonably  incurred or paid by him in connection with the performance
of his duties under this  Agreement  (whether as an employee or as a consultant)
upon  presentation of expense  statements or vouchers and such other  supporting
documentation as the Company may from time to time reasonably request.

         13.      Benefits Payable Upon Disability or Death.

                  (a) In the event of the disability (as hereinafter defined) of
Turley during the Contract Period,  the Company shall continue to pay Turley the
applicable  compensation  provided in Section 4 or Section 9 hereof (as the case
may be) during  the period of his  disability  or  earlier  termination  hereof;
provided,  however, that in the event Turley is disabled for a continuous period
exceeding six (6) consecutive calendar months, the Company may, at its election,
terminate  this  Agreement at the close of business on the date thirty (30) days
after the  Company  shall have  delivered a written  notice of such  election to
Turley,  in which event Turley shall be entitled to (i) receive  benefits  under
the Company's Long Term Disability Plan as such plan may exist as of the date of
termination of this Agreement  (provided that he is then  participating  in such
plan),  and (ii) promptly receive a lump sum payment equal to the amount of Base
Salary or Consulting Fee, or both, as the case may be, that would otherwise have
been payable to him during the remainder of the Contract Period pursuant to this
Agreement.

                  As used in this Agreement,  the term  "disability"  shall mean
the  inability  of Turley due to  illness or  physical  or mental  infirmity  to
perform his duties under this Agreement as determined by a physician selected by
Turley and acceptable to the Company.

                  (b) During  the period  Turley  shall be  entitled  to receive
monthly  payments under Section 13(a) above, to the extent that he is physically
and mentally able to do so, he shall,  upon the request of the Company,  furnish
information  and assistance to the Company,  and, in addition,  upon  reasonable
request  of Chief  Executive  Officer or the Board of  Directors,  he shall make
himself available to the Company to undertake reasonable  assignments consistent
with the  dignity,  importance  and scope of his  position  and his physical and
mental health.

                  (c) In the event of the death of Turley  during  the  Contract
Period,  the  Company  shall pay, or cause to be paid,  to  Turley's  designated
beneficiary or beneficiaries or estate or legal representatives: (i) the payment
due pursuant to the terms of the group term  insurance  policies  together  with
such other death  benefits as may be payable under the  Company's  benefit plans
which he then  participates  in, and (ii) a lump sum payment equal to the amount
of Base  Salary or  Consulting  Fee,  or both,  as the case may be,  that  would
otherwise  have been payable to him during the remainder of the Contract  Period
pursuant to this Agreement.

         14.      Termination.

                  (a) Except as  otherwise  provided in  subsection  (c) and (d)
hereof,  this Agreement and the Company's  contractual  relationship with Turley
hereunder  shall  terminate  upon the  earliest to occur of the dates  specified
below:

                  (i) the close of  business on the date that is the last day of
the Contract Period;

                  (ii) the close of business on the date of death of Turley;

                  (iii) the close of business  on the date the Company  delivers
to Turley a written  notice of its  election to  terminate  this  Agreement  for
"Cause" (as defined in paragraph (b) below);

                  (iv) the close of  business on the date thirty (30) days after
the Company shall have  delivered to Turley a written notice of its intention to
terminate this Agreement because the Board of Directors has determined that such
termination is in the best interests of the Company and such  termination is not
for cause, death, or disability; or

                  (v) the close of business on the date of a termination  by the
Company pursuant to Section 13(a) hereof; or

                  (vi)  the  close  of  business  on the  date on  which  Turley
terminates this Agreement other than pursuant to Section 17(c) hereof.

                  (b) For purposes of this  Agreement,  the term  "Cause"  shall
mean: (i) Turley's conviction (which, through lapse of time or otherwise, is not
subject to appeal)  of, or a plea of guilty or nolo  contendre  to, any crime or
offense  which  constitutes  a felony in the  jurisdiction  involved or involves
moral  turpitude,  (ii)  the  commission  of an act of  fraud,  embezzlement  or
intentional  dishonesty against the Company or any of its subsidiaries,  (iii) a
breach of this  Agreement by Turley,  or (iv) breach of fiduciary duty resulting
in injury to the Company or its subsidiaries.

                  (c) For purposes hereof, upon termination of this Agreement as
provided  in Section  14(a)(i)-(vi),  all  obligations  and  liabilities  of the
parties hereto shall cease and be of no effect except for those  liabilities and
obligations provided for in Section 13, 15 and 16 hereof.

                  (d) For purposes of clause (iv) of Section 14(a) above, Turley
shall be  relieved of his duties and shall  vacate his office and the  Company's
premises on the date of receipt of the notice  required  by such  clause  unless
requested  by the  Company  to  remain  in the  active  employment  of,  or as a
consultant  to, the Company during such period between the receipt of notice and
the effective date of termination.

         15.      Payments to Employee Upon Termination.

                  (a) Upon the  termination  of this Agreement by the Company in
accordance  with clause  (iv) of Section  14(a) of this  Agreement,  the Company
shall pay to Turley, or in the event of his subsequent death, to his beneficiary
or beneficiaries or his estate or legal  representative,  as severance pay (i) a
lump sum payment equal to the amount of Base Salary or Consulting  Fee, or both,
as the case may be,  that would  otherwise  have been  payable to him during the
remainder of the Contract Period  pursuant to this  Agreement,  plus (ii) if the
termination  occurs  during  the  Employment  Period,  subject  to the terms and
provisions  of the  Executive  Three Year Bonus Plan,  a pro rata portion of any
bonus  compensation  payable to Turley under the Company's  Executive Three Year
Bonus Plan.

                  (b) Upon the termination of this Agreement  pursuant to clause
(iv) of Section  14(a) of this  Agreement  during  the  Employment  Period,  the
Company  shall at its  expense  continue  on  behalf  of  Turley  the  following
benefits:   life   insurance,   short  and   long-term   disability   insurance,
hospitalization  insurance and medical and dental  reimbursement plan insurance.
The coverage of any such insurance provided by the Company hereunder shall be no
less favorable to Turley, in terms of amounts and deductibles, than the coverage
provided under the benefit programs  maintained by the Company from time to time
for the Company's executives. The Company's obligation hereunder with respect to
each of the foregoing  benefit plans shall terminate upon the earlier of the end
of the Severance Period or the date Turley obtains any such benefits pursuant to
a subsequent employer's benefit plans.

                  (c)  Benefits  pursuant to the  Company's  Profit  Sharing and
Pension  Plans (and such other plans in which  Employee  participates)  shall be
payable to Turley in accordance with the terms of such Plans.

                  (d) For purposes of this Agreement, the Severance Period shall
mean eighteen (18) months.

                  (e) Turley further  acknowledges that as a condition precedent
to receiving any benefits under this Agreement,  Turley shall complete,  execute
and deliver to the Company at the time of the  termination  of this  Agreement a
Release in the form of Exhibit "A" hereto which releases any and all claims that
Turley may have against the Company as of the date of termination  arising under
federal, state, local or common law.

         16.      Covenants of Turley.

                  (a) Turley  agrees that during the  Contract  Period and for a
period  of time  equal to (i) one year in the  event  of a  termination  of this
Agreement in accordance  with clause (iii) of Section  14(a);  (ii) two years in
the event of a termination of this  Agreement in accordance  with Section 13(a);
or (iii) the Severance Period in the event of a termination of this Agreement in
accordance  with clause (iv) of Section  14(a) or in the event of a  termination
under any other  circumstance,  he will not,  directly  or  indirectly,  engage,
assist or  participate  in,  whether as a director,  officer,  employee,  agent,
manager,   consultant,   partner,  owner  or  independent  contractor  or  other
participant,  any  business,  firm,  corporation,   partnership,  enterprise  or
organization  that competes with the business engaged or hereafter engaged in by
the  Company or any of its  subsidiaries  (including,  but not  limited  to, the
operation of retail drug stores in which  prescription  drugs are sold, the sale
of photofinishing products or services, the mail order pharmacy business, and/or
the  pharmacy   benefits   management   business)  in  the   Company's  or  such
subsidiaries'  trade areas (for  purposes  hereof  "trade  areas" shall mean any
county in any state of the United States in which retail drug stores operated by
the Company and its  subsidiaries  are located or in which services are provided
by the Company or its  subsidiaries).  Nothing  contained  herein shall  prevent
Turley from acquiring less than 2% of any class of outstanding securities of any
Company that has any of its securities listed on a national  securities exchange
or traded in the over-the-counter market.

                  (b) Turley  agrees that during the  Contract  Period and for a
period of two years after the  termination of this Agreement for any reason,  he
will not directly induce or solicit any person employed or hereafter employed by
the Company or any of its subsidiaries to leave the employ of the Company or any
of its subsidiaries.

                  (c)  Turley  agrees  and  acknowledges  that the  Confidential
Information  of the Company and its  subsidiaries  (as  hereinafter  defined) is
valuable,  special and unique to their business;  that such business  depends on
such  Confidential  Information;  and that the  Company  wishes to protect  such
Confidential  Information by keeping it confidential  for the use and benefit of
the Company.  Based on the  foregoing,  Turley agrees to undertake the following
obligations with respect to such Confidential Information:

                  (i) Turley agrees to keep any and all Confidential Information
in trust for the use and benefit of the Company;

                  (ii) Turley agrees that, except as required by Turley's duties
or  authorized  in writing by the  Company and its  subsidiaries  or required by
applicable  law,  he will not at any time  during  and for a period  of five (5)
years after the termination of this Agreement, disclose, directly or indirectly,
any Confidential Information of the Company or any of its subsidiaries.

                  (iii) Turley agrees to take all reasonable steps necessary, or
reasonably  requested  by the Company and its  subsidiaries,  to ensure that all
Confidential  Information  of the Company is kept  confidential  for the use and
benefit of the Company and its subsidiaries; and

                  (iv) Turley agrees that, upon termination of this Agreement by
the Company or any of its  subsidiaries  or at any other time the Company may in
writing so  request,  he will  promptly  deliver to the  Company  all  materials
constituting Confidential Information (including all copies thereof) that are in
his possession or under his control. Turley further agrees that, if requested by
the Company to return any Confidential  Information  pursuant to this Subsection
(iv), he will not make or retain any copy or extract from such materials.

                  For purposes of this Section 16(c),  Confidential  Information
means any and all  information  developed  by or for the  Company  or any of its
subsidiaries of which Turley gained knowledge by reason of his employment by (or
consultant  relationship  with) the Company or any of its subsidiaries  prior to
the date hereof or his  employment  under this  Agreement  that is not generally
known  in  any  industry  in  which  the  Company  is  or  may  become  engaged.
Confidential   Information  includes,  but  is  not  limited  to,  any  and  all
information  developed by or for the Company  concerning  plans,  marketing  and
sales methods, materials, processes, business forms, procedures, devices used by
the Company,  its  subsidiaries,  suppliers and customers with which the Company
had dealt prior to Turley's termination of this Agreement, plans for development
of new  products,  services and  expansion  into new areas or markets,  internal
operations,  and any trade secrets and proprietary information of any type owned
by the Company and its  subsidiaries,  together  with all  written,  graphic and
other materials relating to all or any part of the same.

         17.      Change of Control

                  (a)  Definition  of Change of Control.  No  benefits  shall be
payable  under this Section 17 unless there shall have been a Change of Control,
as set forth below,  and this Agreement shall thereafter have been terminated in
accordance  with  Section  17(b)  below.  As used  herein,  the term  "Change of
Control" shall mean:

                  (i) the  acquisition by any individual,  firm,  corporation or
other entity or any group of individuals,  firms, corporations or other entities
acting in concert  ("Person")  together with all  Affiliates  and Associates (as
such terms are defined in Rule 12b-2 of the General Rules and Regulations  under
the  Securities  Exchange  Act of 1934 (the  "Exchange  Act") of such  Person of
beneficial  ownership  (as such term is defined in Rule 13d-3 under the Exchange
Act) of more than 25% of the outstanding shares of voting stock of the Company;

                  (ii) any change in the  composition  of the Board of Directors
of the  Company  resulting  in members of the Board on the date  hereof (or such
other  persons who are elected  by, or on the  recommendation  of, a majority of
such members or other persons who had been elected by, or on the  recommendation
of, a majority of such members) ("Continuing Directors") ceasing to constitute a
majority of the Board of Directors; or

                  (iii) any other event determined by a majority of the Board of
Directors of the Company to constitute a Change of Control.

                  (b)  Termination  Following  Change of Control.  If any of the
events  described in Section 17(a) above  constituting a Change of Control shall
have  occurred,  Turley  shall be entitled to the  benefits  provided in Section
17(e)  hereof upon the  subsequent  termination  of  employment  during the time
period  referred to in Section  17(e) hereof if such  termination  is (i) by the
Company  pursuant to  Subsections  14(a)(iv) or (v) hereof or (ii) by Turley for
Good Reason.

                  (c)      Definition of Good Reason.

                  (A) Turley shall be entitled to terminate for Good Reason. For
purposes of this Agreement, "Good Reason" shall without Turley's express written
consent, mean, following a Change of Control:

                  (1) the assignment to Turley of any duties  inconsistent  with
Turley's status as a senior executive  officer of, or consultant to, the Company
or a substantial alteration in the nature or status of Turley's responsibilities
from those in effect immediately prior to a Change of Control; or an adverse and
substantial alteration in Turley's reporting responsibilities,  title or offices
as in effect  immediately  prior to a Change of Control or any removal of Turley
from or failure to reelect  Turley to any such  positions  except in  connection
with the termination of this Agreement for Disability or Cause or as a result of
death or by Turley other than for Good Reason;

                  (2) a reduction by the Company in Turley's  annual Base Salary
as in  effect  on  the  date  hereof  during  the  Employment  Period  or in the
Consulting Fee during the Consulting Period;

                  (3) any  material  breach by the Company of any  provision  of
this Agreement; or

                  (4) any purported  termination of this Agreement  which is not
effected  pursuant to a Notice of  Termination  satisfying the  requirements  of
Section  17(d) below and,  for  purposes of this  Agreement,  no such  purported
termination shall be effective.

                  (B) Turley's  right to terminate  his  employment  pursuant to
this  Subsection  17(c)  shall not be affected  by  Turley's  incapacity  due to
physical or mental illness.

                  (d) Notice of  Termination.  Any purported  termination by the
Company or by Turley shall be  communicated  by written Notice of Termination to
the other party hereto in  accordance  with  Section 19 hereof.  For purposes of
this  Agreement,  a "Notice  of  Termination"  shall mean a notice  which  shall
indicate the specific  termination  provision of this Agreement  relied upon and
shall set forth in  reasonable  detail  the facts and  circumstances  claimed to
provide  a basis for  termination  of this  Agreement  under  the  provision  so
indicated.  For purposes of this Agreement,  no such purported termination shall
be effective without such Notice of Termination.

                  (e) Compensation  for Termination.  If this Agreement shall be
terminated  by the Company  within two years after a Change of Control but prior
to the end of the  Contract  Period (a) by the Company  pursuant to  Subsections
(14)(a)(iv) or (v), or (b) by Turley for Good Reason, then:

                  (i) within five (5) days of the date of such termination,  the
Company shall pay Turley a single  severance  payment in cash in an amount equal
to the amount of Base Salary or  Consulting  Fee,  or both,  as the case may be,
that would  otherwise  have been  payable to him  during  the  remainder  of the
Contract  Period  pursuant to this Agreement  plus, if such  termination  occurs
during the  Employment  Period,  a lump sum  payment  equal to two (2) times the
amount of Turley's Base Salary,  plus (x) if the  termination  occurs during the
Employment  Period,  all accrued but unpaid Base Salary and a pro rata amount of
the bonus payable  pursuant to Section 4 hereof through the date of termination,
or (y) if the termination  occurs during the Consulting  Period, all accrued but
unpaid amounts of the Consulting Fee;

                  (ii) for a period of two (2) years  after a  termination  that
occurs during
the Employment  Period,  the Company shall at its expense  continue on behalf of
Turley the benefits described in Section 15(b) of this Agreement; and

                  (iii) any  restrictions  on any outstanding  incentive  awards
(including, but not limited to, restricted stock) granted to Turley under any of
the Company's  benefit plans or otherwise shall lapse and such incentive  awards
shall become 100% vested.

                  (f)  Mitigation.  Turley shall not be required to mitigate the
amount  of any  payment  provided  for  in  this  Section  17 by  seeking  other
employment or otherwise nor shall the amount of any payment or benefit  provided
for in this  Section 17 be reduced by any  compensation  earned by Turley as the
result of employment by another  employer or by  retirement  benefits  after the
date of termination or otherwise.

                  (g)  Compensation  Election.  If Turley receives  compensation
pursuant to this Section 17, Turley shall not be entitled to any other  benefits
hereunder,  other than that referred to in subsection (e) above,  the receipt of
any compensation which Turley had earned but previously elected to defer receipt
of and the  right to  exercise  options  in  accordance  with  the  terms of the
Company's Stock Option Plans under which such options were granted.

                  (h)  Excise  Tax  Payment.  In the event  that any  payment or
benefit (within the meaning of Section  280G(b)(2) of the Internal  Revenue Code
of 1986, as amended (the "Code")), to Turley or for this benefit paid or payable
or  distributed  or  distributable  pursuant to the terms of this  Agreement  or
otherwise in connection  with,  or arising out of, his  employment or consulting
with the  Company  or a  Change  in  Control  of the  Company  (a  "Payment"  or
"Payments"),  would be subject to the excise tax imposed by Section  4999 of the
Code or any  interest or  penalties  are incurred by Turley with respect to such
excise tax (such excise tax, together with any such interest and penalties,  are
hereinafter  collectively  referred to as the "Excise Tax"), then Turley will be
entitled to immediately  receive an additional payment (a "Gross-Up Payment") in
an amount such that after payment by Turley of all taxes (including any interest
or penalties,  other than  interest and penalties  imposed by reason of Turley's
failure  to file  timely a tax  return  or pay taxes  shown  due on his  return,
imposed with respect to such taxes and the Excise Tax), including any Excise Tax
imposed  upon the  Gross-Up  Payment,  Turley  retains an amount of the Gross-Up
Payment equal to the Excise Tax imposed upon the Payments.

         18.      Successors and Assigns.

                  (a) This  Agreement  shall be binding  upon and shall inure to
the benefit of the Company,  its successors  and assigns.  The term "Company" as
used herein shall include such successors and assigns.  The term "successors and
assigns" as used herein shall mean a corporation  or other entity  acquiring all
or  substantially  all the assets and business of this Company  (including  this
Agreement) whether by operation of law or otherwise.

                  (b) Neither this Agreement nor any right or interest hereunder
shall be  assignable  by Turley,  his  beneficiaries,  or legal  representatives
without the Company's prior written consent; provided,  however, that nothing in
this Section 18 shall  preclude (i) Turley from  designating  a  beneficiary  to
receive any benefit  payable  hereunder  upon his death,  or (ii) the executors,
administrators,  or other  legal  representatives  of Turley or his estate  from
assigning  any  rights  hereunder  to  distributees,   legatees,  beneficiaries,
testamentary trustees or other legal heirs of Turley.

                  (c) After a Change of Control,  the Company  will  require any
successor  or  assign  (whether  direct  or  indirect,   by  purchase,   merger,
consolidation of otherwise) to all or  substantially  all of the business and/or
assets of the Company to expressly assume and agree to perform this Agreement in
the same manner and to the same  extent  that the  Company  would be required to
perform it if no such  succession or assignment had taken place.  Failure of the
Company to obtain such  assumption and agreement prior to the  effectiveness  of
any such succession or assignment  shall be a breach of this Agreement and shall
entitle  Turley to  compensation  from the Company in the same amount and on the
same terms as Turley would be entitled hereunder if Turley terminated employment
for Good Reason except that, for purposes of  implementing  the  foregoing,  the
date on which any such  succession  or  assignment  becomes  effective  shall be
deemed the date of termination. As used in this Agreement,  "Company" shall mean
the Company as hereinbefore  defined and any successor or assign to its business
and/or assets as aforesaid which assumes and agrees to perform this Agreement by
operation of law, or otherwise.

         19.      Notices.

                  Any notice  required or permitted by this  Agreement  shall be
given by registered or certified mail,  return receipt  requested,  addressed to
the Company at its then principal  office, or to Turley at his address specified
on page 1 of this Agreement,  or to either party hereto at such other address or
addresses  as he or it may from  time to time  specify  for such  purposes  in a
notice similarly given.

         20.      Governing Law; Litigation; Expenses.

                  (a) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Florida  without  giving effect to the
conflicts of law principles thereof.

                  (b) Turley and the Company hereby agree that the courts of the
State of Florida  shall have  exclusive  jurisdiction  to hear and determine any
claims  or  disputes  pertaining  to this  Agreement  or to any  matter  arising
therefrom.  Each of Turley and the Company  expressly  submits  and  consents in
advance to such  jurisdiction  in any action  commenced  in such  courts  hereby
waiving personal service of the summons and complaint or other process or papers
issued  therein,  and agreeing  that service of such summons and  complaint,  or
other process or papers,  may be made by registered or certified  mail addressed
to the  Company  at its  then  principal  office  or to  Turley  at his  address
specified on page 1 of this  Agreement,  or to either party hereto at such other
addresses  as it or he from time to time  specify to the other  party in writing
for such  purpose.  The  exclusive  choice of forum set forth in this Section 20
shall not be deemed to preclude the enforcement of any judgment obtained in such
forum or the taking of any action under this  Agreement to enforce such judgment
in any appropriate jurisdiction.


                  (c)  All  costs  and  expenses  (including   attorneys'  fees)
incurred  in  connection  with any  litigation  relating  to a claim or  dispute
pertaining to this Agreement shall be paid by the party incurring such expenses,
except if the claim or dispute pertains to the enforcement of Section 17 hereof,
in which case the  prevailing  party shall be entitled to an award of such costs
and expenses from the non-prevailing party.

                  (d) Nothing  contained  in this  Section 20 shall be deemed to
limit  the  Company's  obligation  to  indemnify  Turley to the  fullest  extent
permitted by  applicable  law in respect of any actions,  claims or  proceedings
which are based upon acts or omissions of Turley  related to the  performance of
his duties  hereunder  to the extent he would have  otherwise  been  entitled to
indemnification  under the  by-laws  or  charter  of the  Company  or any of its
subsidiaries or to the extent to which indemnification is to be paid to officers
and directors as a matter of law.

         21.      Entire Agreement.

                  This instrument  contains the entire  agreement of the parties
relating  to the  subject  matter  hereof  and  supersedes  any  and  all  other
agreements and understandings,  whether written, oral or otherwise, with respect
to the subject matter hereof and all of such other agreements and understandings
shall be of no force or effect. Nothing contained in this Agreement shall in any
way limit any  benefits  that Turley  shall  otherwise  be entitled to under the
Company's  profit sharing or pension plans or other employee  benefit plans that
Turley participated or participates in either prior to or after the date hereof.
No modification of this Agreement shall be valid unless in writing and signed by
the  parties  hereto.  The waiver of a breach of any term or  condition  of this
Agreement shall not be deemed to constitute a waiver of any subsequent breach of
the same or any other term or condition of this Agreement.

         22.      Severability.

                  If any term or provision of this Agreement or the  application
thereof to any person,  property or circumstance  shall to any extent be invalid
or  unenforceable,  the remainder of this Agreement,  or the application of such
term or provision to persons,  property or circumstances  other than those as to
which it is invalid or  unenforceable  shall not be affected  thereby,  and each
term and  provision  of this  Agreement  shall be valid and  enforceable  to the
fullest extent permitted by law.

         23.      Injunctive Relief.

                  (a) Turley  acknowledges  and agrees  that the  covenants  and
obligations  contained  in  Sections  16(a),  16(b) and 16(c) of this  Agreement
relate to special,  unique and extraordinary matters and that a violation of any
of the terms of such  Sections  will cause the  Company  irreparable  injury for
which adequate remedies at law are not available.  Therefore, Turley agrees that
the Company  shall be entitled to an  injunction,  restraining  order,  or other
equitable relief from any court of competent  jurisdiction,  restraining  Turley
from  committing  any violation of the covenants  and  obligations  set forth in
Sections 16(a), 16(b) and 16(c) hereof.

                  (b) The  Company's  rights and remedies  under this Section 23
are  cumulative and are in addition to any other rights and remedies the Company
may have at law or in equity. In connection with the foregoing provision of this
Section 23, Turley represents that his economic means and circumstances are such
that such  provisions  will not prevent him from  providing  for himself and his
family on a basis satisfactory to him.

         24.      Withholding Taxes.

                  The Company may deduct from any payments to be made  hereunder
any  federal,  state or local  withholding  or other  taxes  which  the  Company
determines it is required to deduct under applicable law.

         25.      Counterparts.  This  Agreement  may be executed in one or
more  counterparts,  each of which shall be deemed an original of which together
shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement as of the day, month and year first written above.


ECKERD CORPORATION                                   TURLEY


By: /s/ James M. Santo                               /s/ Stewart Turley
     Name:  James M. Santo                           Stewart Turley
     Its:  Executive Vice President


a: turley


                                                                 EXHIBIT 10.26


                              EMPLOYMENT AGREEMENT


         AGREEMENT   made  as  of  February  4,  1996,  by  and  between  Eckerd
Corporation, a Delaware corporation (the "Company") and Frank Newman residing at
820 South Bayside Drive, Tampa, Florida 33609, (the "Employee").

         WHEREAS,  upon  the  terms  and  subject  to  the  conditions  of  this
Agreement,  the  Company  desires to employ the  Employee  and the  Employee  is
willing to accept employment by the Company,

         NOW,  THEREFORE,  in  consideration  of the mutual  covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto hereby agree as follows:

         1.       Employment.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,  the Company  hereby  employs the Employee  and the  Employee  hereby
accepts employment by the Company in the capacity hereinafter set forth.

         2.       Term of Employment.

                  The term of the  Employee's  employment  by the Company  under
this  Agreement  shall  commence on the date hereof,  and shall be for a term of
twelve (12) months,  subject to extension and termination as provided in Section
8 hereof (the "Contract Period").

         3.       Duties; Extent of Services.

                  (a) During the Contract  Period,  the Employee  shall serve as
the Chief  Executive  Officer,  President  and Chief  Operating  Officer  of the
Company  and shall  perform  the  duties,  undertake  the  responsibilities  and
exercise the  authority  customarily  performed,  undertaken  and exercised by a
person in such position in the business in which the Company is engaged.

                  (b)  Except  as  otherwise  provided  herein  and  except  for
illness,  permitted  vacation periods and permitted leaves of absence during the
Contract  Period,  the  Employee  shall (i) devote  his full time and  attention
during  normal   business   hours  to  the  business  of  the  Company  and  its
subsidiaries;  (ii)  use his best  efforts  to  promote  the  Company's  and its
subsidiaries'  interests;  (iii) discharge such other and further  executive and
administrative  duties not inconsistent  with his position as may be assigned to
him by the Board of Directors of the Company or its chief executive officer; and
(iv) in addition to serving as a director of the Company (if elected),  serve as
director of any subsidiary of the Company if elected as such.

                  (c) Except for directorships  held by the Employee on the date
of this Agreement, during the Contract Period the Employee will not, without the
prior written consent of the Company's  Board of Directors,  such consent not to
be unreasonably withheld, serve as a director of any corporation, joint venture,
association or other  commercial  enterprise  not controlled by,  controlling or
under common control with, the Company and its subsidiaries.

         4.       Compensation.

                  (a) In consideration of the services  rendered by the Employee
under this  Agreement,  the Company  shall pay the Employee a base annual salary
(the "Base  Salary") in the amount of $575,000 (or such other  higher  amount as
the Board of Directors of the Company shall  determine)  payable  monthly on the
fifteenth (15th) of each month during the Contract Period. The Base Salary shall
be reviewed as of February 1, 1997 and annually thereafter.

                  (b) During the Contract Period, as additional compensation for
his services and as a further incentive and inducement to the Employee to accept
employment  by the Company and to devote his best  efforts to the  business  and
affairs  of the  Company  and its  subsidiaries,  the  Company  shall pay to the
Employee  additional  compensation  (the "Bonus  Compensation") in the following
amounts:

                  (i) The  Employee  shall be  entitled  to  participate  in the
Company's  annual bonus, and three-year bonus plans (and such other plans as may
be in effect  from  time to time) on the same  terms  and  conditions  generally
applicable to the other senior  executive  officers of the Company as determined
by the Board of Directors of the Company from time to time.

                  (c) The Company  agrees that the Employee shall be entitled to
defer some portion or all of his Base Salary for any calendar year in accordance
with the provisions of the Company's  Executive  Deferred  Compensation  Plan as
adopted by the Board of Directors.

                  (d)  The  Company  shall  provide  either  a top of  the  line
domestic model  automobile  for Employee's use in accordance  with the Company's
standard  policies,  or, at Employee's  option, a monthly  automobile  allowance
sufficient  for Employee to lease a top of the line domestic  model  automobile,
together with reimbursement of automobile  expenses provided the expenses do not
exceed those associated with a top of the line domestic model automobile.

         5.       Fringe Benefits.

                  In addition to the  compensation  provided in Section 4 above,
during the  Contract  Period the  Employee  shall be entitled  to the  following
benefits:

                  (a) The Employee  shall be entitled to paid  vacation time for
at least four (4) weeks annually.

                  (b) The  Employee  shall be  entitled  to  participate  in all
employee benefit programs now or hereafter  maintained by the Company for senior
executive  personnel for which he is eligible,  including,  without  limitation,
group life insurance,  short and long-term disability,  profit sharing, pension,
stock option,  supplemental  retirement income,  hospitalization and medical and
dental  reimbursement plan or program,  his participation in such programs to be
based upon the  applicable  provisions  of such  programs as they may exist from
time to time.

                  (c) The Employee  shall be entitled to a private  office and a
secretary and such other assistance and  accommodations  as shall be suitable to
the character of the  Employee's  position with the Company and adequate for the
performance of his duties hereunder.

         6.       Expenses.

                  The  Company  shall  pay or  reimburse  the  Employee  for all
reasonable  and  normal  business  expenses,   including   reasonable   expenses
associated with participation in professional or similar business  organizations
reasonably  incurred or paid by him in connection  with the  performance  of his
duties  hereunder upon  presentation of expense  statements or vouchers and such
other  supporting  documentation as the Company may from time to time reasonably
request.

         7.       Benefits Payable Upon Disability.

                  (a) In the event of the disability (as hereinafter defined) of
the  Employee  during the Contract  Period,  the Company  shall,  subject to the
provisions  of Section 9 hereof,  continue to pay the Employee the  compensation
provided  in Section 4 hereof  during the  period of his  disability  or earlier
termination  hereof;  provided,  however,  that in the  event  the  Employee  is
disabled for a continuous period exceeding six (6) consecutive  calendar months,
the Company  may, at its  election,  terminate  this  Agreement  at the close of
business on the date thirty (30) days after the Company  shall have  delivered a
written  notice of such  election to the  Employee,  in which event the Employee
shall be entitled to receive  benefits under the Company's Long Term  Disability
Plan as such plan may exist as of the date of  termination of this Agreement and
compensation provided in Section 4(a) hereof shall cease, provided however, that
Employee  shall  receive not less than  $25,000  per month up to age  sixty-five
(65).

                  As used in this Agreement the term "disability" shall mean the
inability  of the  Employee  due to illness or physical or mental  infirmity  to
perform his duties under this Agreement as determined by a physician selected by
the Employee and acceptable to the Company.

                  (b)  During  the  period the  Employee  shall be  entitled  to
receive  payments under Section 7(a) above,  to the extent that he is physically
and mentally  able to do so, he shall,  upon the request of the Company  furnish
information  and assistance to the Company,  and, in addition,  upon  reasonable
request of the chief  executive  officer of the  Company,  he shall make himself
available to the Company to undertake reasonable assignments consistent with the
dignity,  importance  and scope of his  position  and his  physical  and  mental
health.

                  (c) In the event of the death of Employee  during the Contract
Period, the Company shall pay, or cause to be paid, to the Employee's designated
beneficiary or beneficiaries or estate or legal representatives, the payment due
pursuant to the terms of the group term  insurance  policies  together with such
other death benefits as may be payable under the Company's benefit plans.

         8.       Termination.

                  (a)  Except as  otherwise  provided  in  Sections  7, 9 and 10
hereof,  this  Agreement  and the  employment  of the Employee  hereunder  shall
terminate upon the earliest to occur of the dates specified below:

                  (i) the close of  business  on the date that is one year after
the date hereof (the  "Initial  Period"),  except  that this  Agreement  and the
employment of the Employee  hereunder shall be automatically  extended from year
to year  thereafter  unless  terminated  by the  Company or the  Employee by the
delivery of not less than ninety (90) days written notice to the Employee or the
Company, as the case may be, (in which case the employment of the Employee shall
terminate on the date specified for termination in such notice);

                  (ii)  the  close  of  business  on the  date of  death  of the
Employee;

                  (iii) the close of business  on the date the Company  delivers
to the Employee a written notice of its election to terminate his employment for
"cause" (as defined in paragraph (b) below);

                  (iv) the close of  business on the date thirty (30) days after
the  Company  shall  have  delivered  to the  Employee  a written  notice of its
intention  to  terminate  his  employment  because  the Board of  Directors  has
determined  that such  termination  is in the best  interests of the Company and
such  termination  is not for  cause,  death,  disability  or  failure to extend
pursuant to Section 8(a)(i) hereof; or

                  (v) the close of business on the date of a termination  by the
Company pursuant to Section 7(a) hereof.

                  (b) For purposes of this  Agreement,  the term  "cause"  shall
include a willful  refusal to perform  duties in  accordance  with the Company's
policies,  commission  by  Employee  of a material  act of fraud or  intentional
dishonesty,  breach of fiduciary  duty  resulting in  significant  injury to the
Company  and  Employee's  conviction  for,  or a plea of nolo  contendere  to, a
felony.

         9.       Payments to Employee Upon Termination of Employment.

                  (a)  Upon  the   termination  of  the   Employee's   full-time
employment  hereunder by the Company in accordance with clauses (i), (iv) or (v)
of Section 8(a) of this Agreement,  the Company shall pay to the Employee, or in
the event of his subsequent  death, to his beneficiary or  beneficiaries  or his
estate or legal  representative,  as  severance  pay an amount  equal to two (2)
times the then current Base Salary paid to the  Employee  under this  Agreement,
payable in twenty-four  (24) equal monthly  payments plus (y) a pro rata portion
of any Bonus Compensation which would have been paid to the Employee pursuant to
Section  4(b)(i) hereof in respect of the year of termination if he had not been
so  terminated.  The  Employee  shall  continue  to be  entitled  to receive any
compensation  which Employee had earned but previously  elected to defer receipt
of.

                  (b) For a period of two (2) years following the termination of
the Employee's  full-time  employment hereunder for any reason which termination
occurs  during the  Contract  Period other than  termination  by the Company for
cause or  death,  the  Company  shall at its  expense  provide  on behalf of the
Employee the following benefits: life insurance,  short and long-term disability
insurance,  hospitalization  insurance and medical and dental reimbursement plan
insurance with coverage in terms of amounts and  deductibles  comparable to that
provided  from time to time during such two year period to senior  executives of
the Company.  The  Company's  obligation  hereunder  with respect to each of the
foregoing benefit plans shall be limited to the extent that the Employee obtains
any such  benefits  pursuant to a subsequent  employer's  benefit plans in which
case the  Company  may reduce the  coverage  of any  benefits  it is required to
provide the Employee under the foregoing plans as long as the aggregate coverage
of the combined benefit plans is no less favorable to the Employee,  in terms of
amounts and deductibles,  than the coverage  provided under the benefit programs
maintained by the Company for senior executives of the Company from time to time
during such two year period.

                  (c) If the  Company  terminates  Employee  pursuant to clauses
(ii) or (iii) of Section 8(a) or the Employee terminates  employment pursuant to
clause (i) of Section 8(a),  the Employee shall be entitled to Base Salary up to
the date of termination plus any benefits, if any, to the extent provided for in
any Company plans,  and no other  compensation or benefits,  except that: (i) in
the case of a  termination  pursuant to clause (ii) of Section  8(a),  the death
benefits  referred to in Section 7(c) shall be payable,  and (ii) Employee shall
continue to be entitled to receive any  compensation  which  Employee had earned
but previously elected to defer receipt of.


         10.       Covenants of the Employee.

                  (a) The Employee agrees (unless  Employee is terminated by the
Company pursuant to clause (iii) of Section 8(a), which termination has not been
intentionally  induced by Employee)  that during the  Contract  Period and for a
period of two (2) years  thereafter,  (herein  referred  to as the  "Non-Compete
Period"), he will not, directly or indirectly, engage, assist or participate in,
whether as a director, officer, employee, agent, manager,  consultant,  partner,
owner or  independent  contractor  or other  participant,  any  business,  firm,
corporation,  partnership, enterprise or organization that through the operation
of any of the following types of business operations  (collectively  referred to
herein as "Competitive Business"):

                  (i)  retail  drug  chains  similar  to those  operated  by the
Company;

                  (ii) "deep discount" drug chains;

                  (iii) "food/drug" combination retail chains;

                  (iv) Walmart or any similar type of discount chain stores of a
regional  nature  which are  predominately  operating  in the same states as the
Company's stores are located; or

                  (v) any  other  chain  retail  organizations  whose  sales are
comprised of  thirty-five  (35%) percent or more of  prescription  drug sales is
engaged in Competitive Business in any states in which the Company or any of its
subsidiaries is engaged in Competitive  Business during the Contract Period,  on
the date of termination of Employee's employment,  or in any states in which the
Company or any of its  subsidiaries  plans  (which  plans are  evidenced by some
written documentation),  as of the date of Employee's termination of employment,
to engage in  Competitive  Business  within the next  three (3) years,  provided
however,   that  Employee's   covenants  herein  shall  not  extend  beyond  the
Non-Compete  Period.  Nothing  contained  herein shall prevent the Employee from
acquiring  less than 2% of any class of  outstanding  securities  of any company
that has any of its  securities  listed on a  national  securities  exchange  or
traded in the over-the-counter market.

                  (b) The Employee  agrees that during the  Contract  Period and
for a period  of two years  after  the  termination  of this  Agreement  for any
reason,  he will not directly induce or solicit any person employed or hereafter
employed  by the  Company  or any of its  subsidiaries  in an  executive  or key
management  position  to  leave  the  employ  of  the  Company  or  any  of  its
subsidiaries.

                  (c) The Employee agrees and acknowledges that the Confidential
Information  of the Company and its  subsidiaries  (as  hereinafter  defined) is
valuable,  special and unique to their business;  that such business  depends on
such  Confidential  Information;  and that the  Company  wishes to protect  such
Confidential  Information by keeping it confidential  for the use and benefit of
the  Company.  Based on the  foregoing,  the Employee  agrees to  undertake  the
following obligations with respect to such Confidential Information:

                  (i)  The  Employee  agrees  to keep  any and all  Confidential
Information in trust for the use and benefit of the Company;

                  (ii) The  Employee  agrees  that,  except as  required  by the
Employee duties or authorized in writing by the Company and its  subsidiaries or
required by  applicable  law, he will not at any time during and for a period of
five (5) years after the  termination of his employment with the Company and its
subsidiaries,  disclose, directly or indirectly, any Confidential Information of
the Company or any of its subsidiaries;

                  (iii)  The  Employee  agrees  to  take  all  reasonable  steps
necessary,  or  reasonably  requested  by the Company and its  subsidiaries,  to
ensure that all Confidential Information of the Company is kept confidential for
the use and benefit of the Company and its subsidiaries; and

                  (iv)  The  Employee  agrees  that,  upon  termination  of  his
employment  by the Company or any of its  subsidiaries  or at any other time the
Company may in writing so request,  he will promptly  deliver to the Company all
materials constituting  Confidential  Information (including all copies thereof)
that are in the possession of or under the control of the Employee. The Employee
further  agrees that,  if  requested  by the Company to return any  Confidential
Information  pursuant to this  Subsection  (iv),  he will not make or retain any
copy or extract from such materials.

                  For purposes of this Section 10(c),  Confidential  Information
means any and all  information  developed  by or for the  Company  or any of its
subsidiaries of which the Employee gained  knowledge by reason of his employment
by the  Company  or any of its  subsidiaries  prior  to the date  hereof  or his
employment  under this Agreement and does not include  information:  (i) that is
generally  known in any  industry in which the Company is or may become  engaged
(ii) that is  generally  available  to the  public  other  than as a result of a
disclosure  by  Employee   (iii)  that  becomes   available  to  Employee  on  a
non-confidential  basis  from a  source  other  than the  Company  or one of its
representatives; or (iv) information that Employee is legally compelled (by oral
question  or  request  for  information  or  documents  in  legal   proceedings,
interrogatories,  subpoena,  civil  investigative  demand or similar process) to
disclose  provided that prior to complying with such request  Employee gives the
Company  prompt  notice  of  such  request  so  that  the  Company  may  seek an
appropriate  protective  order  and/or  waive  Employee's  compliance  with this
Section 10(c). Confidential Information includes, but is not limited to, any and
all information developed by or for the Company concerning plans,  marketing and
sales methods, materials, processes, business forms, procedures, devices used by
the Company,  its  subsidiaries,  suppliers and customers with which the Company
had dealt prior to the Employee's termination of employment with the Company and
its subsidiaries,  plans for development of new products, services and expansion
into new  areas or  markets,  internal  operations,  and any trade  secrets  and
proprietary  information of any type owned by the Company and its  subsidiaries,
together with all written,  graphic and other  materials  relating to all or any
part of the same.

         11.      Change of Control.

                  (a)  Definition  of Change of Control.  No  benefits  shall be
payable  under this Section 11 unless there shall have been a Change of Control,
as set forth below,  and Employee's  employment by the Company shall  thereafter
have been terminated in accordance with Section 11(b) below. As used herein, the
term "Change of Control" shall mean:

                  (i) the  acquisition by any individual,  firm,  corporation or
other entity or any group of individuals,  firms, corporations or other entities
acting in concert  ("Person")  together with all  Affiliates  and Associates (as
such terms are defined in Rule 12b-2 of the General Rules and Regulations  under
the  Securities  Exchange  Act of 1934 (the  "Exchange  Act") of such  Person of
beneficial  ownership  (as such term is defined in Rule 13d-3 under the Exchange
Act) of more than 25% of the outstanding shares of voting stock of the Company;

                  (ii) any change in the  composition  of the Board of Directors
of the  Company  resulting  in members of the Board on the date  hereof (or such
other  persons who are elected  by, or on the  recommendation  of, a majority of
such members or other persons who had been elected by, or on the  recommendation
of, a majority of such members) ("Continuing Directors") ceasing to constitute a
majority of the Board of Directors; or

                  (iii) any other event determined by a majority of the Board of
Directors of the Company to constitute a Change of Control.

                  (b)  Termination  Following  Change of Control.  If any of the
events  described in Section 11(a) above  constituting a Change of Control shall
have occurred,  Employee  shall be entitled to the benefits  provided in Section
11(e)  hereof upon the  subsequent  termination  of  employment  during the time
period  referred to in Section  11(e) hereof if such  termination  is (i) by the
Company pursuant to Subsections 8(a)(i),  (iv) or (v) hereof or (ii) by Employee
for Good Reason.

                  (c)      Definition of Good Reason.

                  (i)  Employee  shall be entitled to terminate  employment  for
Good  Reason.  For  purposes of this  Agreement,  "Good  Reason"  shall  without
Employee's express written consent, mean, following a Change of Control:

                  (a) the assignment to Employee of any duties inconsistent with
Employee's  status as a senior executive officer of the Company or a substantial
alteration in the nature or status of Employee's  responsibilities from those in
effect  immediately prior to a Change of Control;  or an adverse and substantial
alteration in  Employee's  reporting  responsibilities,  titles or offices as in
effect  immediately prior to a Change of Control or any removal of Employee from
or failure to reelect  Employee to any of such  positions  except in  connection
with the termination of employment for  Disability,  Retirement or Cause or as a
result of death or by Employee other than for Good Reason.

                  (b) a  reduction  by the  Company in  Employee's  annual  Base
Salary as in effect on the date hereof.

                  (c) any  material  breach by the Company of any  provision  of
this Agreement;

                  (d) any purported  termination of Employee's  employment which
is not effected pursuant to a Notice of Termination  satisfying the requirements
of Section 11(d) below and, for purposes of this  Agreement,  no such  purported
termination shall be effective.

                  (ii) Employee's right to terminate his employment  pursuant to
this  Subsection  11(c) shall not be affected by  Employee's  incapacity  due to
physical or mental illness.

                  (d) Notice of  Termination.  Any purported  termination by the
Company or by Employee shall be communicated by written Notice of Termination to
the other party hereto in  accordance  with  Section 13 hereof.  For purposes of
this  Agreement,  a "Notice  of  Termination"  shall mean a notice  which  shall
indicate the specific  termination  provision in this Agreement  relied upon and
shall set forth in  reasonable  detail  the facts and  circumstances  claimed to
provide a basis for termination of employment  under the provision so indicated.
For purposes of this Agreement, no such purported termination shall be effective
without such Notice of Termination.

                  (e) Compensation for Termination.  If Employee's employment by
the Company shall be  terminated  within two years after a Change of Control (a)
by the Company pursuant to Subsections  (8)(a)(i),  (iv), (v) or (b) by Employee
for Good Reason then:

                  (i) within five (5) days of the date of such termination,  the
Company shall pay Employee a single severance payment in cash in an amount equal
to 2.9  multiplied by Employee's  Base Salary paid to Employee by the Company in
the  Company's  fiscal  year  immediately   preceding  the  year  in  which  the
termination  occurs plus all accrued but unpaid Base Salary and a pro rata bonus
amount payable pursuant to Section 4 hereof through the date of termination;

                  (ii) for a period of two (2) years after such termination, the
Company  shall at its  expense  continue  on behalf  of  Employee  the  benefits
described in Section 9(b) of this Agreement; and

                  (iii) any  restrictions  on any outstanding  incentive  awards
(including,  but not limited to, restricted stock) granted to Employee under any
of the  Company's  benefit  plans or  otherwise  shall lapse and such  incentive
awards shall become 100% vested.

                  (f) Mitigation. Employee shall not be required to mitigate the
amount  of any  payment  provided  for  in  this  Section  11 by  seeking  other
employment or otherwise nor shall the amount of any payment or benefit  provided
for in this Section 11 be reduced by any compensation  earned by Employee as the
result of employment by another  employer or by  retirement  benefits  after the
date of termination or otherwise.

                  (g) Compensation  Election.  If Employee receives compensation
pursuant  to this  Section  11,  Employee  shall  not be  entitled  to any other
benefits  hereunder,  other than that referred to in subsection  (e) above,  the
receipt of any compensation  which Employee had earned but previously elected to
defer receipt of and the right to exercise  options in accordance with the terms
of the Company's Stock Option Plans under which such options were granted.

                  (h)  Excise  Tax  Payment.  In the event  that any  payment or
benefit (within the meaning of Section  280G(b)(2) of the Internal  Revenue Code
of 1986,  as amended  (the  "Code")),  to Employee or for this  benefit  paid or
payable or distributed or distributable  pursuant to the terms of this Agreement
or otherwise in  connection  with,  or arising out of, his  employment  with the
Company or a Change in Control of the Company (a "Payment" or "Payments"), would
be subject to the excise tax imposed by Section 4999 of the Code or any interest
or penalties  are incurred by the Employee with respect to such excise tax (such
excise tax,  together  with any such  interest and  penalties,  are  hereinafter
collectively  referred  to as the  "Excise  Tax"),  then  the  Employee  will be
entitled to immediately  receive an additional payment (a "Gross-Up Payment") in
an amount such that after  payment by the Employee of all taxes  (including  any
interest or penalties,  other than  interest and penalties  imposed by reason of
the Employee's failure to file timely a tax return or pay taxes shown due on his
return,  imposed with respect to such taxes and the Excise Tax),  including  any
Excise Tax imposed upon the Gross-Up Payment,  the Employee retains an amount of
the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.

         12.      Successors and Assigns.

                  (a) This  Agreement  shall be binding  upon and shall inure to
the benefit of the Company,  its successors  and assigns.  The term "Company" as
used herein shall include such successors and assigns.  The term "successors and
assigns" as used herein shall mean a corporation  or other entity  acquiring all
or  substantially  all the assets and business of this Company  (including  this
Agreement) whether by operation of law or otherwise.

                  (b) Neither this Agreement nor any right or interest hereunder
shall be assignable by the Employee, his beneficiaries, or legal representatives
without the Company's prior written consent; provided,  however, that nothing in
this Section 12 shall  preclude (i) the Employee from  designating a beneficiary
to receive any benefit payable  hereunder upon his death, or (ii) the executors,
administrators,  or other legal  representatives  of the  Employee or his estate
from assigning any rights  hereunder to distributees,  legatees,  beneficiaries,
testamentary trustees or other legal heirs of the Employee.

                  (c) After a Change of Control,  the Company  will  require any
successor  or  assign  (whether  direct  or  indirect,   by  purchase,   merger,
consolidation or otherwise) to all or  substantially  all of the business and/or
assets of the Company to expressly assume and agree to perform this Agreement in
the same manner and to the same  extent  that the  Company  would be required to
perform it if no such  succession or assignment had taken place.  Failure of the
Company to obtain such  assumption and agreement prior to the  effectiveness  of
any such succession or assignment  shall be a breach of this Agreement and shall
entitle Employee to compensation  from the Company in the same amount and on the
same terms as  Employee  would be  entitled  hereunder  if  Employee  terminated
employment  for Good  Reason  except  that,  for  purposes of  implementing  the
foregoing, the date on which any such succession or assignment becomes effective
shall be deemed the date of termination.  As used in this  Agreement,  "Company"
shall mean the Company as  hereinbefore  defined and any  successor or assign to
its business and/or assets as aforesaid which assumes and agrees to perform this
Agreement by operation of law, or otherwise.

         13.      Notices.

                  Any notice  required or permitted by this  Agreement  shall be
given by registered or certified mail,  return receipt  requested,  addressed to
the  Company at its then  principal  office,  or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
address or  addresses as he or it may from time to time specify for such purpose
in a notice similarly given.

         14.      Governing Law; Litigation; Expenses.

                  (a) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Florida  without  giving effect to the
conflicts of law principles thereof.

                  (b) The Employee and the Company  hereby agree that the courts
of the State of Florida shall have exclusive  jurisdiction to hear and determine
any claims or disputes  pertaining  to this  Agreement or to any matter  arising
therefrom.  Each of the Employee and the Company  expressly submits and consents
in advance to such  jurisdiction  in any action  commenced in such courts hereby
waiving personal service of the summons and complaint or other process or papers
issued  therein,  and agreeing  that service of such summons and  complaint,  or
other process or papers,  may be made by registered or certified  mail addressed
to the Company at its then  principal  office or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
addresses  as it or he from time to time  specify to the other  party in writing
for such  purpose.  The  exclusive  choice of forum set forth in this Section 14
shall not be deemed to preclude the enforcement of any judgment obtained in such
forum or the taking of any action under this  Agreement to enforce such judgment
in any appropriate jurisdiction.

                  (c)  All  costs  and  expenses  (including   attorneys'  fees)
incurred  in  connection  with any  litigation  relating  to a claim or  dispute
pertaining to this Agreement  shall be paid by the party incurring such expenses
except all costs and expenses (including attorneys' fees) incurred in connection
with any litigation  relating to a claim or dispute pertaining to this Agreement
shall be paid by the  party  incurring  such  expenses,  except  if the claim or
dispute  pertains  to the  enforcement  of Section 11 hereof,  in which case the
prevailing  party shall be entitled to an award of such costs and expenses  from
the non-prevailing party.

                  (d) Nothing  contained  in this  Section 14 shall be deemed to
limit the Company's  obligation to indemnify the Employee to the fullest  extent
permitted by  applicable  law in respect of any actions,  claims or  proceedings
which  are  based  upon  acts  or  omissions  of  the  Employee  related  to the
performance  of his duties  hereunder to the extent he would have otherwise been
entitled to  indemnification  under the by-laws or charter of the Company or any
of its subsidiaries or to the extent to which  indemnification  is to be paid to
officers and directors as a matter of law.

         15.      Entire Agreement.

                  This instrument  contains that entire agreement of the parties
relating  to  the  subject  matter  hereof,   and  there  are  no  restrictions,
agreements,  promises,  covenants,  undertakings,  representations or warranties
with respect to the subject  matter hereof other than those  expressly set forth
herein.  No  modification of this Agreement shall be valid unless in writing and
signed by the parties hereto. The waiver of a breach of any term or condition of
this  Agreement  shall not be deemed to  constitute  a waiver of any  subsequent
breach of the same or any other term or condition of this Agreement.

         16.      Severability.

                  If any term or provision of this Agreement or the  application
thereof to any person,  property or circumstance  shall to any extent be invalid
or  unenforceable,  the remainder of this Agreement,  or the application of such
term or provision to persons,  property or circumstances  other than those as to
which it is invalid or  unenforceable  shall not be affected  thereby,  and each
term and  provision  of this  Agreement  shall be valid and  enforceable  to the
fullest extent permitted by law.

         17.      Injunctive Relief.

                  (a) The Employee  acknowledges  and agrees that the  covenants
and obligations  contained in Sections 10(a),  10(b) and 10(c) of this Agreement
relate to special,  unique and extraordinary matters and that a violation of any
of the terms of such  Sections  will cause the  Company  irreparable  injury for
which adequate remedies at law are not available. Therefore, the Employee agrees
that the Company shall be entitled to an injunction, restraining order, or other
equitable  relief  from any court of  competent  jurisdiction,  restraining  the
Employee from  committing  any violation of the  covenants and  obligations  set
forth in Sections 10(a), 10(b), and 10(c) hereof.

                  (b) The  Company's  rights and remedies  under this Section 17
are  cumulative and are in addition to any other rights and remedies the Company
may have at law or in  equity.  The  Company's  rights and  remedies  under this
Section 17 are  cumulative  and are in addition to any other rights and remedies
the Company may have at law or in equity.


         20.      Withholding Taxes.

                  The Company may deduct from any payments to be made  hereunder
any  federal,  state or local  withholding  or other  taxes  which  the  Company
determines it is required to deduct under applicable law.

         21.      Counterparts.

                  This  Agreement  may be executed in one or more  counterparts,
each of which shall be deemed an original of which together shall constitute one
and the same instrument..

         IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement as of the day, month and year first written above.


ECKERD CORPORATION                                            EMPLOYEE

By: /s/ James M. Santo                                      /s/ Frank A. Newman
     Name:  James M. Santo                                  Frank A. Newman
     Its:  Executive Vice President

                          

                                                                  EXHIBT 10.27
                                        
                      EMPLOYMENT AGREEMENT (Exec. VP)

         AGREEMENT   made  as  of  February  1,  1996,  by  and  between  ECKERD
CORPORATION,  a Delaware corporation (the "Company) and JAMES M. SANTO, residing
at 5113 S. Nichol Street , Tampa, Florida 33611 (the "Employee").

         WHEREAS,  upon  the  terms  and  subject  to  the  conditions  of  this
Agreement,  the  Company  desires to employ the  Employee  and the  Employee  is
willing to accept employment by the Company.

         NOW,  THEREFORE,  in  consideration  of the mutual  covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto agree as follows:

         1.       Employment.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,  the Company  hereby  employs the Employee  and the  Employee  hereby
accepts employment by the Company in the capacity hereinafter set forth.

         2.       Term of Employment.

                  The term of the  Employee's  employment  by the Company  under
this  Agreement  shall  commence  on the date  hereof and shall be for a term of
twelve (12) months,  subject to extension and termination as provided in Section
8 hereof (the "Contract Period").

         3.       Duties; Extent of Services.

                  (a) During the Contract  Period,  the Employee  shall serve as
Executive  Vice  President/Administration  of  the  Company  or  in  such  other
executive  capacity  as shall be  determined  from  time to time by the Board of
Directors  of  the  Company  and  shall   perform  the  duties,   undertake  the
responsibilities and exercise the authority  customarily  performed,  undertaken
and  exercised by a person in such position in the business in which the Company
is engaged.

                  (b)  Except  as  otherwise  provided  herein  and  except  for
illness,  permitted  vacation periods and permitted leaves of absence during the
Contract  Period,  the  Employee  shall (i) devote  his full time and  attention
during  normal   business   hours  to  the  business  of  the  Company  and  its
subsidiaries;  (ii)  use his best  efforts  to  promote  the  Company's  and its
subsidiaries' interest; and (iii) discharge such other and further executive and
administrative duties as may be assigned to him by the Board of Directors of the
Company and its subsidiaries.

                  (c) Except for directorships  held by the Employee on the date
of this Agreement, during the Contract Period the Employee will not, without the
prior written consent of the Company's  Board of Directors,  serve as a director
of any corporation,  joint venture,  association or other commercial  enterprise
not controlled by, controlling or under common control with, the Company and its
subsidiaries.

         4.       Compensation.

                  (a) In consideration of the services  rendered by the Employee
under this  Agreement,  the Company  shall pay the Employee a base annual salary
(the "Base Salary") in the amount of $241,000 (or such other amount as the Board
of Directors of the Company shall  determine)  payable  monthly on the fifteenth
(15th) of each month during the Contract Period.

                  (b) During the Contract Period, as additional compensation for
his services and as a further incentive and inducement to the Employee to accept
employment  by the Company and to devote his best  efforts to the  business  and
affairs of the Company and its  subsidiaries,  the Employee shall be entitled to
participate in such  additional  compensation  plans (the "Bonus  Compensation")
which the Company allows the Employee to participate in from time to time.

                  (c) The Company  agrees that the Employee shall be entitled to
defer some portion or all of his Base Salary for any calendar year in accordance
with the provisions of the Company's  Executive  Deferred  Compensation  Plan as
adopted by the Board of Directors.

         5.       Fringe Benefits.

                  In addition to the  compensation  provided in Section 4 above,
during the  Contract  Period the  Employee  shall be entitled  to the  following
benefits:

                  (a) The  Employee  shall be  entitled  to paid  vacation  time
annually in  accordance  with the Company  policy as  determined by the Board of
Directors.

                  (b) The  Employee  shall be  entitled  to  participate  in all
employee  benefit  programs  now or  hereafter  maintained  by the  Company  for
executive  personnel for which he is eligible,  including,  without  limitation,
group life insurance,  short and long-term disability,  profit sharing, pension,
automobile allowance or leasing,  stock option (subject to approval by the Board
of Directors),  supplemental retirement income (subject to approval by the Board
of  Directors),  hospitalization  and medical and dental  reimbursement  plan or
program,  his  participation  in such  programs to be based upon the  applicable
provisions of such programs as they may exist from time to time.

         6.       Expenses.

                  The  Company  shall  pay or  reimburse  the  Employee  for all
reasonable  expenses  reasonably  incurred or paid by him in connection with the
performance of his duties hereunder upon  presentation of expense  statements or
vouchers and such other supporting documentation as the Company may from time to
time reasonably request.

         7.       Benefits Payable Upon Disability, Death, or Retirement.

                  (a) In the event of the disability (as hereinafter defined) of
the Employee during the Contract  Period,  the Company shall continue to pay the
Employee the compensation  provided in Section 4 hereof during the period of his
disability or earlier termination hereof;  provided,  however, that in the event
the Employee is disabled for a continuous  period  exceeding six (6) consecutive
calendar months,  the Company may, at its election,  terminate this Agreement at
the close of business on the date thirty (30) days after the Company  shall have
delivered a written notice of such election to the Employee,  in which event the
Employee  shall be entitled to receive  benefits  under the Company's  Long Term
Disability  Plan as such  plan may exist as of the date of  termination  of this
Agreement.

                  As used in this Agreement,  the term  "disability"  shall mean
the inability of the Employee due to illness or physical or mental  infirmity to
perform his duties under this Agreement as determined by a physician selected by
the Employee and acceptable to the Company.

                  (b)  During  the  period the  Employee  shall be  entitled  to
receive  payments under Section 7(a) above,  to the extent that he is physically
and mentally able to do so, he shall,  upon the request of the Company,  furnish
information  and assistance to the Company,  and, in addition,  upon  reasonable
request of Senior  Management or the Board of  Directors,  he shall make himself
available to the Company to undertake reasonable assignments consistent with the
dignity,  importance  and scope of his  position  and his  physical  and  mental
health.

                  (c) In the  event of the  death  of the  Employee  during  the
Contract  Period,  the Company shall pay, or cause to be paid, to the Employee's
designated beneficiary or beneficiaries or estate or legal representatives,  the
payment due pursuant to the terms of the group term insurance  policies together
with such other death  benefits as may be payable  under the  Company's  benefit
plans.

                  (d) In the  event of the  retirement  of the  Employee  on his
Normal  Retirement Date (as such term is defined in the Company's  Pension Plan)
the  Employee  shall be entitled  to such  retirement  benefits,  if any, as are
available to the Employee upon retirement  pursuant to the Company's  retirement
benefit plans.

         8.       Termination.

                  (a) Except as  otherwise  provided in  subsection  (c) and (d)
hereof,  this  Agreement  and the  employment  of the Employee  hereunder  shall
terminate upon the earliest to occur of the dates specified below:

                  (i) the close of  business  on the date that is one year after
the date hereof (the  "Initial  Period"),  except  that this  Agreement  and the
employment of the Employee  hereunder shall be automatically  extended from year
to year thereafter  unless (x) terminated by the Company by delivery of not less
than 60 days  written  notice to the  Employee  prior to the end of the  Initial
Period or any  extension  thereof in which case the  employment  of the Employee
shall  terminate on the date specified for  termination  in such notice,  or (y)
terminated  by the Employee by delivery of not less than 60 days written  notice
to the Company prior to the end of the Initial  Period or any extension  thereof
in  which  case the  employment  of the  Employee  shall  terminate  on the date
specified for termination in such notice;

                  (ii)  the  close  of  business  on the  date of  death  of the
Employee;

                  (iii) the close of business  on the date the Company  delivers
to the Employee a written notice of its election to terminate his employment for
"Cause" (as defined in paragraph (b) below);

                  (iv) the close of  business on the date thirty (30) days after
the  Company  shall  have  delivered  to the  Employee  a written  notice of its
intention  to  terminate  his  employment  because  the Board of  Directors  has
determined  that such  termination  is in the best  interests of the Company and
such  termination  is not for  Cause,  death,  disability  or  failure to extend
pursuant to Section 8(a)(i)(x) hereof;

                  (v) the close of business on the date of a termination  by the
Company pursuant to Section 7(a) hereof; or

                  (vi) the close of  business on the date of the  retirement  of
the Employee pursuant to Section 7(d) hereof.

                  (b) For purposes of this  Agreement,  the term  "Cause"  shall
mean: (i) the Employee's conviction (which,  through lapse of time or otherwise,
is not  subject to  appeal)  of, or a plea of guilty or nolo  contendre  to, any
crime or offense  which  constitutes  a felony in the  jurisdiction  involved or
involves moral turpitude,  (ii) the commission of an act of fraud,  embezzlement
or intentional dishonesty against the Company or any of its subsidiaries,  (iii)
a breach of this  Agreement  by the  Employee,  (iv)  breach of  fiduciary  duty
resulting in injury to the Company or its  subsidiaries  (v) gross misconduct in
connection with the Employee's  performance of the Employee's  duties hereunder,
or (vi) the  Employee's  continued or willful  failure or refusal to comply with
the  Company's  policies or the policies or written  directives of the Company's
Senior Management or the Board of Directors.

                  (c) For purposes  hereof,  upon  termination of this Agreement
and employment of Employee as provided in Section 8(a)(i)-(vi),  all obligations
and liabilities of the parties hereto shall cease and be of no effect except for
those liabilities and obligations provided for in Section 7, 9 and 10 hereof.

                  (d) For  purposes  of  clauses  (i) and (iv) of  Section  8(a)
above,  the Employee shall be relieved of his duties and shall vacate his office
and the Company's premises on the date of receipt of the notice required by such
clauses  unless  requested by the Company to remain in the active  employment of
the Company  during such period  between the receipt of notice and the effective
date of termination of employment.

         9.       Payments to Employee Upon Termination of Employment.

                  (a)  Upon  the   termination  of  the   Employee's   full-time
employment hereunder by the Company in accordance with clauses (i)(x) or (iv) of
Section 8(a) of this Agreement, the Company shall pay to the Employee, or in the
event of his subsequent death, to his beneficiary or beneficiaries or his estate
or legal  representative,  as severance  pay (i) an amount equal the  Employee's
Base  Salary on the date of  termination  for the  Applicable  Severance  Period
payable in monthly installments on the fifteenth (15th) of each month during the
Applicable Severance Period plus (ii) subject to the terms and provisions of any
additional  compensation  plans that the Employee  participates  in from time to
time, a pro rata portion of any bonus compensation payable to the Employee.

                  (b)  Upon  the   termination  of  the   Employee's   full-time
employment  hereunder pursuant to clauses (i)(x) or (iv) of Section 8(a) of this
Agreement,  the Company shall at its expense  continue on behalf of the Employee
the  following  benefits:   life  insurance,   short  and  long-term  disability
insurance,  hospitalization  insurance and medical and dental reimbursement plan
insurance.  The coverage of any such insurance provided by the Company hereunder
shall be no less favorable to the Employee, in terms of amounts and deductibles,
than the coverage provided under the benefit programs  maintained by the Company
from  time to time  for  the  Company's  executives.  The  Company's  obligation
hereunder  with respect to each of the foregoing  benefit plans shall  terminate
upon the earlier of the end of the Applicable  Severance  Period or the date the
Employee obtains any such benefits pursuant to a subsequent  employer's  benefit
plans.  The Employee agrees that the Company's  continued  provision of benefits
described in this Section 9(b) shall count toward satisfying any obligation that
the Company may have under COBRA.

                  (c)  Benefits  pursuant to the  Company's  Profit  Sharing and
Pension  Plans (and such other plans in which  Employee  participates)  shall be
payable to Employee in accordance with the terms of such Plans.

                  (d) For purposes of this Agreement,  the Applicable  Severance
Period shall be two (2) years.

                  (e)  Employee  further   acknowledges   that  as  a  condition
precedent  to  receiving  any  benefits  under this  Agreement,  Employee  shall
complete,  execute and deliver to the Company at the time of his  termination of
employment  a Release in the form of Exhibit "A" hereto  which  releases any and
all claims  that the  Employee  may have  against  the Company as of the date of
termination arising under federal, state, local or common law.

         10.      Covenants of the Employee.

                  (a) The Employee  agrees that during the  Contract  Period and
for a period  of time  equal to (i) one year in the  event of a  termination  of
employment in accordance  with clauses (i)(y) or (iii) of Section 8(a); (ii) two
years in the event of a termination  of  employment  in accordance  with Section
7(a) or  retirement in  accordance  with Section  7(d); or (iii) the  Applicable
Severance  Period in the event of a termination of employment in accordance with
clauses  (i)(x) or (iv) of Section  8(a), he will not,  directly or  indirectly,
engage,  assist or  participate  in, whether as a director,  officer,  employee,
agent, manager,  consultant,  partner,  owner or independent contractor or other
participant,  any  business,  firm,  corporation,   partnership,  enterprise  or
organization  that competes with the business engaged or hereafter engaged in by
the  Company or any of its  subsidiaries  (including,  but not  limited  to, the
operation of retail drug stores in which  prescription  drugs are sold, the sale
of photofinishing products or services, the mail order pharmacy business, and/or
the  pharmacy   benefits   management   business)  in  the   Company's  or  such
subsidiaries'  trade areas (for  purposes  hereof  "trade  areas" shall mean any
county in any state of the United States in which retail drug stores operated by
the Company and its  subsidiaries  are located or in which services are provided
by the Company or its subsidiaries).  Nothing contained herein shall prevent the
Employee from acquiring  less than 2% of any class of outstanding  securities of
any  Company  that has any of its  securities  listed on a  national  securities
exchange or traded in the over-the-counter market.

                  (b) The Employee  agrees that during the  Contract  Period and
for a period  of two years  after  the  termination  of this  Agreement  for any
reason,  he will not directly induce or solicit any person employed or hereafter
employed  by the Company or any of its  subsidiaries  to leave the employ of the
Company or any of its subsidiaries nor will he directly or indirectly call upon,
solicit, write, direct, divert or accept business with respect to any account or
customer  of the Company or its  subsidiaries,  including,  without  limitation,
accounts or customers obtained before or during the term of this Agreement.

                  (c) The Employee agrees and acknowledges that the Confidential
Information  of the Company and its  subsidiaries  (as  hereinafter  defined) is
valuable,  special and unique to their business;  that such business  depends on
such  Confidential  Information;  and that the  Company  wishes to protect  such
Confidential  Information by keeping it confidential  for the use and benefit of
the  Company.  Based on the  foregoing,  the Employee  agrees to  undertake  the
following obligations with respect to such Confidential Information:

                  (i)  The  Employee  agrees  to keep  any and all  Confidential
Information in trust for the use and benefit of the Company;

                  (ii) The  Employee  agrees  that,  except as  required  by the
Employee's  duties or authorized in writing by the Company and its  subsidiaries
or required by  applicable  law, he will not at any time during and for a period
of five (5) years after the  termination of his employment  with the Company and
its subsidiaries, disclose, directly or indirectly, any Confidential Information
of the Company or any of its subsidiaries.

                  (iii)  The  Employee  agrees  to  take  all  reasonable  steps
necessary,  or  reasonably  requested  by the Company and its  subsidiaries,  to
ensure that all Confidential Information of the Company is kept confidential for
the use and benefit of the Company and its subsidiaries; and

                  (iv)  The  Employee  agrees  that,  upon  termination  of  his
employment  by the Company or any of its  subsidiaries  or at any other time the
Company may in writing so request,  he will promptly  deliver to the Company all
materials constituting  Confidential  Information (including all copies thereof)
that are in the possession of or under the control of the Employee. The Employee
further  agrees that,  if  requested  by the Company to return any  Confidential
Information  pursuant to this  Subsection  (iv),  he will not make or retain any
copy or extract from such materials.

                  For purposes of this Section 10(c),  Confidential  Information
means any and all  information  developed  by or for the  Company  or any of its
subsidiaries of which the Employee gained  knowledge by reason of his employment
by the  Company  or any of its  subsidiaries  prior  to the date  hereof  or his
employment  under this Agreement that is not generally  known in any industry in
which the Company is or may become engaged.  Confidential  Information includes,
but is not limited to, any and all  information  developed by or for the Company
concerning plans, marketing and sales methods,  materials,  processes,  business
forms, procedures, devices used by the Company, its subsidiaries,  suppliers and
customers with which the Company had dealt prior to the  Employee's  termination
of employment  with the Company and its  subsidiaries,  plans for development of
new  products,  services  and  expansion  into new  areas or  markets,  internal
operations,  and any trade secrets and proprietary information of any type owned
by the Company and its  subsidiaries,  together  with all  written,  graphic and
other materials relating to all or any part of the same.

         11.      Change of Control

                  (a)  Definition  of Change of Control.  No  benefits  shall be
payable  under this Section 11 unless there shall have been a Change of Control,
as set forth below,  and Employee's  employment by the Company shall  thereafter
have been terminated in accordance with Section 11(b) below. As used herein, the
term "Change of Control" shall mean:

                  (i) the  acquisition by any individual,  firm,  corporation or
other entity or any group of individuals,  firms, corporations or other entities
acting in concert  ("Person")  together with all  Affiliates  and Associates (as
such terms are defined in Rule 12b-2 of the General Rules and Regulations  under
the  Securities  Exchange  Act of 1934 (the  "Exchange  Act") of such  Person of
beneficial  ownership  (as such term is defined in Rule 13d-3 under the Exchange
Act) of more than 25% of the outstanding shares of voting stock of the Company;

                  (ii) any change in the  composition  of the Board of Directors
of the  Company  resulting  in members of the Board on the date  hereof (or such
other  persons who are elected  by, or on the  recommendation  of, a majority of
such members or other persons who had been elected by, or on the  recommendation
of, a majority of such members) ("Continuing Directors") ceasing to constitute a
majority of the Board of Directors; or

                  (iii) any other event determined by a majority of the Board of
Directors of the Company to constitute a Change of Control.

                  (b)  Termination  Following  Change of Control.  If any of the
events  described in Section 11(a) above  constituting a Change of Control shall
have occurred,  Employee  shall be entitled to the benefits  provided in Section
11(e)  hereof upon the  subsequent  termination  of  employment  during the time
period  referred to in Section  11(e) hereof if such  termination  is (i) by the
Company pursuant to Subsections 8(a)(i),  (iv) or (v) hereof or (ii) by Employee
for Good Reason.

                  (c)      Definition of Good Reason.

                  (A)  Employee  shall be entitled to terminate  employment  for
Good  Reason.  For  purposes of this  Agreement,  "Good  Reason"  shall  without
Employee's express written consent, mean, following a Change of Control:

                  (1) the assignment to Employee of any duties inconsistent with
Employee's  status as a senior executive officer of the Company or a substantial
alteration in the nature or status of Employee's  responsibilities from those in
effect  immediately prior to a Change of Control;  or an adverse and substantial
alteration  in  Employee's  reporting  responsibilities,  title or offices as in
effect  immediately prior to a Change of Control or any removal of Employee from
or failure to reelect  Employee to any such positions  except in connection with
the termination of employment for Disability, Retirement or Cause or as a result
of death or by Employee other than for Good Reason;

                  (2) a  reduction  by the  Company in  Employee's  annual  Base
Salary as in effect on the date hereof;

                  (3) any  material  breach by the Company of any  provision  of
this Agreement; or

                  (4) any purported  termination of Employee's  employment which
is not effected pursuant to a Notice of Termination  satisfying the requirements
of Section 11(d) below and, for purposes of this  Agreement,  no such  purported
termination shall be effective.

                  (B) Employee's  right to terminate his employment  pursuant to
this  Subsection  11(c) shall not be affected by  Employee's  incapacity  due to
physical or mental illness.

                  (d) Notice of  Termination.  Any purported  termination by the
Company or by Employee shall be communicated by written Notice of Termination to
the other party hereto in  accordance  with  Section 13 hereof.  For purposes of
this  Agreement,  a "Notice  of  Termination"  shall mean a notice  which  shall
indicate the specific  termination  provision of this Agreement  relied upon and
shall set forth in  reasonable  detail  the facts and  circumstances  claimed to
provide a basis for termination of employment  under the provision so indicated.
For purposes of this Agreement, no such purported termination shall be effective
without such Notice of Termination.

                  (e) Compensation for Termination.  If Employee's employment by
the Company shall be  terminated  within two years after a Change of Control (a)
by  the  Company  pursuant  to  Subsections  (8)(a)(i),  (iv),  or (v) or (b) by
Employee for Good Reason, then:

                  (i) within five (5) days of the date of such termination,  the
Company shall pay Employee a single severance payment in cash in an amount equal
to 2.9  multiplied by Employee's  Base Salary paid to Employee by the Company in
the  Company's  fiscal  year  immediately   preceding  the  year  in  which  the
termination  occurs plus all accrued but unpaid Base Salary and a pro rata bonus
amount payable pursuant to Section 4 hereof through the date of termination;

                  (ii) for a period of two (2) years after such termination, the
Company  shall at its  expense  continue  on behalf  of  Employee  the  benefits
described in Section 9(b) of this Agreement; and

                  (iii) any  restrictions  on any outstanding  incentive  awards
(including,  but not limited to, restricted stock) granted to Employee under any
of the  Company's  benefit  plans or  otherwise  shall lapse and such  incentive
awards shall become 100% vested.

                  (f) Mitigation. Employee shall not be required to mitigate the
amount  of any  payment  provided  for  in  this  Section  11 by  seeking  other
employment or otherwise nor shall the amount of any payment or benefit  provided
for in this Section 11 be reduced by any compensation  earned by Employee as the
result of employment by another  employer or by  retirement  benefits  after the
date of termination or otherwise.

                  (g) Compensation  Election.  If Employee receives compensation
pursuant  to this  Section  11,  Employee  shall  not be  entitled  to any other
benefits  hereunder,  other than that referred to in subsection  (e) above,  the
receipt of any compensation  which Employee had earned but previously elected to
defer receipt of and the right to exercise  options in accordance with the terms
of the Company's Stock Option Plans under which such options were granted.

                  (h)  Excise  Tax  Payment.  In the event  that any  payment or
benefit (within the meaning of Section  280G(b)(2) of the Internal  Revenue Code
of 1986,  as amended  (the  "Code")),  to Employee or for this  benefit  paid or
payable or distributed or distributable  pursuant to the terms of this Agreement
or otherwise in  connection  with,  or arising out of, his  employment  with the
Company or a Change in Control of the Company (a "Payment" or "Payments"), would
be subject to the excise tax imposed by Section 4999 of the Code or any interest
or penalties  are incurred by the Employee with respect to such excise tax (such
excise tax,  together  with any such  interest and  penalties,  are  hereinafter
collectively  referred  to as the  "Excise  Tax"),  then  the  Employee  will be
entitled to immediately  receive an additional payment (a "Gross-Up Payment") in
an amount such that after  payment by the Employee of all taxes  (including  any
interest or penalties,  other than  interest and penalties  imposed by reason of
the Employee's failure to file timely a tax return or pay taxes shown due on his
return,  imposed with respect to such taxes and the Excise Tax),  including  any
Excise Tax imposed upon the Gross-Up Payment,  the Employee retains an amount of
the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.

         12.      Successors and Assigns.

                  (a) This  Agreement  shall be binding  upon and shall inure to
the benefit of the Company,  its successors  and assigns.  The term "Company" as
used herein shall include such successors and assigns.  The term "successors and
assigns" as used herein shall mean a corporation  or other entity  acquiring all
or  substantially  all the assets and business of this Company  (including  this
Agreement) whether by operation of law or otherwise.

                  (b) Neither this Agreement nor any right or interest hereunder
shall be assignable by the Employee, his beneficiaries, or legal representatives
without the Company's prior written consent; provided,  however, that nothing in
this Section 12 shall  preclude (i) the Employee from  designating a beneficiary
to receive any benefit payable  hereunder upon his death, or (ii) the executors,
administrators,  or other legal  representatives  of the  Employee or his estate
from assigning any rights  hereunder to distributees,  legatees,  beneficiaries,
testamentary trustees or other legal heirs of the Employee.

                  (c) After a Change of Control,  the Company  will  require any
successor  or  assign  (whether  direct  or  indirect,   by  purchase,   merger,
consolidation of otherwise) to all or  substantially  all of the business and/or
assets of the Company to expressly assume and agree to perform this Agreement in
the same manner and to the same  extent  that the  Company  would be required to
perform it if no such  succession or assignment had taken place.  Failure of the
Company to obtain such  assumption and agreement prior to the  effectiveness  of
any such succession or assignment  shall be a breach of this Agreement and shall
entitle Employee to compensation  from the Company in the same amount and on the
same terms as  Employee  would be  entitled  hereunder  if  Employee  terminated
employment  for Good  Reason  except  that,  for  purposes of  implementing  the
foregoing, the date on which any such succession or assignment becomes effective
shall be deemed the date of termination.  As used in this  Agreement,  "Company"
shall mean the Company as  hereinbefore  defined and any  successor or assign to
its business and/or assets as aforesaid which assumes and agrees to perform this
Agreement by operation of law, or otherwise.

         13.      Notices.

                  Any notice  required or permitted by this  Agreement  shall be
given by registered or certified mail,  return receipt  requested,  addressed to
the  Company at its then  principal  office,  or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
address or addresses as he or it may from time to time specify for such purposes
in a notice similarly given.

         14.      Governing Law; Litigation; Expenses.

                  (a) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Florida  without  giving effect to the
conflicts of law principles thereof.

                  (b) The Employee and the Company  hereby agree that the courts
of the State of Florida shall have exclusive  jurisdiction to hear and determine
any claims or disputes  pertaining  to this  Agreement or to any matter  arising
therefrom.  Each of the Employee and the Company  expressly submits and consents
in advance to such  jurisdiction  in any action  commenced in such courts hereby
waiving personal service of the summons and complaint or other process or papers
issued  therein,  and agreeing  that service of such summons and  complaint,  or
other process or papers,  may be made by registered or certified  mail addressed
to the Company at its then  principal  office or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
addresses  as it or he from time to time  specify to the other  party in writing
for such  purpose.  The  exclusive  choice of forum set forth in this Section 13
shall not be deemed to preclude the enforcement of any judgment obtained in such
forum or the taking of any action under this  Agreement to enforce such judgment
in any appropriate jurisdiction.

                  (c)  All  costs  and  expenses  (including   attorneys'  fees)
incurred  in  connection  with any  litigation  relating  to a claim or  dispute
pertaining to this Agreement shall be paid by the party incurring such expenses,
except if the claim or dispute pertains to the enforcement of Section 11 hereof,
in which case the  prevailing  party shall be entitled to an award of such costs
and expenses from the non-prevailing party.

                  (d) Nothing  contained  in this  Section 14 shall be deemed to
limit the Company's  obligation to indemnify the Employee to the fullest  extent
permitted by  applicable  law in respect of any actions,  claims or  proceedings
which  are  based  upon  acts  or  omissions  of  the  Employee  related  to the
performance  of his duties  hereunder to the extent he would have otherwise been
entitled to  indemnification  under the by-laws or charter of the Company or any
of its subsidiaries or to the extent to which  indemnification  is to be paid to
officers and directors as a matter of law.

         15.      Entire Agreement.

                  This instrument  contains the entire  agreement of the parties
relating  to the  subject  matter  hereof  and  supersedes  any  and  all  other
agreements and understandings,  whether written, oral or otherwise, with respect
to the  employment  of the  Employee  by  the  Company  and  all of  such  other
agreements and understandings shall be of no force or effect. No modification of
this  Agreement  shall be valid  unless in  writing  and  signed by the  parties
hereto.  The waiver of a breach of any term or condition of this Agreement shall
not be deemed to constitute a waiver of any subsequent breach of the same or any
other term or condition of this Agreement.

         16.      Severability.

                  If any term or provision of this Agreement or the  application
thereof to any person,  property or circumstance  shall to any extent be invalid
or  unenforceable,  the remainder of this Agreement,  or the application of such
term or provision to persons,  property or circumstances  other than those as to
which it is invalid or  unenforceable  shall not be affected  thereby,  and each
term and  provision  of this  Agreement  shall be valid and  enforceable  to the
fullest extent permitted by law.

         17.      Injunctive Relief.

                  (a) The Employee  acknowledges  and agrees that the  covenants
and obligations  contained in Sections 10(a),  10(b) and 10(c) of this Agreement
relate to special,  unique and extraordinary matters and that a violation of any
of the terms of such  Sections  will cause the  Company  irreparable  injury for
which adequate remedies at law are not available. Therefore, the Employee agrees
that the Company shall be entitled to an injunction, restraining order, or other
equitable  relief  from any court of  competent  jurisdiction,  restraining  the
Employee from  committing  any violation of the  covenants and  obligations  set
forth in Sections 10(a), 10(b) and 10(c) hereof.

                  (b) The  Company's  rights and remedies  under this Section 17
are  cumulative and are in addition to any other rights and remedies the Company
may have at law or in equity. In connection with the foregoing provision of this
Section 17, the Employee  represents  that his economic means and  circumstances
are such that such  provisions  will not prevent him from  providing for himself
and his family on a basis satisfactory to him.

         18.      Withholding Taxes.

                  The Company may deduct from any payments to be made  hereunder
any  federal,  state or local  withholding  or other  taxes  which  the  Company
determines it is required to deduct under applicable law.

         19.      Counterparts.  This  Agreement  may be executed in one or
more  counterparts,  each of which shall be deemed an original of which together
shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement as of the day, month and year first written above.


ECKERD CORPORATION


By: /s/ Frank Newman
     Name:  Frank Newman
     Its:  President/CEO/COO


EMPLOYEE


/s/ James M. Santo
JAMES M. SANTO


g: employ1/winword/forms



                                                                EXHIBIT 10.28

                         EMPLOYMENT AGREEMENT (Exec. VP)


         AGREEMENT  made  as  of  February  1,  1996,  by  and  between  ECKERD
CORPORATION,  a  Delaware  corporation  (the  "Company)  and  SAMUEL G.  WRIGHT,
residing at 1520 Gulf Blvd. #1504, Clearwater, Florida 34630 (the "Employee").

         WHEREAS,  upon  the  terms  and  subject  to  the  conditions  of  this
Agreement,  the  Company  desires to employ the  Employee  and the  Employee  is
willing to accept employment by the Company.

         NOW,  THEREFORE,  in  consideration  of the mutual  covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto agree as follows:

         1.       Employment.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,  the Company  hereby  employs the Employee  and the  Employee  hereby
accepts employment by the Company in the capacity hereinafter set forth.

         2.       Term of Employment.

                  The term of the  Employee's  employment  by the Company  under
this  Agreement  shall  commence  on the date  hereof and shall be for a term of
twelve (12) months,  subject to extension and termination as provided in Section
8 hereof (the "Contract Period").

         3.       Duties; Extent of Services.

                  (a) During the Contract  Period,  the Employee  shall serve as
Executive Vice President/Chief Financial Officer of the Company or in such other
executive  capacity  as shall be  determined  from  time to time by the Board of
Directors  of  the  Company  and  shall   perform  the  duties,   undertake  the
responsibilities and exercise the authority  customarily  performed,  undertaken
and  exercised by a person in such position in the business in which the Company
is engaged.

                  (b)  Except  as  otherwise  provided  herein  and  except  for
illness,  permitted  vacation periods and permitted leaves of absence during the
Contract  Period,  the  Employee  shall (i) devote  his full time and  attention
during  normal   business   hours  to  the  business  of  the  Company  and  its
subsidiaries;  (ii)  use his best  efforts  to  promote  the  Company's  and its
subsidiaries' interest; and (iii) discharge such other and further executive and
administrative duties as may be assigned to him by the Board of Directors of the
Company and its subsidiaries.

                  (c) Except for directorships  held by the Employee on the date
of this Agreement, during the Contract Period the Employee will not, without the
prior written consent of the Company's  Board of Directors,  serve as a director
of any corporation,  joint venture,  association or other commercial  enterprise
not controlled by, controlling or under common control with, the Company and its
subsidiaries.

         4.       Compensation.

                  (a) In consideration of the services  rendered by the Employee
under this  Agreement,  the Company  shall pay the Employee a base annual salary
(the "Base Salary") in the amount of $265,000 (or such other amount as the Board
of Directors of the Company shall  determine)  payable  monthly on the fifteenth
(15th) of each month during the Contract Period.

                  (b) During the Contract Period, as additional compensation for
his services and as a further incentive and inducement to the Employee to accept
employment  by the Company and to devote his best  efforts to the  business  and
affairs of the Company and its  subsidiaries,  the Employee shall be entitled to
participate in such  additional  compensation  plans (the "Bonus  Compensation")
which the Company allows the Employee to participate in from time to time.

                  (c) The Company  agrees that the Employee shall be entitled to
defer some portion or all of his Base Salary for any calendar year in accordance
with the provisions of the Company's  Executive  Deferred  Compensation  Plan as
adopted by the Board of Directors.

         5.       Fringe Benefits.

                  In addition to the  compensation  provided in Section 4 above,
during the  Contract  Period the  Employee  shall be entitled  to the  following
benefits:

                  (a) The  Employee  shall be  entitled  to paid  vacation  time
annually in  accordance  with the Company  policy as  determined by the Board of
Directors.

                  (b) The  Employee  shall be  entitled  to  participate  in all
employee  benefit  programs  now or  hereafter  maintained  by the  Company  for
executive  personnel for which he is eligible,  including,  without  limitation,
group life insurance,  short and long-term disability,  profit sharing, pension,
automobile allowance or leasing,  stock option (subject to approval by the Board
of Directors),  supplemental retirement income (subject to approval by the Board
of  Directors),  hospitalization  and medical and dental  reimbursement  plan or
program,  his  participation  in such  programs to be based upon the  applicable
provisions of such programs as they may exist from time to time.

         6.       Expenses.

                  The  Company  shall  pay or  reimburse  the  Employee  for all
reasonable  expenses  reasonably  incurred or paid by him in connection with the
performance of his duties hereunder upon  presentation of expense  statements or
vouchers and such other supporting documentation as the Company may from time to
time reasonably request.

         7.       Benefits Payable Upon Disability, Death, or Retirement.

                  (a) In the event of the disability (as hereinafter defined) of
the Employee during the Contract  Period,  the Company shall continue to pay the
Employee the compensation  provided in Section 4 hereof during the period of his
disability or earlier termination hereof;  provided,  however, that in the event
the Employee is disabled for a continuous  period  exceeding six (6) consecutive
calendar months,  the Company may, at its election,  terminate this Agreement at
the close of business on the date thirty (30) days after the Company  shall have
delivered a written notice of such election to the Employee,  in which event the
Employee  shall be entitled to receive  benefits  under the Company's  Long Term
Disability  Plan as such  plan may exist as of the date of  termination  of this
Agreement.

                  As used in this Agreement,  the term  "disability"  shall mean
the inability of the Employee due to illness or physical or mental  infirmity to
perform his duties under this Agreement as determined by a physician selected by
the Employee and acceptable to the Company.

                  (b)  During  the  period the  Employee  shall be  entitled  to
receive  payments under Section 7(a) above,  to the extent that he is physically
and mentally able to do so, he shall,  upon the request of the Company,  furnish
information  and assistance to the Company,  and, in addition,  upon  reasonable
request of Senior  Management or the Board of  Directors,  he shall make himself
available to the Company to undertake reasonable assignments consistent with the
dignity,  importance  and scope of his  position  and his  physical  and  mental
health.

                  (c) In the  event of the  death  of the  Employee  during  the
Contract  Period,  the Company shall pay, or cause to be paid, to the Employee's
designated beneficiary or beneficiaries or estate or legal representatives,  the
payment due pursuant to the terms of the group term insurance  policies together
with such other death  benefits as may be payable  under the  Company's  benefit
plans.

                  (d) In the  event of the  retirement  of the  Employee  on his
Normal  Retirement Date (as such term is defined in the Company's  Pension Plan)
the  Employee  shall be entitled  to such  retirement  benefits,  if any, as are
available to the Employee upon retirement  pursuant to the Company's  retirement
benefit plans.

         8.       Termination.

                  (a) Except as  otherwise  provided in  subsection  (c) and (d)
hereof,  this  Agreement  and the  employment  of the Employee  hereunder  shall
terminate upon the earliest to occur of the dates specified below:

                  (i) the close of  business  on the date that is one year after
the date hereof (the  "Initial  Period"),  except  that this  Agreement  and the
employment of the Employee  hereunder shall be automatically  extended from year
to year thereafter  unless (x) terminated by the Company by delivery of not less
than 60 days  written  notice to the  Employee  prior to the end of the  Initial
Period or any  extension  thereof in which case the  employment  of the Employee
shall  terminate on the date specified for  termination  in such notice,  or (y)
terminated  by the Employee by delivery of not less than 60 days written  notice
to the Company prior to the end of the Initial  Period or any extension  thereof
in  which  case the  employment  of the  Employee  shall  terminate  on the date
specified for termination in such notice;

                  (ii)  the  close  of  business  on the  date of  death  of the
Employee;

                  (iii) the close of business  on the date the Company  delivers
to the Employee a written notice of its election to terminate his employment for
"Cause" (as defined in paragraph (b) below);

                  (iv) the close of  business on the date thirty (30) days after
the  Company  shall  have  delivered  to the  Employee  a written  notice of its
intention  to  terminate  his  employment  because  the Board of  Directors  has
determined  that such  termination  is in the best  interests of the Company and
such  termination  is not for  Cause,  death,  disability  or  failure to extend
pursuant to Section 8(a)(i)(x) hereof;

                  (v) the close of business on the date of a termination  by the
Company pursuant to Section 7(a) hereof; or

                  (vi) the close of  business on the date of the  retirement  of
the Employee pursuant to Section 7(d) hereof.

                  (b) For purposes of this  Agreement,  the term  "Cause"  shall
mean: (i) the Employee's conviction (which,  through lapse of time or otherwise,
is not  subject to  appeal)  of, or a plea of guilty or nolo  contendre  to, any
crime or offense  which  constitutes  a felony in the  jurisdiction  involved or
involves moral turpitude,  (ii) the commission of an act of fraud,  embezzlement
or intentional dishonesty against the Company or any of its subsidiaries,  (iii)
a breach of this  Agreement  by the  Employee,  (iv)  breach of  fiduciary  duty
resulting in injury to the Company or its  subsidiaries  (v) gross misconduct in
connection with the Employee's  performance of the Employee's  duties hereunder,
or (vi) the  Employee's  continued or willful  failure or refusal to comply with
the  Company's  policies or the policies or written  directives of the Company's
Senior Management or the Board of Directors.

                  (c) For purposes  hereof,  upon  termination of this Agreement
and employment of Employee as provided in Section 8(a)(i)-(vi),  all obligations
and liabilities of the parties hereto shall cease and be of no effect except for
those liabilities and obligations provided for in Section 7, 9 and 10 hereof.

                  (d) For  purposes  of  clauses  (i) and (iv) of  Section  8(a)
above,  the Employee shall be relieved of his duties and shall vacate his office
and the Company's premises on the date of receipt of the notice required by such
clauses  unless  requested by the Company to remain in the active  employment of
the Company  during such period  between the receipt of notice and the effective
date of termination of employment.

         9.       Payments to Employee Upon Termination of Employment.

                  (a)  Upon  the   termination  of  the   Employee's   full-time
employment hereunder by the Company in accordance with clauses (i)(x) or (iv) of
Section 8(a) of this Agreement, the Company shall pay to the Employee, or in the
event of his subsequent death, to his beneficiary or beneficiaries or his estate
or legal  representative,  as severance  pay (i) an amount equal the  Employee's
Base  Salary on the date of  termination  for the  Applicable  Severance  Period
payable in monthly installments on the fifteenth (15th) of each month during the
Applicable Severance Period plus (ii) subject to the terms and provisions of any
additional  compensation  plans that the Employee  participates  in from time to
time, a pro rata portion of any bonus compensation payable to the Employee.

                  (b)  Upon  the   termination  of  the   Employee's   full-time
employment  hereunder pursuant to clauses (i)(x) or (iv) of Section 8(a) of this
Agreement,  the Company shall at its expense  continue on behalf of the Employee
the  following  benefits:   life  insurance,   short  and  long-term  disability
insurance,  hospitalization  insurance and medical and dental reimbursement plan
insurance.  The coverage of any such insurance provided by the Company hereunder
shall be no less favorable to the Employee, in terms of amounts and deductibles,
than the coverage provided under the benefit programs  maintained by the Company
from  time to time  for  the  Company's  executives.  The  Company's  obligation
hereunder  with respect to each of the foregoing  benefit plans shall  terminate
upon the earlier of the end of the Applicable  Severance  Period or the date the
Employee obtains any such benefits pursuant to a subsequent  employer's  benefit
plans.  The Employee agrees that the Company's  continued  provision of benefits
described in this Section 9(b) shall count toward satisfying any obligation that
the Company may have under COBRA.

                  (c)  Benefits  pursuant to the  Company's  Profit  Sharing and
Pension  Plans (and such other plans in which  Employee  participates)  shall be
payable to Employee in accordance with the terms of such Plans.

                  (d) For purposes of this Agreement,  the Applicable  Severance
Period shall be two (2) years.

                  (e)  Employee  further   acknowledges   that  as  a  condition
precedent  to  receiving  any  benefits  under this  Agreement,  Employee  shall
complete,  execute and deliver to the Company at the time of his  termination of
employment  a Release in the form of Exhibit "A" hereto  which  releases any and
all claims  that the  Employee  may have  against  the Company as of the date of
termination arising under federal, state, local or common law.

         10.      Covenants of the Employee.

                  (a) The Employee  agrees that during the  Contract  Period and
for a period  of time  equal to (i) one year in the  event of a  termination  of
employment in accordance  with clauses (i)(y) or (iii) of Section 8(a); (ii) two
years in the event of a termination  of  employment  in accordance  with Section
7(a) or  retirement in  accordance  with Section  7(d); or (iii) the  Applicable
Severance  Period in the event of a termination of employment in accordance with
clauses  (i)(x) or (iv) of Section  8(a), he will not,  directly or  indirectly,
engage,  assist or  participate  in, whether as a director,  officer,  employee,
agent, manager,  consultant,  partner,  owner or independent contractor or other
participant,  any  business,  firm,  corporation,   partnership,  enterprise  or
organization  that competes with the business engaged or hereafter engaged in by
the  Company or any of its  subsidiaries  (including,  but not  limited  to, the
operation of retail drug stores in which  prescription  drugs are sold, the sale
of photofinishing products or services, the mail order pharmacy business, and/or
the  pharmacy   benefits   management   business)  in  the   Company's  or  such
subsidiaries'  trade areas (for  purposes  hereof  "trade  areas" shall mean any
county in any state of the United States in which retail drug stores operated by
the Company and its  subsidiaries  are located or in which services are provided
by the Company or its subsidiaries).  Nothing contained herein shall prevent the
Employee from acquiring  less than 2% of any class of outstanding  securities of
any  Company  that has any of its  securities  listed on a  national  securities
exchange or traded in the over-the-counter market.

                  (b) The Employee  agrees that during the  Contract  Period and
for a period  of two years  after  the  termination  of this  Agreement  for any
reason,  he will not directly induce or solicit any person employed or hereafter
employed  by the Company or any of its  subsidiaries  to leave the employ of the
Company or any of its subsidiaries nor will he directly or indirectly call upon,
solicit, write, direct, divert or accept business with respect to any account or
customer  of the Company or its  subsidiaries,  including,  without  limitation,
accounts or customers obtained before or during the term of this Agreement.

                  (c) The Employee agrees and acknowledges that the Confidential
Information  of the Company and its  subsidiaries  (as  hereinafter  defined) is
valuable,  special and unique to their business;  that such business  depends on
such  Confidential  Information;  and that the  Company  wishes to protect  such
Confidential  Information by keeping it confidential  for the use and benefit of
the  Company.  Based on the  foregoing,  the Employee  agrees to  undertake  the
following obligations with respect to such Confidential Information:

                  (i)  The  Employee  agrees  to keep  any and all  Confidential
Information in trust for the use and benefit of the Company;

                  (ii) The  Employee  agrees  that,  except as  required  by the
Employee's  duties or authorized in writing by the Company and its  subsidiaries
or required by  applicable  law, he will not at any time during and for a period
of five (5) years after the  termination of his employment  with the Company and
its subsidiaries, disclose, directly or indirectly, any Confidential Information
of the Company or any of its subsidiaries.

                  (iii)  The  Employee  agrees  to  take  all  reasonable  steps
necessary,  or  reasonably  requested  by the Company and its  subsidiaries,  to
ensure that all Confidential Information of the Company is kept confidential for
the use and benefit of the Company and its subsidiaries; and

                  (iv)  The  Employee  agrees  that,  upon  termination  of  his
employment  by the Company or any of its  subsidiaries  or at any other time the
Company may in writing so request,  he will promptly  deliver to the Company all
materials constituting  Confidential  Information (including all copies thereof)
that are in the possession of or under the control of the Employee. The Employee
further  agrees that,  if  requested  by the Company to return any  Confidential
Information  pursuant to this  Subsection  (iv),  he will not make or retain any
copy or extract from such materials.

                  For purposes of this Section 10(c),  Confidential  Information
means any and all  information  developed  by or for the  Company  or any of its
subsidiaries of which the Employee gained  knowledge by reason of his employment
by the  Company  or any of its  subsidiaries  prior  to the date  hereof  or his
employment  under this Agreement that is not generally  known in any industry in
which the Company is or may become engaged.  Confidential  Information includes,
but is not limited to, any and all  information  developed by or for the Company
concerning plans, marketing and sales methods,  materials,  processes,  business
forms, procedures, devices used by the Company, its subsidiaries,  suppliers and
customers with which the Company had dealt prior to the  Employee's  termination
of employment  with the Company and its  subsidiaries,  plans for development of
new  products,  services  and  expansion  into new  areas or  markets,  internal
operations,  and any trade secrets and proprietary information of any type owned
by the Company and its  subsidiaries,  together  with all  written,  graphic and
other materials relating to all or any part of the same.

         11.      Change of Control

                  (a)  Definition  of Change of Control.  No  benefits  shall be
payable  under this Section 11 unless there shall have been a Change of Control,
as set forth below,  and Employee's  employment by the Company shall  thereafter
have been terminated in accordance with Section 11(b) below. As used herein, the
term "Change of Control" shall mean:

                  (i) the  acquisition by any individual,  firm,  corporation or
other entity or any group of individuals,  firms, corporations or other entities
acting in concert  ("Person")  together with all  Affiliates  and Associates (as
such terms are defined in Rule 12b-2 of the General Rules and Regulations  under
the  Securities  Exchange  Act of 1934 (the  "Exchange  Act") of such  Person of
beneficial  ownership  (as such term is defined in Rule 13d-3 under the Exchange
Act) of more than 25% of the outstanding shares of voting stock of the Company;

                  (ii) any change in the  composition  of the Board of Directors
of the  Company  resulting  in members of the Board on the date  hereof (or such
other  persons who are elected  by, or on the  recommendation  of, a majority of
such members or other persons who had been elected by, or on the  recommendation
of, a majority of such members) ("Continuing Directors") ceasing to constitute a
majority of the Board of Directors; or

                  (iii) any other event determined by a majority of the Board of
Directors of the Company to constitute a Change of Control.

                  (b)  Termination  Following  Change of Control.  If any of the
events  described in Section 11(a) above  constituting a Change of Control shall
have occurred,  Employee  shall be entitled to the benefits  provided in Section
11(e)  hereof upon the  subsequent  termination  of  employment  during the time
period  referred to in Section  11(e) hereof if such  termination  is (i) by the
Company pursuant to Subsections 8(a)(i),  (iv) or (v) hereof or (ii) by Employee
for Good Reason.

                  (c)      Definition of Good Reason.

                  (A)  Employee  shall be entitled to terminate  employment  for
Good  Reason.  For  purposes of this  Agreement,  "Good  Reason"  shall  without
Employee's express written consent, mean, following a Change of Control:

                  (1) the assignment to Employee of any duties inconsistent with
Employee's  status as a senior executive officer of the Company or a substantial
alteration in the nature or status of Employee's  responsibilities from those in
effect  immediately prior to a Change of Control;  or an adverse and substantial
alteration  in  Employee's  reporting  responsibilities,  title or offices as in
effect  immediately prior to a Change of Control or any removal of Employee from
or failure to reelect  Employee to any such positions  except in connection with
the termination of employment for Disability, Retirement or Cause or as a result
of death or by Employee other than for Good Reason;

                  (2) a  reduction  by the  Company in  Employee's  annual  Base
Salary as in effect on the date hereof;

                  (3) any  material  breach by the Company of any  provision  of
this Agreement; or

                  (4) any purported  termination of Employee's  employment which
is not effected pursuant to a Notice of Termination  satisfying the requirements
of Section 11(d) below and, for purposes of this  Agreement,  no such  purported
termination shall be effective.

                  (B) Employee's  right to terminate his employment  pursuant to
this Subsection 11(c) shall not be affected by Employee's  incapacity due to 
physical or mental illness.

                  (d) Notice of  Termination.  Any purported  termination by the
Company or by Employee shall be communicated by written Notice of Termination to
the other party hereto in  accordance  with  Section 13 hereof.  For purposes of
this  Agreement,  a "Notice  of  Termination"  shall mean a notice  which  shall
indicate the specific  termination  provision of this Agreement  relied upon and
shall set forth in  reasonable  detail  the facts and  circumstances  claimed to
provide a basis for termination of employment  under the provision so indicated.
For purposes of this Agreement, no such purported termination shall be effective
without such Notice of Termination.

                  (e) Compensation for Termination.  If Employee's employment by
the Company shall be  terminated  within two years after a Change of Control (a)
by  the  Company  pursuant  to  Subsections  (8)(a)(i),  (iv),  or (v) or (b) by
Employee for Good Reason, then:

                  (i) within five (5) days of the date of such termination,  the
Company shall pay Employee a single severance payment in cash in an amount equal
to 2.9  multiplied by Employee's  Base Salary paid to Employee by the Company in
the  Company's  fiscal  year  immediately   preceding  the  year  in  which  the
termination  occurs plus all accrued but unpaid Base Salary and a pro rata bonus
amount payable pursuant to Section 4 hereof through the date of termination;

                  (ii) for a period of two (2) years after such termination, the
Company  shall at its  expense  continue  on behalf  of  Employee  the  benefits
described in Section 9(b) of this Agreement; and

                  (iii) any  restrictions  on any outstanding  incentive  awards
(including,  but not limited to, restricted stock) granted to Employee under any
of the  Company's  benefit  plans or  otherwise  shall lapse and such  incentive
awards shall become 100% vested.

                  (f) Mitigation. Employee shall not be required to mitigate the
amount  of any  payment  provided  for  in  this  Section  11 by  seeking  other
employment or otherwise nor shall the amount of any payment or benefit  provided
for in this Section 11 be reduced by any compensation  earned by Employee as the
result of employment by another  employer or by  retirement  benefits  after the
date of termination or otherwise.

                  (g) Compensation  Election.  If Employee receives compensation
pursuant  to this  Section  11,  Employee  shall  not be  entitled  to any other
benefits  hereunder,  other than that referred to in subsection  (e) above,  the
receipt of any compensation  which Employee had earned but previously elected to
defer receipt of and the right to exercise  options in accordance with the terms
of the Company's Stock Option Plans under which such options were granted.

                  (h)  Excise  Tax  Payment.  In the event  that any  payment or
benefit (within the meaning of Section  280G(b)(2) of the Internal  Revenue Code
of 1986,  as amended  (the  "Code")),  to Employee or for this  benefit  paid or
payable or distributed or distributable  pursuant to the terms of this Agreement
or otherwise in  connection  with,  or arising out of, his  employment  with the
Company or a Change in Control of the Company (a "Payment" or "Payments"), would
be subject to the excise tax imposed by Section 4999 of the Code or any interest
or penalties  are incurred by the Employee with respect to such excise tax (such
excise tax,  together  with any such  interest and  penalties,  are  hereinafter
collectively  referred  to as the  "Excise  Tax"),  then  the  Employee  will be
entitled to immediately  receive an additional payment (a "Gross-Up Payment") in
an amount such that after  payment by the Employee of all taxes  (including  any
interest or penalties,  other than  interest and penalties  imposed by reason of
the Employee's failure to file timely a tax return or pay taxes shown due on his
return,  imposed with respect to such taxes and the Excise Tax),  including  any
Excise Tax imposed upon the Gross-Up Payment,  the Employee retains an amount of
the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.

         12.      Successors and Assigns.

                  (a) This  Agreement  shall be binding  upon and shall inure to
the benefit of the Company,  its successors  and assigns.  The term "Company" as
used herein shall include such successors and assigns.  The term "successors and
assigns" as used herein shall mean a corporation  or other entity  acquiring all
or  substantially  all the assets and business of this Company  (including  this
Agreement) whether by operation of law or otherwise.

                  (b) Neither this Agreement nor any right or interest hereunder
shall be assignable by the Employee, his beneficiaries, or legal representatives
without the Company's prior written consent; provided,  however, that nothing in
this Section 12 shall  preclude (i) the Employee from  designating a beneficiary
to receive any benefit payable  hereunder upon his death, or (ii) the executors,
administrators,  or other legal  representatives  of the  Employee or his estate
from assigning any rights  hereunder to distributees,  legatees,  beneficiaries,
testamentary trustees or other legal heirs of the Employee.

                  (c) After a Change of Control,  the Company  will  require any
successor  or  assign  (whether  direct  or  indirect,   by  purchase,   merger,
consolidation of otherwise) to all or  substantially  all of the business and/or
assets of the Company to expressly assume and agree to perform this Agreement in
the same manner and to the same  extent  that the  Company  would be required to
perform it if no such  succession or assignment had taken place.  Failure of the
Company to obtain such  assumption and agreement prior to the  effectiveness  of
any such succession or assignment  shall be a breach of this Agreement and shall
entitle Employee to compensation  from the Company in the same amount and on the
same terms as  Employee  would be  entitled  hereunder  if  Employee  terminated
employment  for Good  Reason  except  that,  for  purposes of  implementing  the
foregoing, the date on which any such succession or assignment becomes effective
shall be deemed the date of termination.  As used in this  Agreement,  "Company"
shall mean the Company as  hereinbefore  defined and any  successor or assign to
its business and/or assets as aforesaid which assumes and agrees to perform this
Agreement by operation of law, or otherwise.

         13.      Notices.

                  Any notice  required or permitted by this  Agreement  shall be
given by registered or certified mail,  return receipt  requested,  addressed to
the  Company at its then  principal  office,  or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
address or addresses as he or it may from time to time specify for such purposes
in a notice similarly given.

         14.      Governing Law; Litigation; Expenses.

                  (a) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Florida  without  giving effect to the
conflicts of law principles thereof.

                  (b) The Employee and the Company  hereby agree that the courts
of the State of Florida shall have exclusive  jurisdiction to hear and determine
any claims or disputes  pertaining  to this  Agreement or to any matter  arising
therefrom.  Each of the Employee and the Company  expressly submits and consents
in advance to such  jurisdiction  in any action  commenced in such courts hereby
waiving personal service of the summons and complaint or other process or papers
issued  therein,  and agreeing  that service of such summons and  complaint,  or
other process or papers,  may be made by registered or certified  mail addressed
to the Company at its then  principal  office or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
addresses  as it or he from time to time  specify to the other  party in writing
for such  purpose.  The  exclusive  choice of forum set forth in this Section 13
shall not be deemed to preclude the enforcement of any judgment obtained in such
forum or the taking of any action under this  Agreement to enforce such judgment
in any appropriate jurisdiction.

                  (c)  All  costs  and  expenses  (including   attorneys'  fees)
incurred  in  connection  with any  litigation  relating  to a claim or  dispute
pertaining to this Agreement shall be paid by the party incurring such expenses,
except if the claim or dispute pertains to the enforcement of Section 11 hereof,
in which case the  prevailing  party shall be entitled to an award of such costs
and expenses from the non-prevailing party.

                  (d) Nothing  contained  in this  Section 14 shall be deemed to
limit the Company's  obligation to indemnify the Employee to the fullest  extent
permitted by  applicable  law in respect of any actions,  claims or  proceedings
which  are  based  upon  acts  or  omissions  of  the  Employee  related  to the
performance  of his duties  hereunder to the extent he would have otherwise been
entitled to  indemnification  under the by-laws or charter of the Company or any
of its subsidiaries or to the extent to which  indemnification  is to be paid to
officers and directors as a matter of law.

         15.      Entire Agreement.

                  This instrument  contains the entire  agreement of the parties
relating  to the  subject  matter  hereof  and  supersedes  any  and  all  other
agreements and understandings,  whether written, oral or otherwise, with respect
to the  employment  of the  Employee  by  the  Company  and  all of  such  other
agreements and understandings shall be of no force or effect. No modification of
this  Agreement  shall be valid  unless in  writing  and  signed by the  parties
hereto.  The waiver of a breach of any term or condition of this Agreement shall
not be deemed to constitute a waiver of any subsequent breach of the same or any
other term or condition of this Agreement.

         16.      Severability.

                  If any term or provision of this Agreement or the  application
thereof to any person,  property or circumstance  shall to any extent be invalid
or  unenforceable,  the remainder of this Agreement,  or the application of such
term or provision to persons,  property or circumstances  other than those as to
which it is invalid or  unenforceable  shall not be affected  thereby,  and each
term and  provision  of this  Agreement  shall be valid and  enforceable  to the
fullest extent permitted by law.

         17.      Injunctive Relief.

                  (a) The Employee  acknowledges  and agrees that the  covenants
and obligations  contained in Sections 10(a),  10(b) and 10(c) of this Agreement
relate to special,  unique and extraordinary matters and that a violation of any
of the terms of such  Sections  will cause the  Company  irreparable  injury for
which adequate remedies at law are not available. Therefore, the Employee agrees
that the Company shall be entitled to an injunction, restraining order, or other
equitable  relief  from any court of  competent  jurisdiction,  restraining  the
Employee from  committing  any violation of the  covenants and  obligations  set
forth in Sections 10(a), 10(b) and 10(c) hereof.

                  (b) The  Company's  rights and remedies  under this Section 17
are  cumulative and are in addition to any other rights and remedies the Company
may have at law or in equity. In connection with the foregoing provision of this
Section 17, the Employee  represents  that his economic means and  circumstances
are such that such  provisions  will not prevent him from  providing for himself
and his family on a basis satisfactory to him.

         18.      Withholding Taxes.

                  The Company may deduct from any payments to be made  hereunder
any  federal,  state or local  withholding  or other  taxes  which  the  Company
determines it is required to deduct under applicable law.

         19.      Counterparts.  This  Agreement  may be executed in one or
more  counterparts,  each of which shall be deemed an original of which together
shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement as of the day, month and year first written above.


ECKERD CORPORATION


By: /s/ Frank Newman
     Name:  Frank Newman
     Its:  President/CEO/COO


EMPLOYEE


/s/ Samuel G. Wright
SAMUEL G. WRIGHT


g: employ1/winword/forms



                                                                 EXHIBIT 10.29

                        EMPLOYMENT AGREEMENT (Sen. Exec.)


         AGREEMENT   made  as  of  February  1,  1996,  by  and  between  ECKERD
CORPORATION,  a Delaware  corporation  (the  "Company)  and  KENNETH  L.  FLYNN,
residing at 8673 Laurel Drive, Pinellas Park, Florida 34666 (the "Employee").

         WHEREAS,  upon  the  terms  and  subject  to  the  conditions  of  this
Agreement,  the  Company  desires to employ the  Employee  and the  Employee  is
willing to accept employment by the Company.

         NOW,  THEREFORE,  in  consideration  of the mutual  covenants set forth
herein and other good and valuable consideration, the receipt and sufficiency of
which is hereby acknowledged, the parties hereto agree as follows:

         1.       Employment.

                  Upon  the  terms  and  subject  to  the   conditions  of  this
Agreement,  the Company  hereby  employs the Employee  and the  Employee  hereby
accepts employment by the Company in the capacity hereinafter set forth.

         2.       Term of Employment.

                  The term of the  Employee's  employment  by the Company  under
this  Agreement  shall  commence  on the date  hereof and shall be for a term of
twelve (12) months,  subject to extension and termination as provided in Section
8 hereof (the "Contract Period").

         3.       Duties; Extent of Services.

                  (a) During the Contract  Period,  the Employee  shall serve as
Senior  Vice  President/Operations  of the  Company or in such  other  executive
capacity as shall be  determined  from time to time by the Board of Directors of
the Company and shall  perform the duties,  undertake the  responsibilities  and
exercise the  authority  customarily  performed,  undertaken  and exercised by a
person in such position in the business in which the Company is engaged.

                  (b)  Except  as  otherwise  provided  herein  and  except  for
illness,  permitted  vacation periods and permitted leaves of absence during the
Contract  Period,  the  Employee  shall (i) devote  his full time and  attention
during  normal   business   hours  to  the  business  of  the  Company  and  its
subsidiaries;  (ii)  use his best  efforts  to  promote  the  Company's  and its
subsidiaries' interest; and (iii) discharge such other and further executive and
administrative duties as may be assigned to him by the Board of Directors of the
Company and its subsidiaries.

                  (c) Except for directorships  held by the Employee on the date
of this Agreement, during the Contract Period the Employee will not, without the
prior written consent of the Company's  Board of Directors,  serve as a director
of any corporation,  joint venture,  association or other commercial  enterprise
not controlled by, controlling or under common control with, the Company and its
subsidiaries.

         4.       Compensation.

                  (a) In consideration of the services  rendered by the Employee
under this  Agreement,  the Company  shall pay the Employee a base annual salary
(the "Base Salary") in the amount of $309,000 (or such other amount as the Board
of Directors of the Company shall  determine)  payable  monthly on the fifteenth
(15th) of each month during the Contract Period.

                  (b) During the Contract Period, as additional compensation for
his services and as a further incentive and inducement to the Employee to accept
employment  by the Company and to devote his best  efforts to the  business  and
affairs of the Company and its  subsidiaries,  the Employee shall be entitled to
participate in such  additional  compensation  plans (the "Bonus  Compensation")
which the Company allows the Employee to participate in from time to time.

                  (c) The Company  agrees that the Employee shall be entitled to
defer some portion or all of his Base Salary for any calendar year in accordance
with the provisions of the Company's  Executive  Deferred  Compensation  Plan as
adopted by the Board of Directors.

         5.       Fringe Benefits.

                  In addition to the  compensation  provided in Section 4 above,
during the  Contract  Period the  Employee  shall be entitled  to the  following
benefits:

                  (a) The  Employee  shall be  entitled  to paid  vacation  time
annually in  accordance  with the Company  policy as  determined by the Board of
Directors.

                  (b) The  Employee  shall be  entitled  to  participate  in all
employee  benefit  programs  now or  hereafter  maintained  by the  Company  for
executive  personnel for which he is eligible,  including,  without  limitation,
group life insurance,  short and long-term disability,  profit sharing, pension,
automobile allowance or leasing,  stock option (subject to approval by the Board
of Directors),  supplemental retirement income (subject to approval by the Board
of  Directors),  hospitalization  and medical and dental  reimbursement  plan or
program,  his  participation  in such  programs to be based upon the  applicable
provisions of such programs as they may exist from time to time.

         6.       Expenses.

                  The  Company  shall  pay or  reimburse  the  Employee  for all
reasonable  expenses  reasonably  incurred or paid by him in connection with the
performance of his duties hereunder upon  presentation of expense  statements or
vouchers and such other supporting documentation as the Company may from time to
time reasonably request.

         7.       Benefits Payable Upon Disability, Death, or Retirement.

                  (a) In the event of the disability (as hereinafter defined) of
the Employee during the Contract  Period,  the Company shall continue to pay the
Employee the compensation  provided in Section 4 hereof during the period of his
disability or earlier termination hereof;  provided,  however, that in the event
the Employee is disabled for a continuous  period  exceeding six (6) consecutive
calendar months,  the Company may, at its election,  terminate this Agreement at
the close of business on the date thirty (30) days after the Company  shall have
delivered a written notice of such election to the Employee,  in which event the
Employee  shall be entitled to receive  benefits  under the Company's  Long Term
Disability  Plan as such  plan may exist as of the date of  termination  of this
Agreement.

                  As used in this Agreement,  the term  "disability"  shall mean
the inability of the Employee due to illness or physical or mental  infirmity to
perform his duties under this Agreement as determined by a physician selected by
the Employee and acceptable to the Company.

                  (b)  During  the  period the  Employee  shall be  entitled  to
receive  payments under Section 7(a) above,  to the extent that he is physically
and mentally able to do so, he shall,  upon the request of the Company,  furnish
information  and assistance to the Company,  and, in addition,  upon  reasonable
request of Senior  Management or the Board of  Directors,  he shall make himself
available to the Company to undertake reasonable assignments consistent with the
dignity,  importance  and scope of his  position  and his  physical  and  mental
health.

                  (c) In the  event of the  death  of the  Employee  during  the
Contract  Period,  the Company shall pay, or cause to be paid, to the Employee's
designated beneficiary or beneficiaries or estate or legal representatives,  the
payment due pursuant to the terms of the group term insurance  policies together
with such other death  benefits as may be payable  under the  Company's  benefit
plans.

                  (d) In the  event of the  retirement  of the  Employee  on his
Normal  Retirement Date (as such term is defined in the Company's  Pension Plan)
the  Employee  shall be entitled  to such  retirement  benefits,  if any, as are
available to the Employee upon retirement  pursuant to the Company's  retirement
benefit plans.

         8.       Termination.

                  (a) Except as  otherwise  provided in  subsection  (c) and (d)
hereof,  this  Agreement  and the  employment  of the Employee  hereunder  shall
terminate upon the earliest to occur of the dates specified below:

                  (i) the close of  business  on the date that is one year after
the date hereof (the  "Initial  Period"),  except  that this  Agreement  and the
employment of the Employee  hereunder shall be automatically  extended from year
to year thereafter  unless (x) terminated by the Company by delivery of not less
than 60 days  written  notice to the  Employee  prior to the end of the  Initial
Period or any  extension  thereof in which case the  employment  of the Employee
shall  terminate on the date specified for  termination  in such notice,  or (y)
terminated  by the Employee by delivery of not less than 60 days written  notice
to the Company prior to the end of the Initial  Period or any extension  thereof
in  which  case the  employment  of the  Employee  shall  terminate  on the date
specified for termination in such notice;

                  (ii)  the  close  of  business  on the  date of  death  of the
Employee;

                  (iii) the close of business  on the date the Company  delivers
to the Employee a written notice of its election to terminate his employment for
"Cause" (as defined in paragraph (b) below);

                  (iv) the close of  business on the date thirty (30) days after
the  Company  shall  have  delivered  to the  Employee  a written  notice of its
intention  to  terminate  his  employment  because  the Board of  Directors  has
determined  that such  termination  is in the best  interests of the Company and
such  termination  is not for  Cause,  death,  disability  or  failure to extend
pursuant to Section 8(a)(i)(x) hereof;

                  (v) the close of business on the date of a termination  by the
Company pursuant to Section 7(a) hereof; or

                  (vi) the close of  business on the date of the  retirement  of
the Employee pursuant to Section 7(d) hereof.

                  (b) For purposes of this  Agreement,  the term  "Cause"  shall
mean: (i) the Employee's conviction (which,  through lapse of time or otherwise,
is not  subject to  appeal)  of, or a plea of guilty or nolo  contendre  to, any
crime or offense  which  constitutes  a felony in the  jurisdiction  involved or
involves moral turpitude,  (ii) the commission of an act of fraud,  embezzlement
or intentional dishonesty against the Company or any of its subsidiaries,  (iii)
a breach of this  Agreement  by the  Employee,  (iv)  breach of  fiduciary  duty
resulting in injury to the Company or its  subsidiaries  (v) gross misconduct in
connection with the Employee's  performance of the Employee's  duties hereunder,
or (vi) the  Employee's  continued or willful  failure or refusal to comply with
the  Company's  policies or the policies or written  directives of the Company's
Senior Management or the Board of Directors.

                  (c) For purposes  hereof,  upon  termination of this Agreement
and employment of Employee as provided in Section 8(a)(i)-(vi),  all obligations
and liabilities of the parties hereto shall cease and be of no effect except for
those liabilities and obligations provided for in Section 7, 9 and 10 hereof.

                  (d) For  purposes  of  clauses  (i) and (iv) of  Section  8(a)
above,  the Employee shall be relieved of his duties and shall vacate his office
and the Company's premises on the date of receipt of the notice required by such
clauses  unless  requested by the Company to remain in the active  employment of
the Company  during such period  between the receipt of notice and the effective
date of termination of employment.

         9.       Payments to Employee Upon Termination of Employment.

                  (a)  Upon  the   termination  of  the   Employee's   full-time
employment hereunder by the Company in accordance with clauses (i)(x) or (iv) of
Section 8(a) of this Agreement, the Company shall pay to the Employee, or in the
event of his subsequent death, to his beneficiary or beneficiaries or his estate
or legal  representative,  as severance  pay (i) an amount equal the  Employee's
Base  Salary on the date of  termination  for the  Applicable  Severance  Period
payable in monthly installments on the fifteenth (15th) of each month during the
Applicable Severance Period plus (ii) subject to the terms and provisions of any
additional  compensation  plans that the Employee  participates  in from time to
time, a pro rata portion of any bonus compensation payable to the Employee.

                  (b)  Upon  the   termination  of  the   Employee's   full-time
employment  hereunder pursuant to clauses (i)(x) or (iv) of Section 8(a) of this
Agreement,  the Company shall at its expense  continue on behalf of the Employee
the  following  benefits:   life  insurance,   short  and  long-term  disability
insurance,  hospitalization  insurance and medical and dental reimbursement plan
insurance.  The coverage of any such insurance provided by the Company hereunder
shall be no less favorable to the Employee, in terms of amounts and deductibles,
than the coverage provided under the benefit programs  maintained by the Company
from  time to time  for  the  Company's  executives.  The  Company's  obligation
hereunder  with respect to each of the foregoing  benefit plans shall  terminate
upon the earlier of the end of the Applicable  Severance  Period or the date the
Employee obtains any such benefits pursuant to a subsequent  employer's  benefit
plans.  The Employee agrees that the Company's  continued  provision of benefits
described in this Section 9(b) shall count toward satisfying any obligation that
the Company may have under COBRA.

                  (c)  Benefits  pursuant to the  Company's  Profit  Sharing and
Pension  Plans (and such other plans in which  Employee  participates)  shall be
payable to Employee in accordance with the terms of such Plans.

                  (d) For purposes of this Agreement,  the applicable  Severance
Period shall mean (i) twelve (12) months for a termination which occurs prior to
the Employee's tenth (10th) anniversary of employment with the Company,  or (ii)
eighteen (18) months for a termination  which occurs after the Employee's  tenth
(10th) anniversary of employment with the Company.

                  (e)  Employee  further   acknowledges   that  as  a  condition
precedent  to  receiving  any  benefits  under this  Agreement,  Employee  shall
complete,  execute and deliver to the Company at the time of his  termination of
employment  a Release in the form of Exhibit "A" hereto  which  releases any and
all claims  that the  Employee  may have  against  the Company as of the date of
termination arising under federal, state, local or common law.

         10.      Covenants of the Employee.

                  (a) The Employee  agrees that during the  Contract  Period and
for a period  of time  equal to (i) one year in the  event of a  termination  of
employment in accordance  with clauses (i)(y) or (iii) of Section 8(a); (ii) two
years in the event of a termination  of  employment  in accordance  with Section
7(a) or  retirement in  accordance  with Section  7(d); or (iii) the  Applicable
Severance  Period in the event of a termination of employment in accordance with
clauses  (i)(x) or (iv) of Section  8(a), he will not,  directly or  indirectly,
engage,  assist or  participate  in, whether as a director,  officer,  employee,
agent, manager,  consultant,  partner,  owner or independent contractor or other
participant,  any  business,  firm,  corporation,   partnership,  enterprise  or
organization  that competes with the business engaged or hereafter engaged in by
the  Company or any of its  subsidiaries  (including,  but not  limited  to, the
operation of retail drug stores in which  prescription  drugs are sold, the sale
of photofinishing products or services, the mail order pharmacy business, and/or
the  pharmacy   benefits   management   business)  in  the   Company's  or  such
subsidiaries'  trade areas (for  purposes  hereof  "trade  areas" shall mean any
county in any state of the United States in which retail drug stores operated by
the Company and its  subsidiaries  are located or in which services are provided
by the Company or its subsidiaries).  Nothing contained herein shall prevent the
Employee from acquiring  less than 2% of any class of outstanding  securities of
any  Company  that has any of its  securities  listed on a  national  securities
exchange or traded in the over-the-counter market.

                  (b) The Employee  agrees that during the  Contract  Period and
for a period  of two years  after  the  termination  of this  Agreement  for any
reason,  he will not directly induce or solicit any person employed or hereafter
employed  by the Company or any of its  subsidiaries  to leave the employ of the
Company or any of its subsidiaries nor will he directly or indirectly call upon,
solicit, write, direct, divert or accept business with respect to any account or
customer  of the Company or its  subsidiaries,  including,  without  limitation,
accounts or customers obtained before or during the term of this Agreement.

                  (c) The Employee agrees and acknowledges that the Confidential
Information  of the Company and its  subsidiaries  (as  hereinafter  defined) is
valuable,  special and unique to their business;  that such business  depends on
such  Confidential  Information;  and that the  Company  wishes to protect  such
Confidential  Information by keeping it confidential  for the use and benefit of
the  Company.  Based on the  foregoing,  the Employee  agrees to  undertake  the
following obligations with respect to such Confidential Information:

                  (i)  The  Employee  agrees  to keep  any and all  Confidential
Information in trust for the use and benefit of the Company;

                  (ii) The  Employee  agrees  that,  except as  required  by the
Employee's  duties or authorized in writing by the Company and its  subsidiaries
or required by  applicable  law, he will not at any time during and for a period
of five (5) years after the  termination of his employment  with the Company and
its subsidiaries, disclose, directly or indirectly, any Confidential Information
of the Company or any of its subsidiaries.

                  (iii)  The  Employee  agrees  to  take  all  reasonable  steps
necessary,  or  reasonably  requested  by the Company and its  subsidiaries,  to
ensure that all Confidential Information of the Company is kept confidential for
the use and benefit of the Company and its subsidiaries; and

                  (iv)  The  Employee  agrees  that,  upon  termination  of  his
employment  by the Company or any of its  subsidiaries  or at any other time the
Company may in writing so request,  he will promptly  deliver to the Company all
materials constituting  Confidential  Information (including all copies thereof)
that are in the possession of or under the control of the Employee. The Employee
further  agrees that,  if  requested  by the Company to return any  Confidential
Information  pursuant to this  Subsection  (iv),  he will not make or retain any
copy or extract from such materials.

                  For purposes of this Section 10(c),  Confidential  Information
means any and all  information  developed  by or for the  Company  or any of its
subsidiaries of which the Employee gained  knowledge by reason of his employment
by the  Company  or any of its  subsidiaries  prior  to the date  hereof  or his
employment  under this Agreement that is not generally  known in any industry in
which the Company is or may become engaged.  Confidential  Information includes,
but is not limited to, any and all  information  developed by or for the Company
concerning plans, marketing and sales methods,  materials,  processes,  business
forms, procedures, devices used by the Company, its subsidiaries,  suppliers and
customers with which the Company had dealt prior to the  Employee's  termination
of employment  with the Company and its  subsidiaries,  plans for development of
new  products,  services  and  expansion  into new  areas or  markets,  internal
operations,  and any trade secrets and proprietary information of any type owned
by the Company and its  subsidiaries,  together  with all  written,  graphic and
other materials relating to all or any part of the same.

         11.      Change of Control

                  (a)  Definition  of Change of Control.  No  benefits  shall be
payable  under this Section 11 unless there shall have been a Change of Control,
as set forth below,  and Employee's  employment by the Company shall  thereafter
have been terminated in accordance with Section 11(b) below. As used herein, the
term "Change of Control" shall mean:

                  (i) the  acquisition by any individual,  firm,  corporation or
other entity or any group of individuals,  firms, corporations or other entities
acting in concert  ("Person")  together with all  Affiliates  and Associates (as
such terms are defined in Rule 12b-2 of the General Rules and Regulations  under
the  Securities  Exchange  Act of 1934 (the  "Exchange  Act") of such  Person of
beneficial  ownership  (as such term is defined in Rule 13d-3 under the Exchange
Act) of more than 25% of the outstanding shares of voting stock of the Company;

                  (ii) any change in the  composition  of the Board of Directors
of the  Company  resulting  in members of the Board on the date  hereof (or such
other  persons who are elected  by, or on the  recommendation  of, a majority of
such members or other persons who had been elected by, or on the  recommendation
of, a majority of such members) ("Continuing Directors") ceasing to constitute a
majority of the Board of Directors; or

                  (iii) any other event determined by a majority of the Board of
Directors of the Company to constitute a Change of Control.

                  (b)  Termination  Following  Change of Control.  If any of the
events  described in Section 11(a) above  constituting a Change of Control shall
have occurred,  Employee  shall be entitled to the benefits  provided in Section
11(e)  hereof upon the  subsequent  termination  of  employment  during the time
period  referred to in Section  11(e) hereof if such  termination  is (i) by the
Company pursuant to Subsections 8(a)(i),  (iv) or (v) hereof or (ii) by Employee
for Good Reason.

                  (c)      Definition of Good Reason.

                  (A)  Employee  shall be entitled to terminate  employment  for
Good  Reason.  For  purposes of this  Agreement,  "Good  Reason"  shall  without
Employee's express written consent, mean, following a Change of Control:

                  (1) the assignment to Employee of any duties inconsistent with
Employee's  status as a senior executive officer of the Company or a substantial
alteration in the nature or status of Employee's  responsibilities from those in
effect  immediately prior to a Change of Control;  or an adverse and substantial
alteration  in  Employee's  reporting  responsibilities,  title or offices as in
effect  immediately prior to a Change of Control or any removal of Employee from
or failure to reelect  Employee to any such positions  except in connection with
the termination of employment for Disability, Retirement or Cause or as a result
of death or by Employee other than for Good Reason;

                  (2) a  reduction  by the  Company in  Employee's  annual  Base
Salary as in effect on the date hereof;

                  (3) any  material  breach by the Company of any  provision  of
this Agreement; or
                  (4) any purported termination of  Employee's  employment which
is not effected pursuant to a Notice of Termination  satisfying the requirements
of Section 11(d) below and, for purposes of this  Agreement,  no such  purported
termination shall be effective.

                  (B) Employee's  right to terminate his employment  pursuant to
this  Subsection  11(c) shall not be affected by  Employee's  incapacity  due to
physical or mental illness.

                  (d) Notice of  Termination.  Any purported  termination by the
Company or by Employee shall be communicated by written Notice of Termination to
the other party hereto in  accordance  with  Section 13 hereof.  For purposes of
this  Agreement,  a "Notice  of  Termination"  shall mean a notice  which  shall
indicate the specific  termination  provision of this Agreement  relied upon and
shall set forth in  reasonable  detail  the facts and  circumstances  claimed to
provide a basis for termination of employment  under the provision so indicated.
For purposes of this Agreement, no such purported termination shall be effective
without such Notice of Termination.

                  (e) Compensation for Termination.  If Employee's employment by
the Company shall be  terminated  within two years after a Change of Control (a)
by  the  Company  pursuant  to  Subsections  (8)(a)(i),  (iv),  or (v) or (b) by
Employee for Good Reason, then:

                  (i) within five (5) days of the date of such termination,  the
Company shall pay Employee a single severance payment in cash in an amount equal
to 2.9  multiplied by Employee's  Base Salary paid to Employee by the Company in
the  Company's  fiscal  year  immediately   preceding  the  year  in  which  the
termination  occurs plus all accrued but unpaid Base Salary and a pro rata bonus
amount payable pursuant to Section 4 hereof through the date of termination;

                  (ii) for a period of two (2) years after such termination, the
Company  shall at its  expense  continue  on behalf  of  Employee  the  benefits
described in Section 9(b) of this Agreement; and

                  (iii) any  restrictions  on any outstanding  incentive  awards
(including,  but not limited to, restricted stock) granted to Employee under any
of the  Company's  benefit  plans or  otherwise  shall lapse and such  incentive
awards shall become 100% vested.

                  (f) Mitigation. Employee shall not be required to mitigate the
amount  of any  payment  provided  for  in  this  Section  11 by  seeking  other
employment or otherwise nor shall the amount of any payment or benefit  provided
for in this Section 11 be reduced by any compensation  earned by Employee as the
result of employment by another  employer or by  retirement  benefits  after the
date of termination or otherwise.

                  (g) Compensation  Election.  If Employee receives compensation
pursuant  to this  Section  11,  Employee  shall  not be  entitled  to any other
benefits  hereunder,  other than that referred to in subsection  (e) above,  the
receipt of any compensation  which Employee had earned but previously elected to
defer receipt of and the right to exercise  options in accordance with the terms
of the Company's Stock Option Plans under which such options were granted.

                  (h)  Excise  Tax  Payment.  In the event  that any  payment or
benefit (within the meaning of Section  280G(b)(2) of the Internal  Revenue Code
of 1986,  as amended  (the  "Code")),  to Employee or for this  benefit  paid or
payable or distributed or distributable  pursuant to the terms of this Agreement
or otherwise in  connection  with,  or arising out of, his  employment  with the
Company or a Change in Control of the Company (a "Payment" or "Payments"), would
be subject to the excise tax imposed by Section 4999 of the Code or any interest
or penalties  are incurred by the Employee with respect to such excise tax (such
excise tax,  together  with any such  interest and  penalties,  are  hereinafter
collectively  referred  to as the  "Excise  Tax"),  then  the  Employee  will be
entitled to immediately  receive an additional payment (a "Gross-Up Payment") in
an amount such that after  payment by the Employee of all taxes  (including  any
interest or penalties,  other than  interest and penalties  imposed by reason of
the Employee's failure to file timely a tax return or pay taxes shown due on his
return,  imposed with respect to such taxes and the Excise Tax),  including  any
Excise Tax imposed upon the Gross-Up Payment,  the Employee retains an amount of
the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.

         12.      Successors and Assigns.

                  (a) This  Agreement  shall be binding  upon and shall inure to
the benefit of the Company,  its successors  and assigns.  The term "Company" as
used herein shall include such successors and assigns.  The term "successors and
assigns" as used herein shall mean a corporation  or other entity  acquiring all
or  substantially  all the assets and business of this Company  (including  this
Agreement) whether by operation of law or otherwise.

                  (b) Neither this Agreement nor any right or interest hereunder
shall be assignable by the Employee, his beneficiaries, or legal representatives
without the Company's prior written consent; provided,  however, that nothing in
this Section 12 shall  preclude (i) the Employee from  designating a beneficiary
to receive any benefit payable  hereunder upon his death, or (ii) the executors,
administrators,  or other legal  representatives  of the  Employee or his estate
from assigning any rights  hereunder to distributees,  legatees,  beneficiaries,
testamentary trustees or other legal heirs of the Employee.

                  (c) After a Change of Control,  the Company  will  require any
successor  or  assign  (whether  direct  or  indirect,   by  purchase,   merger,
consolidation of otherwise) to all or  substantially  all of the business and/or
assets of the Company to expressly assume and agree to perform this Agreement in
the same manner and to the same  extent  that the  Company  would be required to
perform it if no such  succession or assignment had taken place.  Failure of the
Company to obtain such  assumption and agreement prior to the  effectiveness  of
any such succession or assignment  shall be a breach of this Agreement and shall
entitle Employee to compensation  from the Company in the same amount and on the
same terms as  Employee  would be  entitled  hereunder  if  Employee  terminated
employment  for Good  Reason  except  that,  for  purposes of  implementing  the
foregoing, the date on which any such succession or assignment becomes effective
shall be deemed the date of termination.  As used in this  Agreement,  "Company"
shall mean the Company as  hereinbefore  defined and any  successor or assign to
its business and/or assets as aforesaid which assumes and agrees to perform this
Agreement by operation of law, or otherwise.

         13.      Notices.

                  Any notice  required or permitted by this  Agreement  shall be
given by registered or certified mail,  return receipt  requested,  addressed to
the  Company at its then  principal  office,  or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
address or addresses as he or it may from time to time specify for such purposes
in a notice similarly given.

         14.      Governing Law; Litigation; Expenses.

                  (a) This  Agreement  shall be  governed  by and  construed  in
accordance  with the laws of the State of Florida  without  giving effect to the
conflicts of law principles thereof.

                  (b) The Employee and the Company  hereby agree that the courts
of the State of Florida shall have exclusive  jurisdiction to hear and determine
any claims or disputes  pertaining  to this  Agreement or to any matter  arising
therefrom.  Each of the Employee and the Company  expressly submits and consents
in advance to such  jurisdiction  in any action  commenced in such courts hereby
waiving personal service of the summons and complaint or other process or papers
issued  therein,  and agreeing  that service of such summons and  complaint,  or
other process or papers,  may be made by registered or certified  mail addressed
to the Company at its then  principal  office or to the  Employee at his address
specified on page 1 of this  Agreement,  or to either party hereto at such other
addresses  as it or he from time to time  specify to the other  party in writing
for such  purpose.  The  exclusive  choice of forum set forth in this Section 13
shall not be deemed to preclude the enforcement of any judgment obtained in such
forum or the taking of any action under this  Agreement to enforce such judgment
in any appropriate jurisdiction.

                  (c)  All  costs  and  expenses  (including   attorneys'  fees)
incurred  in  connection  with any  litigation  relating  to a claim or  dispute
pertaining to this Agreement shall be paid by the party incurring such expenses,
except if the claim or dispute pertains to the enforcement of Section 11 hereof,
in which case the  prevailing  party shall be entitled to an award of such costs
and expenses from the non-prevailing party.

                  (d) Nothing  contained  in this  Section 14 shall be deemed to
limit the Company's  obligation to indemnify the Employee to the fullest  extent
permitted by  applicable  law in respect of any actions,  claims or  proceedings
which  are  based  upon  acts  or  omissions  of  the  Employee  related  to the
performance  of his duties  hereunder to the extent he would have otherwise been
entitled to  indemnification  under the by-laws or charter of the Company or any
of its subsidiaries or to the extent to which  indemnification  is to be paid to
officers and directors as a matter of law.

         15.      Entire Agreement.

                  This instrument  contains the entire  agreement of the parties
relating  to the  subject  matter  hereof  and  supersedes  any  and  all  other
agreements and understandings,  whether written, oral or otherwise, with respect
to the  employment  of the  Employee  by  the  Company  and  all of  such  other
agreements and understandings shall be of no force or effect. No modification of
this  Agreement  shall be valid  unless in  writing  and  signed by the  parties
hereto.  The waiver of a breach of any term or condition of this Agreement shall
not be deemed to constitute a waiver of any subsequent breach of the same or any
other term or condition of this Agreement.

         16.      Severability.

                  If any term or provision of this Agreement or the  application
thereof to any person,  property or circumstance  shall to any extent be invalid
or  unenforceable,  the remainder of this Agreement,  or the application of such
term or provision to persons,  property or circumstances  other than those as to
which it is invalid or  unenforceable  shall not be affected  thereby,  and each
term and  provision  of this  Agreement  shall be valid and  enforceable  to the
fullest extent permitted by law.

         17.      Injunctive Relief.

                  (a) The Employee  acknowledges  and agrees that the  covenants
and obligations  contained in Sections 10(a),  10(b) and 10(c) of this Agreement
relate to special,  unique and extraordinary matters and that a violation of any
of the terms of such  Sections  will cause the  Company  irreparable  injury for
which adequate remedies at law are not available. Therefore, the Employee agrees
that the Company shall be entitled to an injunction, restraining order, or other
equitable  relief  from any court of  competent  jurisdiction,  restraining  the
Employee from  committing  any violation of the  covenants and  obligations  set
forth in Sections 10(a), 10(b) and 10(c) hereof.

                  (b) The  Company's  rights and remedies  under this Section 17
are  cumulative and are in addition to any other rights and remedies the Company
may have at law or in equity. In connection with the foregoing provision of this
Section 17, the Employee  represents  that his economic means and  circumstances
are such that such  provisions  will not prevent him from  providing for himself
and his family on a basis satisfactory to him.

         18.      Withholding Taxes.

                  The Company may deduct from any payments to be made  hereunder
any  federal,  state or local  withholding  or other  taxes  which  the  Company
determines it is required to deduct under applicable law.

         19.      Counterparts.  This  Agreement  may be executed in one or
more  counterparts,  each of which shall be deemed an original of which together
shall constitute one and the same instrument.

         IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement as of the day, month and year first written above.


ECKERD CORPORATION


By: /s/ Frank Newman
     Name:  Frank Newman
     Its:  President/CEO/COO


EMPLOYEE


/s/ Kenneth L. Flynn
KENNETH L. FLYNN


g: employ1/winword/forms



                                                                 EXHIBIT 10.30

                                       THE
                          EXECUTIVE EXCESS BENEFIT PLAN
                                       OF
                             JACK ECKERD CORPORATION
                              AND ITS SUBSIDIARIES


         Effective  December  1,  1989,  JACK  ECKERD  CORPORATION,  a  Delaware
corporation,  hereby  establishes  this EXECUTIVE EXCESS BENEFIT PLAN to provide
benefits  on  behalf of those of its  executive  officers  participating  in its
Profit  Sharing Plan and Pension Plan (as  hereinafter  defined)  whose benefits
under those plans are reduced by reason of the limits  imposed by either or both
of  Sections  401(a)(17)  and 415 of the Code.  The Plan is  intended  solely to
replace  (and thus to provide  benefits  equal to) the amount of Profit  Sharing
Plan and Pension Plan benefits that  participating  employees  will be prevented
from  earning  under  those Plans by reason of such limits but would have earned
had such limits not applied. Accordingly, the Plan provides benefits only to the
extent that such limits reduce the Profit Sharing Plan and Pension Plan benefits
to which participating employees would otherwise be entitled.

         It is  intended  that the  Plan  shall  benefit  only  those  executive
employees of the Company who are nominated by either its Chief Executive Officer
or its Senior Vice President, Finance and Administration and who are approved by
the Executive Compensation and Stock Option Committee of its Board of Directors.

         1. Definitions  Provided in Pension Plan. Except as otherwise  provided
in Section 2, the terms used  herein  shall have the  meanings  assigned to them
under the Jack Eckerd  Corporation  Pension Plan, as now in effect and as it may
be amended hereafter from time to time.

         2.  Specific  Definitions.  Notwithstanding  Section  1, the  following
terms,  when used herein,  shall have the following  meanings unless a different
meaning is plainly required by the context:

         a."Account"  shall  mean a  Participant's  Excess  Pension  Account  or
           Excess Profit Sharing Account, or both, as the context requires.

         b."Beneficiary"  shall mean either or both of a Pension  Beneficiary or
           a Profit Sharing Beneficiary, as the context requires.

         c."Board" or "Board of Directors"  shall mean the Board of Directors of
           Jack Eckerd Corporation.

         d."Change in Control"  shall have the meaning  ascribed to that term in
           the Trust.

         e."Code" shall mean the Internal  Revenue of 1986, as amended from time
           to time.

         f."Committee"  shall mean the  Administrative  Committee  appointed  to
           manage and administer  the Plan in accordance  with the provisions of
           Section  14. The  members of the  Committee  at any time shall be the
           same  individuals  who  are at  that  time  members  of  the  Pension
           Committee under the Pension Plan.

         g."Company"  shall mean Jack Eckerd  Corporation  and any of its direct
           and indirect  subsidiaries  that are authorized to participate in the
           Pension Plan and the Profit Sharing Plan.

         h."Compensation  Committee"  shall mean the Executive  Compensation and
           Stock Option Committee of the Board.

         i."Computation  Date" shall mean the earliest of (i) the day before the
           date as of which the Participant  begins receiving benefits under the
           Pension Plan,  (ii) the date as of which the  Compensation  Committee
           determines,  in accordance with Section 3(b), that the Participant is
           no  longer   employed  in  a  position  that  qualifies   him/her  to
           participate  in the Plan,  and (iii) the day before the date the Plan
           is terminated.

         j."Disabled" or  "Disability"  shall mean that a  Participant  has been
           determined, in accordance with Section 5.1 of the Pension Plan, to be
           entitled to receive a disability pension under the Pension Plan.

         k."Employee" shall mean any person regularly  employed full time by the
           Company  in  any  capacity  (including  officers  and  directors  who
           regularly  render  services  to  the  Company  as  regular  full-time
           employees).   Employees  shall  not  include   part-time   employees,
           consultants or independent contractors of the Company.

         l."Excess  Pension  Account"  shall  mean the  account  established  to
           record a  participant's  Excess Pension Amount (as defined in Section
           4(d)) under the Plan.

         m."Excess  Pension  Benefit"  shall have the  meaning  ascribed to that
           term in Section 8(a).

         n."Excess  Profit Sharing  Account" shall mean the Account  established
           to record amounts  credited to a Participant  under Sections 4(b) and
           4(c).

         o."Excess  Profit Sharing  Benefit" shall have the meaning  ascribed to
           that term in Section 8(a).

         p."Participant"  shall mean an Employee who is eligible to  participate
           in the Plan and has become a  participant  in the Plan in  accordance
           with Section 3.

         q."Pension  Beneficiary"  shall mean the  Participant's  spouse (if the
           spouse survives the Participant),  except that if, on the date of his
           death, the Participant has attained the age of fifty-five (55) years,
           has  completed  any Service  Period (as defined in the Pension  Plan)
           that may then be required for such purpose under the provision of the
           Pension  Plan that  corresponds  to clause  (i)(B)  of  Section  6(a)
           hereof, and is unmarried but has children under the age of twenty-one
           (21) years living at home or enrolled in an educational  institution,
           his   Pension    Beneficiary   shall   be   his   eligible   children
           (collectively).

         r."Pension Plan" shall mean the Jack Eckerd  Corporation  Pension Plan,
           as amended from time to time.

         s."Pension  Retirement  Date" shall mean the Normal  Retirement Date as
           defined in the Pension Plan or, in the case of a  Participant  who is
           eligible  for,  and who has elected to receive,  an early  retirement
           pension under Article 4 of the Pension Plan, the date the Participant
           becomes  eligible for an early  retirement  pension under the Pension
           Plan.

         t."Plan"  shall  mean  the  Executive  Excess  Benefit  Plan of  Eckerd
           Corporation  and its  subsidiaries,  which shall be evidenced by this
           instrument, as amended from time to time, and by each Plan Agreement.

         u."Plan  Agreement"  shall  mean  the  written  agreement,  in the form
           attached  hereto as Exhibit A, that is entered into from time to time
           by and between the Company and a Participant.

         v."Plan  Year"  shall mean the period  from  December  1, 1989  through
           December 31, 1989, and each calendar year thereafter.

         w."Profit  Sharing  Account"  shall mean the account  maintained  for a
           Participant in the Profit Sharing Plan.

         x."Profit  Sharing  Beneficiary"  shall  mean  the  person  or  persons
           (including  a trust  created  by a person or the  estate of a person)
           designated  by a  Participant  to receive  the  Participant's  Excess
           Profit  Sharing  Benefit  under  the  Plan  upon  the  death  of  the
           Participant or, in the event no such person or persons are designated
           or survive the Participant,  then the Participant's beneficiary under
           the Profit Sharing Plan.

         y."Profit  Sharing  Normal  Retirement  Date"  shall  mean  the  Normal
           Retirement Date as defined in the Profit Sharing Plan.

         z."Profit Sharing Plan" shall mean the Jack Eckerd  Corporation  Profit
           Sharing  Plan.  References  herein to Sections or  provisions  of the
           Profit  Sharing  Plan refer to Sections or  provisions  of the Profit
           Sharing  Plan  document  in  effect  on  December  31,  1988 (as such
           Sections or provisions may be subsequently renumbered or amended).

        aa."Retirement"  and "Retire" shall mean severance from  employment with
           the Company on or after a  Participant's  Pension  Retirement Date or
           Profit Sharing Normal Retirement Date.

        bb."Section" shall mean, unless specified otherwise, a section hereof.

        cc."Section 401(a)(17)  Limitations" and "Section 415 Limitations" shall
           mean the  limitations  imposed  by Section  401(a)(17)  or 415 of the
           Code,   respectively,   and   regulations   and  other   governmental
           interpretations  thereunder  and by the  provisions  of any qualified
           plan  maintained  by the Company  that are intended to give effect to
           those limitations.

        dd."Trust" shall mean the Jack Eckerd  Corporation  Benefit Plans Trust,
           as amended from time to time.

        ee."Trustee" shall mean the trustee of the Trust.

         3. Eligibility to Participate in the Plan.

         a. Those executive  Employees who are  participants in the Pension Plan
and the  Profit  Sharing  Plan  and who are  selected  from  time to time by the
Compensation Committee upon the recommendation of the Chief Executive Officer or
the Senior Vice President,  Finance and  Administration  of the Company shall be
eligible to become  Participants  in the Plan. As a condition of  participation,
each  individual  so  selected  shall  complete,   execute  and  return  to  the
Compensation Committee a Plan Agreement in the form attached hereto as Exhibit A
and shall comply with such further  conditions as may be  established  by and in
the sole discretion of the Compensation Committee.

         b. In the event that subsequent to commencement of participation in the
Plan, a  Participant  fails to maintain a position of  employment in the Company
that,  in the sole  discretion  of the  Compensation  Committee,  qualifies  for
participation in the Plan, then such Participant  shall have his Account balance
adjusted,  in  accordance  with Section 4(e) below,  by the amount of his Excess
Pension Benefit, and shall cease to accrue further benefits under the Plan. Such
Participant  shall be entitled to receive  his vested  benefits,  if any, at the
time and in the manner provided by the Plan.

         c. An individual  shall remain a  Participant  so long as any amount is
credited to any of his  Accounts,  whether or not he is still an Employee at the
time such amount continues to be credited to his Accounts.

         4. Computation of Benefits.

         a. Calculation of Imputed Profit Sharing Allocation. For each Plan Year
with respect to which the  Participant  is an active  participant  in the Profit
Sharing  Plan and the Pension  Plan, a  Participant's  "Imputed  Profit  Sharing
Allocation"  shall  be  equal  to  the  amount  of  Company   contributions  and
forfeitures that would be allocated to the Participant's  Profit Sharing Account
for the Plan Year of the  Profit  Sharing  Plan that ends on the last day of the
Plan Year of the Plan under  Sections 6.2 and 7.1 of the Profit  Sharing Plan if
the Section 415 Limitations and Section 401(a)(17)  Limitations did not apply to
the Profit Sharing Plan.

         b. Annual Adjustment of Account.

                  (i)      As of each  Adjustment Date (as defined in the Profit
                           Sharing Plan),  the Excess Profit Sharing  Account of
                           each Participant shall be adjusted upward or downward
                           by  the   same   percentage   as  the   accounts   of
                           participants  in the Profit Sharing Plan are adjusted
                           in accordance  with Section 7.3 of the Profit Sharing
                           Plan.

                  (ii)     As of the  Adjustment  Date (as defined in the Profit
                           Sharing  Plan) for each Plan  Year  with  respect  to
                           which a Participant  is an active  participant in the
                           Profit  Sharing Plan and the Pension Plan, the Excess
                           Profit  Sharing  Account of each  Participant  (after
                           adjustment in  accordance  with  subparagraph  (1) of
                           this  paragraph  (b))  shall  be  credited  with  the
                           Participant's   Imputed  Profit  Sharing   Allocation
                           reduced (but not below zero) by the amount of Company
                           contributions  and forfeitures  actually  credited to
                           such  Participant's  Profit Sharing  Account for that
                           Plan Year.

         c. Final Adjustment. If the Quarterly Valuation Date (as defined in the
Profit Sharing Plan) immediately  preceding a Participant's  Computation Date is
not  an  Adjustment   Date  (as  defined  in  the  Profit  Sharing  Plan),   the
Participant's  Excess Profit Sharing Account as of such Quarterly Valuation Date
shall be multiplied by the adjustment  ratio calculated under Section 7.6 of the
Profit Sharing Plan for such Quarterly Valuation Date.

         d.  Calculation  of Excess  Pension  Amount.  A  Participant's  "Excess
Pension Amount" shall be computed as of his Computation  Date and shall be equal
to (i) the amount that the Participant would have accrued as a benefit under the
Pension Plan (as in effect on his  Computation  Date) if the Section  401(a)(17)
Limitations  and the Section 415  Limitations did not apply to the Pension Plan,
the Profit Sharing Plan, or any other  qualified plan maintained by the Company,
reduced (but not below zero) by (ii) the Participant's Accrued Benefit under the
Pension  Plan.  In  computing,  in  accordance  with clause (i) of the preceding
sentence,  the amount that a  Participant  would have accrued as a benefit under
the Pension Plan,  (I) the amount of the offset for the benefit under the Profit
Sharing Plan shall be computed as if the Section 401(a)(17)  Limitations and the
Section 415  Limitations  did not apply to the Profit Sharing Plan, and (II) all
provisions  of the Pension  Plan and the Profit  Sharing  Plan  effective on the
Computation  Date,  including,  but not limited to, any provisions  freezing any
benefits as of a date prior to or coincident with the Computation Date, shall be
taken into account.  In determining a Participant's  Excess Pension Amount,  the
Committee shall reduce, in accordance with Section 4.,2 of the Pension Plan, the
level of any benefits that commence  prior to the  Participant's  Pension Normal
Retirement Date.

         e.One-Time  Adjustment of Excess Pension Account. As of a Participant's
Computation Date, the Committee shall credit his Excess Pension Account with his
Excess Pension Amount.

         5. Retirement or Death After Retirement.

         a.  Retirement.  If a  Participant  Retires  on or  after  his  Pension
Retirement  Date,  distribution  of his Excess Pension Benefit shall commence in
the form  determined  in  accordance  with  Section 8(b) on the same date as the
distribution  of  the  Participant's  benefits  under  the  Pension  Plan.  If a
Participant  Retires  on or after his Profit  Sharing  Normal  Retirement  Date,
distribution of his Excess Profit Sharing Benefit shall be made in a single lump
sum in cash  as  soon as  administratively  practicable  after  the  Participant
terminates service.

         b. Death After  Retirement or Disability.  If a Participant  dies after
Retiring or becoming  Disabled but before receiving all payments from his Excess
Pension  Account under the Plan, the  Participant's  Pension  Beneficiary  shall
receive the remaining payments from the Participant's  Excess Pension Account to
which the Participant  would have been entitled if the Participant had lived. If
a Participant dies after Retiring or becoming  Disabled,  but before receiving a
distribution of his entire vested interest in his Excess Profit Sharing Account,
his Profit Sharing  Beneficiary  shall receive a single lump sum cash payment of
the Participant's Excess Profit Sharing Account.

         6. Death Before Retirement, Disability and Termination of Employment.

         a. Benefits in the Case of a Death.  If a Participant  dies (whether or
not he is an Employee  on the date of his death)  before  Retirement  and is not
Disabled at the time of his death,  (i)(A) if the  Participant is married on the
date of his  death,  his Excess  Pension  Benefit  shall be paid to his  Pension
Beneficiary in a Single Life Annuity (as defined in Section 8(b))  commencing on
the same date as the  distribution of the Pension  Beneficiary's  benefits under
Article  7 of the  Pension  Plan,  and (B) if,  on the  date of his  death,  the
Participant  has attained the age of  fifty-five  (55) years,  has completed any
Service  Period (as defined in the Pension  Plan) that may then be required  for
such purpose  under the  provision of the Pension Plan that  corresponds  to his
clause (B), and is unmarried but has children  under the age of twenty-one  (21)
years  living at home or  enrolled  in an  educational  institution,  his Excess
Pension  Benefit  shall be paid to his  eligible  children  (collectively)  in a
Single Life Annuity (as defined in Section 8(b))  commencing on the same date as
the  distribution  of benefits to such  children  under Article 7 of the Pension
Plan;  and (ii) his Excess  Profit  Sharing  Benefit shall be paid to his Profit
Sharing  Beneficiary  in  a  single  lump  sum  cash  distribution  as  soon  as
administratively  practicable  after the  Participant's  death.  If an unmarried
Participant dies before Retirement and is not Disabled at the time of his death,
and  if  subparagraph  (i)(B)  of  this  Section  6(a)  does  not  apply  to the
Participant, then his Excess Pension Benefit shall be forfeited.

         b. Benefits in the Case of Disability. If a Participant is Disabled, he
shall  be  entitled  to  receive  (i) his  Excess  Pension  Benefit  in the form
determined  in accordance  with Section 8(b) and  commencing on the same date as
the distribution of his disability benefits under Article 5 of the Pension Plan,
and  (ii)  his  Excess  Profit  Sharing  Benefit  in  a  single  lump  sum  cash
distribution as soon as  administratively  practicable after he is determined to
be Disabled.

         c. Benefits in the Case of Termination of Employment.  Upon termination
of  employment  (other  than by  Retirement,  as provided in Section 5, death or
Disability),  a Participant  shall be entitled to receive (i) his Excess Pension
Benefit,  payable in the form  determined  in  accordance  with Section 8(b) and
commencing on the same date as the  distribution of his benefits under Article 6
of the Pension Plan, and (ii) his Excess Profit Sharing Benefit in a single lump
sum  cash  distribution  as  soon  as  administratively  practicable  after  his
termination.

         7.  Obligation  to Pay  Benefits  Hereunder.  Except as required by the
Trust,  the  Company  shall  have no  obligation  to fund a trust fund or escrow
account or  otherwise  to segregate  assets to  guarantee,  secure or assure the
payment of any  benefit  under the Plan,  but the Company may (and to the extent
required by the Trust, shall) fund a non-qualified  grantor trust to provide for
the payment of benefits under the Plan. The establishment or funding of any such
non-qualified  grantor  trust  shall  not  relieve  the  Company  of  any of its
obligations  pursuant to the Plan,  except that amounts paid to the Participants
or other payees hereunder from any such trust shall be offset against the amount
of payments  required to be made hereunder by the Company to the  Participant or
other payee. To the extent that any person acquires a right to receive  payments
from the Company or from any trust pursuant to the Plan,  such right shall be no
greater than the right of an unsecured general creditor of the Company and shall
not be  deemed  to be a right  to  payment  of  wages  for  purposes  of any law
providing  for a lien or any other  priority  for claims  for  wages.  Any trust
established to provide for any payments hereunder shall be subject to the claims
of creditors of the Company in the event of any  insolvency of the Company,  and
all the  Company's  obligations  to pay  benefits  pursuant  to the  Plan  shall
constitute only a general and unsecured  contractual liability of the Company to
the Participants and other payees hereunder in accordance with the terms hereof.
Amounts payable  hereunder,  whether from such a non-qualified  grantor trust or
from the Company's general assets, shall be subject in all respects to claims of
general  creditors  of the Company  until  actually  paid over to the  person(s)
entitled to receive the same.

         8. Vesting and Payment of Benefits.

         a. Vesting. A Participant's Excess Pension Benefit under the Plan shall
be equal to the vested  percentage of the amount  credited to his Excess Pension
Account.  At any given time, such vested percentage shall be equal to the vested
percentage  of the  Participant's  Accrued  Benefit  under the Pension  Plan.  A
Participant's Excess Profit Sharing Benefit under the Plan shall be equal to the
vested  percentage of the amount credited to his Excess Profit Sharing  Account.
At any  given  time,  such  vested  percentage  shall  be  equal  to the  vested
percentage of the Participant's account balance under the Profit Sharing Plan.

         b.  Election of Form of  Distribution  of Excess  Pension  Benefit.  An
Eligible  Employee  who has been  approved,  in  accordance  with  Section 3, to
participate  in the  Plan,  and who is  married  on the day  before  the date he
commences  participation  in the Plan,  shall file, prior to his commencement of
participation,  an irrevocable  written  election of the form of distribution of
his Excess Pension  Benefit upon his Retirement or other  termination of service
(his "Initial Election").  The Initial Election shall be made on a form provided
by the Committee.  Such married Eligible Employee may elect either  consecutive,
approximately  level  monthly  payments  for life with no  survivor  benefit  (a
"Single Life  Annuity") or a joint and  survivor  annuity that is the  actuarial
equivalent of a Single Life Annuity and that provides consecutive, approximately
level  monthly  payments for the life of the Eligible  Employee  and,  after his
death,  consecutive,  approximately  level  monthly  payments  to  the  Eligible
Employee's Pension Beneficiary in a monthly amount equal to 50%, 75% or 100% (as
elected by the Eligible Employee as part of his Initial Election) of the monthly
amount  paid to the  Eligible  Employee  during his life (a "Joint and  Survivor
Annuity").  An Eligible  Employee  who has been  approved,  in  accordance  with
Section 3, to participate in the Plan and who is unmarried on the day before the
date he commences  participation  in the Plan,  shall receive his Excess Pension
Benefit in the form of a Single Life  Annuity,  except that, if he is married on
or  after  the  date  he  commences  participation  in the  Plan  but  prior  to
commencement of payment of his Excess Pension  Benefit,  then he may irrevocably
elect,  within 90 days after the date of his  marriage,  a 50%,  75% or 100% (as
elected by the Eligible  Employee as part of such  election)  Joint and Survivor
Annuity (a "Marital Election"). If such a Participant fails to make such Marital
Election  within 90 days after the date of his  marriage,  he shall  receive his
Excess Pension  Benefit in the form a of a Single Life Annuity.  A Participant's
Initial  Election or Martial  Election to receive a Joint and  Survivor  Annuity
shall be null and void if, prior to the date of the  commencement  of payment of
his Excess Pension  Benefit,  (i) the spouse to whom the Participant was married
on the date of such  Initial  Election  or Marital  Election  dies,  or (ii) the
Participant  is divorced  from such  spouse,  and in that event the  Participant
shall receive his Excess  Pension  Benefit in the form of a Single Life Annuity;
provided that, if a widowed or divorced  Participant  described in this sentence
is  subsequently  married  prior to the date of  commencement  of payment of his
Excess Pension  Benefit,  he may make a new Marital  Election in accordance with
the preceding sentence.

         c. Withholding Taxes, Etc. All amounts payable during the lifetime of a
Participant  shall be paid directly to the  Participant  unless  applied for the
Participant's  benefit in  accordance  with  Section  11. All  amounts  payable,
whether to a living person or to the estate of a deceased person,  shall be paid
out net after the  withholding of any federal,  state or local income,  earnings
and other taxes that might be required to be withheld from such payments.

         d.  Notwithstanding  any  provisions  hereof  to  the  contrary,  if  a
Participant (or Beneficiary of a deceased  Participant) submits to the Committee
evidence  satisfactory  to the Committee (in its  reasonable  judgment) that the
Internal Revenue Service has determined that any portion (which may include all)
of his benefit  under the Plan is  includible  in his gross  income for any year
prior to the year in which  such  portion  of his  benefit  would be paid to him
accordance  with the  provisions of the Plan other than this Section 8(d),  then
such  portion  of his  benefit  shall be paid to him in a  single  lump sum cash
distribution  as soon as  administratively  practicable  after the Committee has
received such evidence.

         9. Profit Sharing Beneficiary.

         a. Each Participant  shall  specifically  designate,  by name, on forms
provided by the Company,  the Profit Sharing  Beneficiary or  Beneficiaries  who
shall  receive any benefits that might be payable under the Plan from his Excess
Profit Sharing Account after his death. Such designation may be made at any time
satisfactory  to the  Company.  If a  Participant  has not  designated  a Profit
Sharing Beneficiary in the manner provided above, the Participant's  beneficiary
under the Profit Sharing Plan shall also be his Profit Sharing Beneficiary under
the Plan.

         b. A  designation  of a Profit  Sharing  Beneficiary  may be changed or
revoked in writing without the consent of the Profit Sharing  Beneficiary at any
time or from time to time in such manner as may be provided by the Company,  and
the  Company  shall  have no duty to notify any  person  designated  as a Profit
Sharing Beneficiary of any change in any such designation that might affect such
person's present or future rights  hereunder.  If the designated  Profit Sharing
Beneficiary does not survive the  Participant,  all amounts that would have been
paid  to  such  deceased  Profit  Sharing  Beneficiary  shall  be  paid  to  the
alternative or successor Profit Sharing  Beneficiary or  Beneficiaries  (if any)
designated by the  Participant  or, if the  Participant  has not  designated any
alternative  or  successor  Profit  Sharing  Beneficiary,  to the  estate of the
deceased  Participant.  Not more than five (5) persons or, if a greater  number,
that  number of  persons as shall be  necessary  to permit  the  Participant  to
designate  as  simultaneous  Profit  Sharing  Beneficiaries  any  or  all of the
Participant's surviving children and spouse, may be named as simultaneous Profit
Sharing  Beneficiaries  of any  Participant at any one time, and, if two or more
persons  are  to be  simultaneous  Profit  Sharing  Beneficiaries,  or,  if  the
Participant  wishes to designate  alternative,  successor or  contingent  Profit
Sharing  Beneficiaries,  the  Participant  shall  specify the shares,  terms and
conditions  upon  which  amounts  shall be paid to such  multiple,  alternative,
successor  or  contingent  Profit  Sharing  Beneficiaries,  all of which must be
clearly stated to the satisfaction of the Committee.

         c. If a designated Beneficiary,  having survived the Participant,  dies
before receiving all of the amount payable  hereunder to such  Beneficiary,  the
amount that such  Beneficiary  would have received had he lived shall be paid to
the estate of such deceased  Beneficiary unless a contrary direction was made by
the Participant in writing in such manner as may be satisfactory to the Company,
in which event such direction shall control.

         10.  Payee  Presumed  Competent.  Every  person  receiving  or claiming
amounts  payable under this Plan shall be  conclusively  presumed to be mentally
competent and of legal age until the Company receives a written notice, in form,
manner and  substance  acceptable  to it,  that such  person  has been  adjudged
legally  incompetent  or is a minor or that a guardian or other  person  legally
vested with the care of such person's estate has been appointed.

         11.  Distribution  to Persons Under a Legal  Disability.  If any amount
payable  hereunder is payable to a minor or other person under legal disability,
the  Company  shall make  payments  thereof in one (or any  combination)  of the
following  ways,  as the  Committee  shall  determine  in its  sole  discretion;
provided,  however,  the Company shall have the right, but is not obligated,  to
insist that a legal guardian be appointed before making any payments hereunder:

         a. directly to said minor or other person;

         b. to the legal representatives of said minor or other person; or

         c.to some  relative  or friend of said  minor or other  person  for the
           support, welfare or education of such minor or other person.

The Company  shall not be required to see to the  application  of any payment so
made, and the receipt of the person in one of the above three categories to whom
such payment is actually made shall fully discharge the Company from any further
accountability or responsibility with respect to the amount so paid.

         12. Notice of Address; Lost Payees.

         a.  Every  Participant  shall  file a notice of his or her post  office
address  and of the post  office  address  and  Social  Security  number of each
Beneficiary  designated by him or her and of each change of any such address, in
writing,  with the Company. Any communication,  statement or notice addressed to
any such person at the latest post office  address on file shall be binding upon
such person for all purposes, and the Company shall not be obliged to search for
or attempt to ascertain the whereabouts of any such person except as hereinafter
provided.  If a  Participant  fails or  neglects  to file  such  addresses,  the
Participant's address shall be presumed to be his or her last address on file in
the personnel records of the Company,  and, in the case of a person whose rights
accrued through or from a Participant, his or her last address shall be presumed
to be in care of the last address of such  Participant  on file in the personnel
records of the Company.

         b. If the Company is unable to locate any person  entitled to receive a
payment  hereunder  or the estate of any such person,  if  deceased,  and if the
Company shall make a search for such person  and/or such person's  estate in the
manner  hereinafter  prescribed,  the right and interest of such payee in and to
the amount  payable  shall  terminate on the last day of the one (1) year period
commencing with the  publication of the notice  hereinafter  described,  and the
amount so payable shall be payable to the estate of the Participant to whom such
amount had originally been payable;  provided,  however,  that, if the estate of
such Participant cannot be located within an additional one (1) year period, the
unclaimed  amount shall be forfeited.  In its search for such payee, the Company
shall mail a notice,  postage  prepaid,  by U.S.  registered or certified  mail,
return  receipt  requested  and  return  postage  guaranteed,  to the last known
address of such payee or (if the payee is not the Participant and if the address
of the payee is unknown) to such payee in care of the last known  address of the
Participant  from whom such payee's  rights are derived.  If all notices sent as
aforesaid are returned unclaimed or addressee unknown, the Company shall publish
a notice in a newspaper having a general circulation in the same general area as
the last known  address of the payee stating that the Company holds an amount of
payment  hereunder and giving such  additional  information as may be reasonably
calculated to come to the notice of the parties having an interest  herein.  The
foregoing actions shall satisfy the Company's obligation to conduct a search for
such payee or the estate of the Participant; provided, however, that the Company
shall  never be required  to expend in such  search an amount  greater  than the
amount payable  hereunder,  and all amounts so expended shall be charged against
the amounts held for payment.

         13. No Liability for  Participant's  Debts (Other than  Indebtedness to
the Company).  If, at the time any benefit becomes payable  hereunder,  there is
any  indebtedness  due the Company from the payee thereof,  the Company (without
being  obligated to do so) may direct that some or all of the amount  payable to
such party be applied against such indebtedness (including any interest properly
payable on such  indebtedness),  and only the unapplied balance shall be paid to
the party  otherwise  entitled  to receive  such  payment.  Except to the extent
amounts otherwise payable are applied against indebtedness of the Participant or
Beneficiary to the Company in accordance with the foregoing authority, this Plan
and the amounts  payable  hereunder  shall not, in any manner,  be liable for or
subject  to the  debts  or  liabilities  of any  payee,  and no  amount  payable
hereunder  shall,  at any time or in any  manner,  be subject  to  anticipation,
alienation,  sale,  transfer,  assignment,  pledge or  encumbrance  of any kind,
whether to the Company or to any other  party  whomsoever,  and whether  with or
without  consideration.  If any payee shall  attempt  to, or shall,  anticipate,
alienate,  sell,  transfer,  assign,  pledge or  otherwise  encumber any amounts
payable  hereunder or any part thereof,  or, if by reason of bankruptcy or other
event,  such amounts  would at any time be received or enjoyed by persons  other
than such payee except as otherwise  permitted by this Plan, the Company, in its
sole  discretion,  may terminate such person's  interest in any such amounts and
hold or apply  such  amounts to or for the use of such  person or such  person's
spouse,  children  or other  dependents,  or any of  them,  as the  Company  may
determine.

         14.  Administration.  This Plan shall be administered by the Committee,
which shall have full power, authority and discretion to do all things necessary
or appropriate to the proper administration hereof, except that the Compensation
Committee shall have sole power to determine whether any Employee is entitled to
participate in the Plan. The Committee's  power,  authority and discretion shall
include, without limiting the generality of the foregoing, full power, authority
and discretion to construe and interpret the Plan and the Plan Agreements and to
determine all questions that may arise hereunder  relating to the administration
of the Plan and the Plan Agreement (other than eligibility to participate in the
Plan),  including  questions  relating to the status and rights of Participants,
Beneficiaries  and other persons  hereunder.  Any rules adopted by the Committee
shall be administered  uniformly and applied with equal  effectiveness  and in a
nondiscriminatory manner to all persons similarly situated.  Notwithstanding any
other  provision  hereof,  the  Trustee  shall  have the power,  authority,  and
discretion, pursuant to and to the extent provided in the Trust, to override any
determination or interpretation by the Committee,  the Compensation Committee or
the Company  affecting the rights of any Participant or Beneficiary to a benefit
under the Plan. Notwithstanding any other provision hereof, all power, authority
and  discretion  vested in the Committee,  the  Compensation  Committee,  or the
Company under the Plan shall, on and after the date on which a Change in Control
occurs, no longer be vested in the Company, the Compensation  Committee,  or the
Committee and instead shall be vested in the Trustee.

        15. Negation of Employment Contract. This Plan is intended to, and does,
relate  exclusively to benefits payable after termination of employment and does
not create an employment  contract.  Nothing  contained  herein shall be deemed:
a.to give a Participant the right to be retained in the employ of the Company;

         b.to  interfere  with the right of the Company to discharge or demote a
           Participant at any time;

         c.to give the Company the right to require a  Participant  to remain in
           its employ; or

         d.to interfere with the right of a Participant to terminate  employment
           at any time.

        16. Modification, Amendment or Termination.

         a. The Company reserves the absolute right to modify or amend this Plan
in whole or in part,  at any  time and from  time to time,  effective  as of any
specified prior,  current or future date, by action of the Board of Directors or
its  delegate,  including the right to modify or amend the Plan in a manner that
would  reduce the amount that would  otherwise  be  credited to a  Participant's
Accounts under the Plan.  Notwithstanding  the preceding  sentence,  the Company
shall have no power to modify or amend the Plan in any manner that would  reduce
any  Participant's  Excess Profit Sharing Account balance hereunder on the later
of (I) the  effective  date or (II) the adoption  date, of the  modification  or
amendment,  or that would reduce the Excess Pension Benefit that any Participant
would be entitled to hereunder if his  Computation  Date were the day before the
later of (I) the effective date or (II) the adoption date of the modification or
amendment,  unless  such  action is  necessary  to  prevent  the Plan from being
subject to any provision of Title I, Subtitle B, Parts 2, 3 or 4 of the Employee
Retirement  Income  Security Act of 1974, as amended  ("ERISA") or any successor
thereto or to comply with applicable law.  Notwithstanding the first sentence of
this Section 16a, on or after the date of a Change in Control, the Company shall
have no power to modify,  amend or  interpret  the Plan in any manner that would
result in any  Participant  receiving a smaller Excess Pension Benefit or Excess
Profit Sharing Benefit than such Participant would have received under the terms
of the Plan as in  effect  on the day  before  the date on which  the  Change in
Control  occurs.  Nothing  contained  herein  shall  prevent  the  Company  from
amending,  prior to a Change in Control, to the extent permitted by the Code and
ERISA,  and the regulations  thereunder,  any provision of the Pension Plan that
would affect the amount credited to a Participant's Excess Pension Account under
the Plan.

         b. The Company also reserves the right to terminate this Plan, in whole
or in part,  voluntarily as of any specified current or future date by action of
the Board. This Plan shall be automatically terminated upon a dissolution of the
Company   (but   not   upon   a   merger,   consolidation,   reorganization   or
recapitalization of the Company if a surviving  corporation therein assumes this
Plan);  upon  the  Company  being  legally  adjudicated  a  bankrupt;  upon  the
appointment of a receiver or trustee in bankruptcy with respect to the Company's
assets and business if such appointment is not set aside within ninety (90) days
thereafter;  or upon the making by the Company of an assignment  for the benefit
of creditors.  Upon  termination of this Plan, no additional  Employees shall be
selected to  participate  herein,  and no additional  benefits  shall be accrued
hereunder.  Notwithstanding  the total or partial  termination  of this Plan, no
Participant  affected  thereby  shall be  deprived  of the right to receive  all
amounts  credited to all of his  Accounts as of the date of  termination  of the
Plan at the time and in the manner  provided  by this Plan upon  observance  and
performance of his obligations under the Plan Agreement to which the Participant
is a party  unless  such  action is  necessary  to prevent  this Plan from being
subject to any provision of Title I, Subtitle B, Parts 2, 3 or 4 of ERISA or any
successor thereto.

         c. In the  event  of the  death  of a  Participant  or any  Beneficiary
designated by him, the Company need not make any payment provided for under this
Plan until it shall have received proof  satisfactory to it of such death and of
the identity, existence and location of the party thereafter entitled to receive
payments under the Plan.

         d. In making any  payment or taking  any  action  under this Plan,  the
Company and the  Committee  shall be  absolutely  protected  in relying upon any
finding or  statement  of facts  believed  by it to be true,  and on any written
instrument believed by it to have been signed by the proper party.

         e. The Plan and all Plan  Agreements  entered into  hereunder  shall be
construed  and enforced  under and in  accordance  with the laws of the State of
Delaware, except to the extent superseded by federal law.

        17. Plan Agreement.  Each  Participant  shall be entitled to benefits in
accordance  with the Plan and his Plan  Agreement.  In the  event of a  conflict
between the Plan Agreement and the Plan, the Plan shall control.

        18. Claims Procedure.  In the event that benefits under the Plan are not
paid to the  Participant  (or his  Beneficiary in the case of the  Participant's
death),  and such person  believes  that he is entitled to receive them, a claim
shall be made in writing to the  Committee  within sixty (60) days from the date
payments are claimed to be due but not made. Such claim shall be reviewed by the
Committee in its sole discretion. If the claim is denied in full or in part, the
Committee  shall provide a written  notice within ninety (90) days setting forth
the specific  reasons for denial,  specific  reference to the  provisions of the
Plan or the Plan  Agreement  upon which the  denial is based and any  additional
material or  information  necessary  to perfect the claim.  Also,  such  written
notice  shall  indicate  the  steps to be taken if a  review  of the  denial  is
desired.  However,  under no  circumstances  shall a notification of denial that
does not satisfy all of the  foregoing  requirements  be deemed to constitute an
acceptance of a claim. If the Committee does not provide the Participant (or the
Beneficiary  in the case that the  Participant  is deceased)  with notice of its
decision  within ninety (90) days, the claim shall be deemed to be denied.  If a
claim is denied and a review is desired, the Participant,  or his Beneficiary in
the case of the  Participant's  death,  shall so notify the Committee in writing
within sixty (60) days after receipt of either the notification of denial or the
expiration of the ninety (90)-day period, whichever first occurs.

         In requesting a review,  the  Participant or his Beneficiary may review
this Plan  document or his Plan  Agreement or any  documents  relating to it and
submit any written issues and comments he believes are appropriate.  In its sole
discretion,  the  Committee  shall then  review the claim and  provide a written
decision,  likewise, shall state the specific reasons for the decision and shall
include  reference to specific  provisions of the Plan or the Plan  Agreement on
which the decision is based.

        19.  Gender  and  Number.  In  order  to  shorten  and  to  improve  the
understandability of the Plan document by eliminating the repeated usage of such
phrases as "her or his" or "Participant or Participants",  masculine terminology
herein also shall include the feminine (and neuter,  where applicable),  and any
term used  herein in the  singular  also shall  refer to the plural  except when
indicated otherwise by the context.

        IN WITNESS WHEREOF,  JACK ECKERD  CORPORATION has caused this Plan to be
executed,  and  its  corporate  seal to be  hereunto  affixed,  by its  officers
thereunto duly authorized, effective as of the date first written above.


                                                        JACK ECKERD CORPORATION



                                                    By:      /s/ Stewart Turley
                                                       Title:

(SEAL)

Attest:

 /s/ Jackie Post
Secretary


                                    EXHIBIT A

                     EXECUTIVE EXCESS BENEFIT PLAN AGREEMENT
                 OF JACK ECKERD CORPORATION AND ITS SUBSIDIARIES


         The undersigned executive employee ("Employee") acknowledges that as an
employee of Jack Eckerd Corporation and its subsidiaries ("Employer"),  Employee
has been offered an opportunity  to participate in the Executive  Excess Benefit
Plan of Jack Eckerd  Corporation and its  subsidiaries  ("Plan")  subject to the
terms and conditions  stated in the Plan, a copy of which is attached hereto and
incorporated herein by reference.  In the event of any inconsistency between the
provisions of this plan Agreement and the Plan, the provisions of the Plan shall
prevail.  Capitalized terms used herein and not otherwise defined shall have the
meanings ascribed to those terms in the Plan.

         1. Employee  elects the following  form of  distribution  of his Excess
Pension  Benefit under the Plan following his retirement or termination  for any
other reason except death (elect one option only):

 [ ]     a.       Single Life Annuity with no survivor benefit.

 [ ]     b.       Life Annuity with 50% survivor benefit.

 [ ]     c.       Life Annuity with 75% survivor benefit.

 [ ]     d.       Life Annuity with 100% survivor benefit.

         2.       Profit Sharing Beneficiary(ies):

         a.  Employee  hereby  designates  the  following  person or  persons as
primary  beneficiary  or  beneficiaries  to receive  any Excess  Profit  Sharing
Benefit payable under the Plan after the death of Employee:

Primary Profit Sharing Beneficiary(ies):

Name             Share            Relationship           Address  and  Social
                                                            Security Number


                                                         S.S. #



         b. Employee  designates  the  following  person or persons as successor
Profit Sharing Beneficiary or Beneficiaries to receive any Excess Profit Sharing
Benefit  payable  under the Plan  after the death of  Employee  and the  primary
Profit Sharing Beneficiary(ies).

Successor Profit Sharing Beneficiary(ies):

Name             Share            Relationship           Address  and  Social
                                                            Security Number


                                                         S.S. #








         3.  Employee has read this Plan  Agreement and the Plan and is aware of
and accepts the terms and conditions set forth in each document.  In particular,
Employee understands that the benefits payable pursuant to the Plan and the Plan
Agreement are unsecured contractual obligations of the Employer.

        IN WITNESS WHEREOF the parties hereto have hereunto set their hands this
      day of           , 19  .
                           

                                                EMPLOYER:

ATTEST:                                         JACK ECKERD CORPORATION

                                                By:
- -----------------------                           ----------------------------
                                                  Title: Chairman of the Board


WITNESS:                                        EMPLOYEE:


- -----------------------
Signature                                       Signature

                                                ------------------------------
                                                Type or Print Name

                                                ------------------------------  
                                                
                                                ------------------------------
                                                Address of Employee


                                 
                                                                 EXHIBIT 10.31
                                     

                               ECKERD CORPORATION
                       EXECUTIVE THREE (3) YEAR BONUS PLAN


         1. Purpose. The purpose of the Executive Three (3) Year Bonus Plan (the
  "Plan") of Eckerd  Corporation  (the  "Company") is to aid in maintaining  and
  developing  strong  management  by rewarding  those  executive  employees  who
  contribute  materially  toward the Company's  objective of earnings growth and
  return on investment and to provide an incentive for the continued  service of
  such executive employees with the Company and its subsidiaries.

         2.  Administration.  The Plan  shall be  administered  by the  Board of
  Directors of the Company.  The Board may  delegate the  administration  of the
  Plan to the Executive  Compensation and Stock Option Committee of the Board of
  Directors  comprised  of  three or more  members  of the  Board or such  other
  committee as the Board may designate from time to time (the "Committee").  The
  Board of Directors or the  Committee  may, from time to time,  establish  such
  rules and  regulations  for carrying out the Plan as they shall deem necessary
  or  desirable.  The Board of  Directors  or the  Committee  shall  decide  all
  questions of fact arising in the  application of the Plan and shall  interpret
  and construe the provisions of the Plan and of any other documents relating to
  the Plan or a bonus award hereunder and any such decision,  interpretation  or
  construction shall be conclusive and binding upon all persons.

         3.  Effective  Date of Plan.  This Plan shall  become  effective  as of
  January  29,  1995  upon  approval  by:  (i) the Board of  Directors  upon the
  recommendation of the Committee, and (ii) the Company's Shareholders.

         4. Eligibility of Executive Employees. Those executive employees of the
  Company and its subsidiaries  selected from time to time by the Committee upon
  the  recommendation  of the  Chairman of the Board or the  President  shall be
  eligible to  participate  in the Plan.  For  purposes  of the Plan,  executive
  employees shall mean corporate,  regional and district  officers and other key
  employees of the Company and its subsidiaries.

         5. Selection of Executive  Employees.  For purposes of this Plan,  each
  performance  period shall be a three (3) year  performance  period.  The first
  performance  period shall be for the 1994,  1995, and 1996 fiscal years of the
  Company. The Committee,  within ninety (90) days of the end of the 1994 fiscal
  year of the  Company,  shall  select  and  notify in  writing  each  executive
  employee who is to  participate (a  "Participant")  under the Plan for a bonus
  award during the 1994, 1995, and 1996 fiscal years of the Company (the "1994 -
  1996  Performance  Period")  and the 1995,  1996 and 1997 fiscal  years of the
  Company (the "1995 - 1997 Performance Period"). Thereafter, within ninety (90)
  days after the end of each fiscal year, the Committee may select  Participants
  for a new performance period so that, for example,  within ninety (90) days of
  the end of the 1995 fiscal year of the Company,  the  Committee may select and
  notify  Participants  for a performance  period to be designated the 1996-1998
  Performance  Period.  In addition,  where an executive  employee is added or a
  present  employee is  promoted to an  executive  status  during a  performance
  period, the Committee,  upon the special recommendation of the Chairman of the
  Board or the President,  may select any such executive employee to participate
  in the Plan for a pro rata portion of the performance period and on a pro rata
  basis.
         6.  Determination  of the Amount of a Bonus Award.  For purposes of the
  determination  of a Participant's  bonus award, the following terms shall have
  the meaning described below:

                  Adjusted EBIT shall mean, with respect to any fiscal year, (a)
                  earnings  of the  Company  and its  consolidated  subsidiaries
                  before  interest and income  taxes for such fiscal year,  plus
                  (b)  extraordinary or non-recurring  losses of the Company and
                  its  consolidated  subsidiaries for such fiscal year, less (c)
                  extraordinary  or  non-recurring  gains of the Company and its
                  consolidated  subsidiaries  for such fiscal  year  relating to
                  management strategies, approved by the Committee.

                  Return on  Investment  shall mean,  with respect to any fiscal
                  year,  Adjusted  EBIT  for such  fiscal  year  divided  by the
                  monthly  average during such fiscal year of the: (i) the total
                  assets of the  Company,  less (ii)  liabilities  exclusive  of
                  interest accruing debt.

         The amount of a bonus award to a Participant will be that percentage of
  a  Participant's  annual base salary at the beginning of a performance  period
  which is  determined by the average  annual  increase in Adjusted EBIT and the
  average annual Return on Investment determined by the Committee. The Committee
  may change the manner in which  Adjusted  EBIT and  average  annual  Return on
  Investment are  calculated  from time to time. The maximum bonus award payable
  to a Participant may not exceed  $1,000,000 with respect to any fiscal year of
  the Company.  The  Committee is  authorized to set the levels of Adjusted EBIT
  and average  annual Return on Investment  which must be met for the payment of
  bonus awards under this Plan and the  percentage  of base salary which will be
  paid as a bonus  award:  (i)  within  ninety  (90)  days  after the end of the
  Company's 1994 fiscal year for the 1994 - 1996 Performance Period and the 1995
  - 1997 Performance  Period,  and (ii) within ninety days after the end of each
  succeeding fiscal year for each performance period beginning thereafter.
         The  Committee,  in its sole  discretion,  is  authorized  to change or
  modify the  performance  objectives and to add earnings per share or sales (or
  any combination thereof) as additional or alternative  performance criteria in
  any respect for any future  performance  period and to establish  durations of
  greater  or less than  three (3) years for future  performance  periods  which
  performance  periods may  overlap or be  co-extensive  with other  performance
  periods. In addition, the Committee, in its sole discretion,  is authorized to
  change or modify the  criteria for any  performance  period in the event of an
  acquisition,  disposition  or other change in the  composition  of the Company
  during such period.

         7. Payment of Awards.  Payment of bonus awards shall,  at the option of
  the Committee,  be made: (i) 100% in cash,  (ii) 50% in cash and 50% in shares
  of common stock of the  Company,  or (iii) any other  combination  of cash and
  common stock of the Company, as determined by the Committee. Payments shall be
  made as soon as  practical  after  the  end of each  performance  period.  The
  percentage  of a bonus award that is payable in shares of common  stock of the
  Company shall be valued at the market value of the common stock of the Company
  as of the close of business on the day prior to the date the Company  publicly
  discloses its earnings for the final fiscal year of the respective performance
  period. As soon as practical after the public disclosure of the earnings,  the
  Committee shall notify each Participant of the  Participant's  bonus award. At
  the time of receipt of written notice of the  Participant's  bonus award, each
  Participant  shall  arrange  with the Company for the payment of the amount of
  any taxes  required to be  collected or withheld as a result of the payment of
  the bonus award.  Upon receipt of the aforesaid taxes, the Company shall cause
  the bonus award to be paid.

         8. Award Shares.  The maximum number of shares of common stock reserved
  for the  payment  of awards  under  this Plan  shall be  250,000,  subject  to
  adjustment for stock splits,  reverse stock splits, stock dividends,  and like
  transactions.  The source of the Company's  stock which may be made subject to
  awards  under the Plan shall be shares of the $ .01 per value  common stock of
  the Company. Such shares may be treasury shares or shares of original issue or
  a combination of the forgoing.  Fractional shares of common stock shall not be
  issued as an award and any award which would be  represented  by a  fractional
  share shall be paid in cash.

         9.  Termination  of  Obligation  to Pay Award.  The  obligation  of the
  Company to pay any bonus award shall  terminate  upon the occurrence of any of
  the following:

                  a. Upon the failure of the Company to achieve the  performance
  objectives  set  by the  Board  of  Directors  or the  Committee  pursuant  to
  Paragraph 6.

                  b.  Upon  the  date of a change  in the  position  held by the
  Participant  with  the  Company  or one of its  subsidiaries  unless  such new
  position,  in the sole  judgment of the Board of Directors  or the  Committee,
  qualifies for participation in the Plan.

                  c. Upon the  termination  of employment of a Participant  with
  the Company or its subsidiaries;  provided, however, the Board of Directors or
  the Committee,  in its sole discretion,  may pay a prorated bonus award to any
  Participant   who  has   terminated   employment   with  the  Company  or  its
  subsidiaries,  provided (i) the  Participant  was not terminated for cause (as
  defined in the  Participant's  written  employment  agreement with the Company
  and, if none,  as defined by the  Committee  from time to time),  and (ii) the
  Participant  participated  in the  Plan for a  period  up to at least  six (6)
  months prior to the end of the performance period for which the bonus award is
  payable.

                  d. Upon the death,  disability or retirement of a Participant;
  provided,  however,  the  Board of  Directors  or the  Committee,  in its sole
  discretion,  may pay a prorated  bonus award to a Participant or the estate of
  any  Participant  who  has  become  disabled,   retired  or  died  during  the
  performance  period,  provided that such  Participant had  participated in the
  Plan for a period of time  equal to or  greater  than  one-third  (1/3) of the
  total number of months  comprising the performance  period for which the bonus
  award is payable.  For purposes  hereof:  (i) retire or retirement  shall mean
  retirement  pursuant to the Eckerd Corporation  Pension Plan (Pension Plan) at
  or on the Participant's Normal Retirement Date (as that term is defined in the
  Pension  Plan) or  retirement at an earlier date with the consent of the Board
  of Directors,  and (ii) disabled or disability shall mean the inability of the
  Participant   to  perform   substantially   such   Participant's   duties  and
  responsibilities  to the  Company  or any of its  subsidiaries  by  reason  of
  physical or mental  disability or infirmity for a continuous period of six (6)
  months.  The date of such disability  shall be on the last day of such six (6)
  month period.

                  e. Upon the commission of an intentional  act by a Participant
  determined  by the Board of Directors  or the  Committee to be contrary to the
  interests of the Company or its subsidiaries.

         10.  Termination  of Plan.  The Plan shall  terminate upon the close of
  business on January 31, 2004, unless it shall have sooner terminated by action
  of the Board of Directors.

         11.  Requirements of Law. If any law,  regulation of the Securities and
  Exchange  Commission,  or any  regulation  of any other  commission  or agency
  having  jurisdiction  shall require the Company or any Participant to take any
  action  with  respect to the shares of common  stock  acquired  by reason of a
  bonus award,  then the date upon which the Company  shall issue or cause to be
  issued the certificate or certificates for the shares of common stock shall be
  postponed  until full  compliance has been made with all such  requirements of
  law or regulation. Further, if requested by the Company, at or before the time
  of the  issuance of the shares of common  stock with  respect to which a bonus
  award has been made, the Participant  shall deliver to the Company his written
  statement, satisfactory in form and content to the Company, that he intends to
  hold the shares so awarded him for investment and not with a view to resale or
  other  distribution  thereof to the public in violation of the requirements of
  the  exemption  contained in Section 4 (2) of the  Securities  Act of 1933, as
  amended.  Moreover,  in the event that the Company  shall  determine  that, in
  compliance  with the Securities Act of 1933, or other  applicable  statutes or
  regulations,  it is  necessary  to register  any of the shares of common stock
  with respect to which an award has been made or to qualify any such shares for
  exemption  from any of the  requirements  of the Securities Act of 1933 or any
  other applicable  statute or regulation,  the shares of common stock shall not
  be issued to the Participant until such action has been completed.

         12. Amendment or  Discontinuance of Plan. The Board of Directors or the
  Committee may, insofar as permitted by law, amend, suspend or discontinue this
  Plan at any time without restriction,  provided,  however,  that the Board may
  not  alter  or  amend  or  discontinue  or  revoke  or  otherwise  impair  the
  participation  of any  Participant  notified by the Board of  Directors or the
  Committee  in  accordance  with  Paragraph  5 hereof  except  as  provided  in
  Paragraph  9 hereof or unless  there is  secured  the  written  consent of the
  Participant.  Nothing contained in this paragraph, however, shall, in any way,
  condition  or limit the  termination  of an award as provided  in  Paragraph 9
  hereof.

         13.  Liquidation  of the  Corporation.  In the  event  of the  complete
  liquidation  or  dissolution  of the  Company  (except  for a  reorganization,
  merger, consolidation,  acquisition or sale of substantially all of the assets
  of the Company as provided in Paragraph 14), any participation  under the Plan
  shall  be  deemed  canceled  without  regard  to or  limitation  by any  other
  provision of this Plan. In the event of a complete  liquidation or dissolution
  of a subsidiary  of the Company or in the event that such a subsidiary  ceases
  to be a subsidiary  corporation as defined  hereinabove,  any participation by
  employees of such  subsidiary  pursuant to this Plan shall be deemed  canceled
  unless  the  employee  shall,  at or  before  the time of the  liquidation  or
  dissolution or cessation of subsidiary relationship,  be or become employed by
  the Company or by any other  subsidiary of the Company in a position which, in
  the sole  judgment of the Board of Directors or the  Committee,  qualifies for
  participation in the Plan, or in the event that the Board or the Committee, in
  its sole  discretion,  elects to pay a prorated bonus award in accordance with
  Paragraph 9 (c).

         14. Merger,  Sale of Assets. In the event of a reorganization,  merger,
  consolidation,  acquisition or sale of substantially  all of the assets of the
  Company, any participation under the Plan shall be deemed canceled;  provided,
  however,  the  Board  or the  Committee,  in its  sole  discretion,  may pay a
  prorated bonus award to Participants  who have  participated in the Plan for a
  period equal to or greater than one-third  (1/3) of the total number of months
  comprising the performance period for which the bonus award is payable.

         15.  Shareholder  Approval.  The Plan  shall be  submitted  to the next
  annual  meeting of the  shareholders  of the  Company  for the  purpose of its
  approval and ratification of the shareholders as provided in Paragraph 3.

 a: 3yrexec1/disk


                                                                    Exhibit 12.2

<TABLE>
<CAPTION>                                                                                       


                                           ECKERD CORPORATION AND SUBSIDIARIES
                                    Computation of Ratio of Earnings to Fixed Charges
                                    Years Ended February 3, 1996 and January 28, 1995



                                                                 February 3, 1996    January 28, 1995
                                                                 ----------------    ----------------
<S>                                                                     <C>                  <C>
Earnings before income taxes and extraordinary item                     $123,383              87,084
Add:
     Portion of rents representative of the interest factor (*)           39,599              37,282
     Interest expense                                                     76,836              93,735
                                                                        --------             -------

         Income as adjusted                                             $239,818             218,101
                                                                        ========             =======

Fixed charges:
     Interest expense                                                     76,836              93,735
     Portion of rents representative of interest factor                   39,599              37,282
                                                                        --------             ------- 

         Total fixed charges                                            $116,435             131,017
                                                                        ========             =======

Ratio of earnings to fixed charges                                          2.06                1.66
                                                                            ====                ====

(*)   The portion of rents  representative  of the interest factor is calculated
      as 33-1/3% of minimum rentals.

</TABLE>

<TABLE>                                 
EXHIBIT 13
Five Year Financial Operating Summary

(In thousands, except per share amounts                Fiscal years ended February 3, January 28, January 29, January 30
 and drug stores)                                                                   and February 1, respectively (1) (2)

                                                      1996            1995           1994            1993         1992
<S>                                               <C>             <C>             <C>            <C>          <C>
Summary of Operations Data:
   Sales and other operating revenue              $4,997,073      4,589,517(3)    4,228,747      3,923,750    3,774,852
   Cost of sales, including store
     occupancy, warehousing and
     delivery expense                              3,874,723      3,484,627       3,213,583      2,933,202    2,773,545
   Operating and administrative
     expenses                                        922,131        924,071(3)      857,980        855,165      854,209
   Earnings before interest expense                  200,219        180,819         157,184        135,383      147,098
   Net interest expense                               76,836         93,735         113,215        137,404      143,194
   Earnings (loss) before income taxes
     and extraordinary items                         123,383         87,084          43,969         (2,021)       3,904
   Income tax expense                                 20,600          8,753(3)        2,556          2,864        2,927
   Earnings (loss) before extraordinary
     items                                           102,783         78,331          41,413         (4,885)         977
   Extraordinary item-early retirement
     of debt and preferred stock,
     net of tax benefit                               (9,306)       (30,523)        (44,354)            --           --
   Extraordinary item-tax effect of
     utilization of net operating loss
     carryforward                                         --             --              --            762        1,680
   Net earnings (loss) for the year                   93,477         47,808          (2,941)        (4,123)       2,657
   Preferred stock dividends                              --             --           4,924         10,815       10,823
   Net earnings (loss) available
     to common shares                             $   93,477         47,808          (7,865)       (14,938)      (8,166)
   Earnings (loss) before extraordinary           
     items per common share                       $     1.50           1.21             .62           (.30)        (.19)
   Net earnings (loss) per common share           $     1.36            .74            (.13)          (.28)        (.16)
   Dividends per common share                     $       --             --              --             --           --
   Weighted average common shares
     outstanding                                      68,606         64,863          58,786         53,148       51,354

Balance Sheet Data:
   Working capital                                $  320,618        280,289         306,588        367,027      328,617
   Total assets                                    1,490,699      1,342,347       1,420,137      1,418,922    1,412,249
   Long-term debt (4)                                702,818        787,013         954,891      1,048,222    1,023,106
   Preferred stock                                        --             --              --         75,000       75,000
   Stockholders' equity (deficit)                     54,741       (122,742)       (179,022)      (243,291)    (228,353)

Drug Store Data:
   Stores open at end of year                          1,715          1,735           1,718          1,696        1,675
   Comparable store sales growth                         8.8%           8.1             6.1            3.1          5.7

</TABLE>
Notes:
(1)  Years ended the Saturday nearest January 31. All fiscal
     years include 52 weeks of operations except fiscal year
     ended February 3, 1996 which includes 53 weeks of
     operations.
(2)  All fiscal years have been restated to reflect the
     two-for-one stock split effected in the form of a stock
     dividend declared April 1, 1996 (payable May 13, 1996).
     Fiscal years prior to January 29, 1994 have been restated to
     reflect the reclassification of previously issued Class A
     and Class B common stock into Common Stock, to reflect a
     two-for-three reverse stock split and the exchange of EDS
     Holdings Inc. common stock and merger into the Company.
(3)  Sales and other operating revenue includes $54,125 and
     income tax expense includes $4,655 from the gain on the sale
     of Insta-Care Pharmacy Services and operating and
     administrative expenses includes a $48,988 charge for future
     store closings.
(4)  Includes current installments.


<PAGE>
Management's Discussion and Analysis of Results of Operations and Financial 
Condition 

<TABLE>
Condensed Consolidated Statements of Operations
(In thousands)                          1995 Fiscal Year        1994 Fiscal Year                1993 Fiscal Year
                                        Ended February 3,       Ended January 28,               Ended January 29,
                                             1996                      1995                            1994
                                                          As Reported    As Adjusted(1)    As Reported    As Adjusted(2)
<S>                                       <C>              <C>             <C>              <C>             <C>
Sales and other operating revenue         $4,997,073       4,589,517       4,446,728        4,228,747       4,060,614
Cost of sales                              3,874,723       3,484,627       3,425,860        3,213,583       3,104,734
Operating and administrative expenses        922,131         924,071         849,253          857,980         805,603
Earnings before interest expense             200,219         180,819         171,615          157,184         150,277
Interest expense                              76,836          93,735          93,735          113,215         113,215
Income tax expense                            20,600           8,753           3,895            2,556           2,155
Earnings before extraordinary items          102,783          78,331          73,985           41,413          34,907
Extraordinary items                           (9,306)        (30,523)        (30,523)         (44,354)        (44,354)
Net earnings (loss) for the year          $   93,477          47,808          43,462           (2,941)         (9,447)
</TABLE>
(1)  Sales and other operating revenue excludes $54.1 million
     from the gain on the sale of Insta-Care Holdings, Inc.
     ("Insta-Care"), as well as $88.7 million of Insta-Care sales
     prior to the disposition. Cost of sales, operating and
     administrative expenses and income tax expense exclude $58.8 
     million, $25.8 million and $4.9 million of expenses related
     to Insta-Care's operations and sale. Operating and 
     administrative expenses also exclude a charge of $49.0
     million for future store closings.
(2)  Sales and other operating revenue excludes $168.1 million
     for the Vision Group and Insta-Care operations prior to
     disposition. Cost of sales, operating and administrative
     expenses and income tax expense exclude $108.8 million,
     $52.4 million and $0.4 million of expenses related to the
     Vision Group and Insta-Care operations.

Results of Operations
Fiscal Year 1995 compared with Fiscal Year 1994
        The preceding as adjusted condensed consolidated
statement of operations for fiscal 1994 and the following
management's discussion and analysis exclude the items noted
above in footnote (1) to the condensed consolidated statement of
operations to eliminate the operations and gain on the sale of
Insta-Care (sold effective November 15, 1994) and exclude the 
charge for accelerated future store closings.
        The Company's sales and other operating revenue for
fiscal 1995 were $5.0 billion, a 12.4% increase over fiscal 1994.
Sales benefited from significant increases in both prescription
and front end sales. Also contributing to the increased sales
were revenues from Florida drug stores acquired from Rite Aid
(the "Florida Rite Aid Acquisition") and from one additional week
in fiscal 1995 which was a 53 week year compared to fiscal 1994
which was a 52 week year.  For fiscal 1995, prescription sales
were $2.7 billion, a 19.6% increase over fiscal 1994. In
addition, front end sales increased to $2.3 billion, a 5.1%
increase over fiscal 1994.
        Comparable drug store sales (stores open for one year or
more, excluding relocated stores open less than one year) for
identical periods increased 8.8% during fiscal 1995 compared to
an 8.1% increase in fiscal 1994. The increase in comparable drug
store sales was primarily attributable to the increase in sales
of prescription drugs. Comparable drug store sales growth was
also positively affected by increased sales of non-prescription 
items in the health, greeting card, convenience food and
photofinishing categories.
        Prescription sales as a percentage of drug store sales
was 53.7% for fiscal 1995 compared with 50.5% for fiscal 1994.
The growth in prescription sales was primarily the result of
increased managed care prescription sales, the Company's
competitive cash pricing strategy and the Florida Rite Aid 
Acquisition. Additionally, these sales benefited from a higher
incidence of cough, cold and flu virus during both the first and
fourth quarters of fiscal 1995 compared to fiscal 1994. Managed
care prescription sales represented 70.6% and 64.6% of the
Company's prescription sales in fiscal 1995 and 1994,
respectively. The Company expects prescription sales to managed
care payors, in terms of both dollar volume and as a percentage
of total prescription sales, to continue to increase in fiscal
1996 and for the foreseeable future. Managed care payors
typically negotiate lower prescription prices than those 
of non-managed care prescriptions, resulting in decreasing gross
profit margins on the Company's prescription sales. However,
contracts with managed care payors generally increase the volume
of prescription sales and gross profit dollars.
<PAGE>
        Cost of sales and related expenses in fiscal 1995 were
$3.9 billion, a 13.1% increase over fiscal 1994. As a percentage
of sales, cost of sales and related expenses were 77.5% and 77.0%
for fiscal 1995 and 1994, respectively. The increase in cost of
sales and related expenses as a percentage of sales resulted
primarily from the continued increase in managed care
prescription sales, which generally have lower gross profit
margins than non-managed care prescription sales. The LIFO charge
was $15.0 million in fiscal 1995 compared to $10.8 million in
fiscal 1994.
        Operating and administrative expenses in fiscal 1995 were
$922.1 million, an 8.6% increase over fiscal 1994. As a
percentage of sales, operating and administrative expenses were
reduced to 18.5% for fiscal 1995 from 19.1% for fiscal 1994. The
decrease in operating and administrative expenses in fiscal 1995
as a percentage of sales resulted primarily from operating
efficiencies related to the higher sales (including benefits 
derived from closing certain under-performing stores) and cost
controls which helped produce lower costs as a percentage of
sales in such expense categories as payroll and insurance.
        Earnings before interest expense, income taxes and
extraordinary items in fiscal 1995 were $200.2 million, a 16.7%
increase over fiscal 1994. The increase in earnings before
interest expense, income taxes and extraordinary items was due
primarily to the increase in gross profit dollars as a result of
higher sales and other operating revenue and the decrease in
operating and administrative expenses as a percentage of sales
due to improved productivity and expense control in fiscal 1995
compared to fiscal 1994.
        Total interest expense was $76.8 million in fiscal 1995,
a decrease of 18.0% from fiscal 1994. The decrease in interest
expense was due to lower average borrowings in fiscal 1995, due
primarily to paydowns of borrowings from net proceeds from the
sale of non-retail drug store operations, lower bank loan
interest spreads and the early retirement of high interest cost 
subordinated debentures.
        Income tax expense was $20.6 million (17% effective rate)
and $3.9 million (5% effective rate) in fiscal 1995 and 1994,
respectively. Income tax expense in both fiscal years represents
alternative minimum tax and state income taxes for the Company,
and reflects the utilization of net operating loss carryforwards.
       As a result of the foregoing factors, the Company had
earnings before extraordinary items of $102.8 million in fiscal
1995 compared to earnings on an adjusted basis before
extraordinary items of $74.0 million in fiscal 1994, an increase
of $28.8 million or 38.9%, and net income more than doubled to 
$93.5 million in fiscal 1995 compared to $43.5 million on an
adjusted basis in fiscal 1994, a $50.0 million increase.
        The Company had extraordinary items of $9.3 million (net
of tax benefit of $1.9 million) and $30.5 million (net of tax
benefit of $1.6 million) in fiscal 1995 and 1994, respectively.
The extraordinary items in fiscal 1995 and 1994 are primarily
from the write-off of deferred costs related to the significant
revisions of the bank credit agreement, as well as the write-off
of deferred costs and original issue discount from the early 
retirement of $95.5 million in 1995 and $50.0 million in 1994 of
the 11.125% subordinated debentures.

Fiscal Year 1994 compared with Fiscal Year 1993
        The following fiscal 1994 comparison is based on the
preceding as adjusted condensed consolidated statements of
operations and footnotes for fiscal 1994 and fiscal 1993. The
fiscal 1994 results exclude the operations and gain on the sale
of Insta-Care and the charge for accelerated future store        
closings. The fiscal 1993 results exclude the Company's Vision
Group (sold effective January 30, 1994) and Insta-Care        
operations.
        The Company's sales and other operating revenue for       
fiscal 1994 were $4.4 billion, a 9.5% increase over fiscal 1993. 
Sales benefited from significant increases in prescription sales
and increases in front end sales. For fiscal 1994, prescription
sales were $2.2 billion, a 15.2% increase over fiscal 1993. In
addition, front end sales increased to $2.2 billion, a 4.2%
increase over fiscal 1993.
        Comparable drug store sales (stores open for one year or
more) increased 8.1% during fiscal 1994 compared to a 6.1%
increase in fiscal 1993. The increase in comparable drug store
sales was primarily attributable to the increase in sales of
prescription drugs. Comparable drug store sales growth was also
positively affected by increased sales of non-prescription
categories such as health, toiletries, convenience food and
photofinishing items resulting from increased marketing emphasis
and shelf space for these categories.
<PAGE>
        Prescription sales as a percentage of drug store sales
was 50.5% for fiscal 1994 compared with 48.0% for fiscal 1993.
The growth in prescription sales was primarily the result of
increased managed care prescription sales and the Company's
competitive cash pricing strategy. These sales were strong 
despite a lower incidence of cough, cold and flu virus during the
first and fourth quarters of fiscal 1994 compared to fiscal 1993.
Managed care prescription sales represented 64.6% and 58.0% of
the Company's prescription sales in fiscal 1994 and 1993,
respectively.
        Cost of sales and related expenses in fiscal 1994 were
$3.4 billion, a 10.3% increase over fiscal 1993. As a percentage
of sales, cost of sales and related expenses were 77.0% and 76.5%
for fiscal 1994 and 1993, respectively. The increase in cost of
sales and related expenses as a percentage of sales resulted
primarily from the continued increase in managed care
prescription sales which generally have lower gross profit
margins than non-managed care prescription sales. The LIFO charge
was $10.8 million in fiscal 1994 compared to $8.5 million in
fiscal 1993.
        Operating and administrative expenses in fiscal 1994 were
$849.3 million, a 5.4% increase over fiscal 1993. As a percentage
of sales, operating and administrative expenses were reduced to
19.1% for fiscal 1994 from 19.8% in fiscal 1993. The decrease in
operating and administrative expenses in fiscal 1994 as a
percentage of sales resulted primarily from the economies of
scale related to the higher sales and cost controls which helped 
produce lower costs as a percentage of sales in such expense
categories as payroll, insurance and supplies.
        In the fourth quarter of fiscal 1994, the Company decided
to accelerate the closing of approximately 90 geographically
dispersed, under-performing stores, and established a $49.0
million reserve for future store closings. These closings were in
addition to the small number of stores the Company closes in the
normal course of business. The $49.0 million reserve included
approximately $27.0 million for lease settlements and
obligations, approximately $4.0 million for severance and other
expenses directly related to the store closings, and
approximately $18.0 million for the write-off of impaired assets
which include inventory liquidation and the write-off of
intangible and fixed assets.
        Earnings before interest expense, income taxes and
extraordinary items in fiscal 1994 were $171.6 million, a 14.2%
increase over fiscal 1993. The increase in earnings before
interest expense, income taxes and extraordinary items was due
primarily to the increase in gross profit dollars as a result of
higher sales and other operating revenue and the decrease in 
operating and administrative expenses as a percentage of sales in
fiscal 1994 compared to fiscal 1993.
        Total interest expense was $93.7 million in fiscal 1994,
a decrease of 17.2% from fiscal 1993. The decrease was due
primarily to the lower cost of debt to the Company resulting from
fiscal 1993's refinancing, initial public offering of stock and
9.25% senior subordinated note issuance and the bank credit
agreement revision which provided improved pricing. In addition, 
the decrease in interest expense was due to lower average
borrowings in fiscal 1994, due primarily to paydowns of
borrowings from net proceeds from the sale of Vision Group and
Insta-Care operations, partially offset by the numerous
marketplace interest rate increases during fiscal 1994.
        Income tax expense was $3.9 million and $2.2 million in
fiscal 1994 and 1993, respectively. Income tax expense in both
fiscal years represents alternative minimum tax and state income
taxes for the Company, and reflects the utilization of net
operating loss carryforwards.
        As a result of the foregoing factors, the Company had
earnings on an adjusted basis before extraordinary items of $74.0
million in fiscal 1994 compared to $34.9 million in fiscal 1993,
an increase of $39.1 million or 111.9%, and net income of $43.5
million in fiscal 1994 compared to a net loss before $4.9 million
of preferred dividends of $9.4 million in fiscal 1993, a $52.9
million increase.
        The Company had extraordinary items of $30.5 million (net
of tax benefit of $1.6 million) and $44.4 million (net of tax
benefit of $0.9 million) in fiscal 1994 and 1993, respectively.
The extraordinary item in fiscal 1994 is primarily from the
write-off of deferred costs related to the significant revision
of the bank credit agreement, as well as the write-off 
of deferred costs and original issue discount from the early
retirement of $50.0 million of the 11.125% subordinated
debentures. The extraordinary item in fiscal 1993 is       
primarily from the write-off of deferred costs and original issue 
discount from the early retirement of a portion of the 
<PAGE>
11.125% subordinated debentures, all of the 13% subordinated 
debentures and the redemption of the 14.5% preferred stock.

Liquidity and Capital Resources
        On November 29, 1995, the Company entered into a
significant revision of the bank credit agreement. The revised
agreement provides for a total loan facility of $750.0 million.
The revolving loan facility was increased to $500.0 million and
the term loan facility was reduced to $250.0 million to be 
amortized equally over five years. Although the revision did not
provide any additional proceeds to the Company, it does provide
improved pricing and increased operating flexibility with respect
to acquisitions and term loan amortization.
        At February 3, 1996, the Company had approximately $230.0
million outstanding under the term loan facility, $230.0 million
outstanding under the revolving loan facility and $184.4 million
available for borrowing under the revolving loan facility portion
of the bank credit agreement which is net of $85.6 million of
letters of credit. Pursuant to the bank credit agreement, 
the Company is required to make scheduled payments of the
outstanding principal amount of the term loan facility in
quarterly payments. Prepayments made pursuant to the bank credit
agreement are applied pro rata among the remaining scheduled term
loan principal payments. The bank credit agreement matures in     
November 2000.
        On February 3, 1996, the Company had working capital of
$320.6 million and a current ratio of 1.5 to 1 compared to $280.3
million and 1.5 to 1 at January 28, 1995. Cash flow provided by
operating activities increased $45.3 million to $164.3 million
for fiscal 1995 compared with $119.0 million for fiscal 1994. The
increase was principally attributable to higher net earnings
which increased $45.7 million during fiscal 1995 partially offset
by a reduction of $20.9 million in non-cash extraordinary charges
related to the early retirement of debt and significant revisions
to the bank credit agreement.  Depreciation and amortization
including original issue discount amortization increased $2.9
million in 1995 to a total of $86.6 million. Working capital
items, including receivables, inventory, other assets, 
accounts payable and accrued expenses, combined to use operating
cash of $27.0 million in fiscal 1995 compared to a source of cash
of $9.5 million in fiscal 1994, an increase in use of funds of
$36.5 million.
        Net cash from investing activities for fiscal 1995 and
1994 used $171.5 million and provided $50.6 million,
respectively. Uses of cash were principally for capital
expenditures of $109.8 million and $57.2 million for 
fiscal 1995 and 1994, respectively, for additions to the
Company's drug stores and Express Photo units and improvements to
existing stores and for the installation of point-of-sale product
scanning equipment. Fiscal 1995 also included the acquisition of
$76.9 million in drug store assets primarily as a result of the
Florida Rite Aid Acquisition. In fiscal 1994, a source of 
cash to the Company from investing activities was provided by the
sales of the Insta-Care and Vision Group operations. Capital
improvements planned for fiscal 1996, including those to be
acquired under a deferred payment arrangement and through
operating leases, are expected to total approximately 
$130 million. Funds for the planned cash capital expenditures are
expected to come from cash flow from operating activities and
available borrowings, if necessary.
        Financing activities for fiscal 1995 provided $6.2
million. Proceeds from the sale of common stock of $82.4 million
combined with increased bank debit balances of $15.2 million at
year end together offset the redemption of the remaining $95.5
million of 11.125% subordinated debentures. Financing 
activities for fiscal 1994 used $172.8 million primarily for the
reduction of bank borrowings and the early retirement of $50.0
million of the 11.125% subordinated debentures.
        Based upon the Company's ability to generate cash flow
from operating activities, the available unused portion of the
revolving loan facility under the bank credit agreement and other
existing sources, the Company believes that it will have the
funds necessary to meet the principal and interest payments on
its debt as they become due and to operate and expand its 
business.
        The payment of dividends and other distributions by the
Company is subject to restrictions under certain of the financing
agreements to which the Company is a party, including the bank
credit agreement and the 9.25% senior subordinated notes. The
Company currently does not plan to pay dividends on its common
stock.
<PAGE>
<TABLE>
Consolidated Statements of Operations
(In thousands, except per share amounts)                            February 3, January 28 and January 29, respectively
                                                                              1996           1995            1994

<S>                                                                        <C>             <C>             <C>
Sales and other operating revenue (note 1(c))                              $4,997,073      4,589,517       4,228,747
Costs and expenses:
    Cost of sales, including store occupancy, warehousing 
      and delivery expense                                                  3,874,723      3,484,627       3,213,583
    Operating and administrative expenses  (note 9)                           922,131        924,071         857,980
                                                                            4,796,854      4,408,698       4,071,563
          Earnings before interest expense                                    200,219        180,819         157,184
Interest expense:
    Interest expense, net                                                      75,030         87,838         105,999
    Amortization of original issue discount
      and deferred debt expenses                                                1,806          5,897           7,216
          Total interest expense                                               76,836         93,735         113,215
          Earnings before income taxes and extraordinary items                123,383         87,084          43,969
Income tax expense (note 5)                                                    20,600          8,753           2,556
          Earnings before extraordinary items                                 102,783         78,331          41,413
Extraordinary items:
    Early retirement of debt and preferred stock, 
      net of tax benefit of $1,907, $1,607 and $929 (note 4)                   (9,306)       (30,523)        (44,354)
          Net earnings (loss) for the year                                     93,477         47,808          (2,941)
Preferred stock dividends                                                          --            --            4,924
          Net earnings (loss) attributable to common shares                $   93,477         47,808          (7,865)
Earnings (loss) per common share:
    Earnings before extraordinary items                                    $     1.50           1.21             .62
    Extraordinary items                                                          (.14)          (.47)           (.75)
          Net earnings (loss)                                              $     1.36            .74            (.13)
</TABLE>
See accompanying notes to consolidated financial statements.
<PAGE>

<TABLE>
Consolidated Balance Sheets
(In thousands, except share amounts)                                             February 3 and January 28, respectively
                                                                                           1996             1995
<S>                                                                                     <C>               <C>
Assets
Current assets:
    Cash                                                                                $    7,922            8,898
    Receivables, less allowance for doubtful receivables of $3,000                          70,137           52,487
    Merchandise inventories                                                                835,551          771,122
    Prepaid expenses and other current assets                                                4,396            2,366
            Total current assets                                                           918,006          834,873
Property, plant and equipment, at cost:
    Land                                                                                    17,420           17,814
    Buildings                                                                               73,955           74,002
    Furniture and equipment                                                                368,251          306,962
    Transportation equipment                                                                14,225           11,911
    Leasehold improvements                                                                 160,172          131,502
                                                                                           634,023          542,191
      Less accumulated depreciation                                                        282,974          249,214
            Net property, plant and equipment                                              351,049          292,977
Excess of cost over net assets acquired, less accumulated amortization of 
    $19,986 and $16,715                                                                     62,162           27,667
Favorable lease interests, less accumulated amortization of $404,001 and $383,708          131,961          153,664
Unamortized debt expenses (note 4)                                                           6,086           10,138
Other assets                                                                                21,435           23,028
                                                                                        $1,490,699        1,342,347

Liabilities and Stockholders' Equity (Deficit)
Current liabilities:
    Bank debit balances                                                                 $   59,620           44,373
    Current installments of long-term debt (note 4)                                          1,020            1,452
    Accounts payable                                                                       311,411          287,551
    Accrued interest                                                                        12,533           19,246
    Accrued payroll                                                                         70,205           70,640
    Other accrued expenses (note 9)                                                        142,599          131,322
            Total current liabilities                                                      597,388          554,584
Other noncurrent liabilities (note 9)                                                      136,772          124,944
Long-term debt, excluding current installments (note 4)                                    701,798          785,561

Stockholders' equity (deficit) (notes 1 and 6):
    Preferred stock of $.01 par value. Authorized 20,000,000 shares; 
      none issued or outstanding                                                                --               --

    Voting common stock of $.01 par value. Authorized 96,481,272 
      shares; issued 69,937,790 and 64,211,548                                                 700              642
    Nonvoting common stock of $.01 par value. Authorized 
      3,518,728 shares; no shares issued                                                        --               --
    Capital in excess of par value                                                         317,654          233,706
    Retained deficit                                                                      (263,613)        (357,090)
            Total stockholders' equity (deficit)                                            54,741         (122,742)
Commitments and related party transactions (notes 7 and 8)
                                                                                        $1,490,699        1,342,347
</TABLE>
See accompanying notes to consolidated financial statements.
<PAGE>
<TABLE>
Consolidated Statements of Stockholders' Equity (Deficit)

(In thousands, except share amounts)                 Years ended February 3, 1996, January 28, 1995 and January 29, 1994
                                                                          Capital                             Total
                                             Voting      Nonvoting           in                            stockholders'
                                             common        common        excess of         Retained           equity
                                              stock         stock        par value          deficit          (deficit)
<S>                                            <C>          <C>           <C>              <C>               <C>
Balance at January 30, 1993                    $472           6           153,264          (397,033)         (243,291)
Reclassification of common stock previously 
    subject to put options                       42          --             7,258                --             7,300
Common stock sold under employee 
    stock option plan                             2          --               271                --               273
Common stock sold in public stock offering, 
    net of expenses of sale                     104          --            64,457                --            64,561
Net loss for the year                            --          --                --            (2,941)           (2,941)
14 1/2% preferred stock cash dividends           --          --                --            (4,924)           (4,924)

Balance at January 29, 1994                     620           6           225,250          (404,898)         (179,022)
Expenses for secondary public stock offering     --          --              (953)               --              (953)
Common stock sold under employee 
    stock option plan                             2          --               951                --               953
Contribution of common stock to 
    profit sharing plan                           2          --               894                --               896
Issuance of 606,120 shares of common stock at 
    $12.50 per share for drug store acquisition   6          --             7,570                --             7,576
Conversion of nonvoting common stock 
    to voting common stock                       12          (6)               (6)               --                --
Net income for the year                          --          --                --            47,808            47,808

Balance at January 28, 1995                     642          --           233,706          (357,090)         (122,742)
Common stock sold in public stock offering, 
    net of expenses of sale                      54          --            82,340                --            82,394
Expenses for secondary public stock offering     --          --              (329)               --              (329)
Common stock sold under employee
    stock option plan                             2          --             1,043                --             1,045
Contribution of common stock to 
    profit sharing plan                           2          --               894                --               896
Net income for the year                          --          --                --            93,477            93,477

Balance at February 3, 1996                    $700          --           317,654          (263,613)           54,741
</TABLE>
See accompanying notes to consolidated financial statements.
<PAGE>
<TABLE>
Consolidated Statements of Cash Flows
(In thousands)                                                       February 3, January 28 and January 29, respectively
                                                                            1996              1995              1994

<S>                                                                      <C>                <C>                <C>
Cash flows from operating activities:
    Net earnings (loss) for the year                                      $  93,477           47,808            (2,941)
    Adjustments to reconcile net earnings (loss) for the 
      year to net cash provided by operating activities:
        Gain on sale of subsidiary                                               --          (54,125)               --
        Extraordinary charge related to early retirement of debt
          and preferred stock                                                11,213           32,130            45,283
        Depreciation and amortization                                        84,750           77,794            85,660
        Amortization of original issue discount and
          deferred debt expenses                                              1,806            5,897             7,216
        Decrease (increase) in receivables                                  (17,650)          12,047           (13,867)
        Increase in merchandise inventories                                 (44,475)         (22,621)          (35,455)
        Decrease (increase) in prepaid expenses and other
          current assets                                                     (2,030)           3,048            (3,408)
        Increase in accounts payable and accrued expenses                    37,183           17,010            87,393
            Net cash provided by operating activities                       164,274          118,988           169,881
Cash flows from investing activities:
    Additions to property, plant and equipment*                            (109,782)         (57,246)          (39,327)
    Sale of property, plant and equipment                                     8,255            4,253            37,942
    Net proceeds from sale of subsidiaries                                    5,231          114,912                --
    Acquisition of certain drug store assets                                (76,902)          (6,080)          (14,314)
    Other                                                                     1,733           (5,216)           (3,341)
            Net cash provided by (used in) investing activities            (171,465)          50,623           (19,040)
Cash flows from financing activities:
    Increase in bank debit balances                                          15,247            3,399            28,743
    14 1/2% preferred stock cash dividends                                       --               --            (4,924)
    Additions to long-term debt                                               1,985            1,604             1,476
    Reductions of long-term debt                                             (1,848)          (2,926)           (3,769)
    Net reductions under prior credit agreement                                  --               --          (221,723)
    Net additions (reductions) under current credit agreement                 4,627         (120,816)          576,189
    Redemption of 141/2% preferred stock                                         --               --           (75,000)
    Common stock sold in public stock offering, net of expenses of sale      82,394               --            64,561
    Issuance of 91/4% senior subordinated notes                                  --               --           200,000
    Redemption of 13% and 111/8% subordinated debentures                    (95,500)         (50,000)         (490,165)
    Redemption of senior notes                                                   --               --          (168,000)
    Other, including redemption fees and deferred financing costs              (690)          (4,084)          (64,761)
            Net cash provided by (used in) financing activities               6,215         (172,823)         (157,373)
Net decrease in cash                                                           (976)          (3,212)           (6,532)
Cash at beginning of year                                                     8,898           12,110            18,642
Cash at end of year                                                       $   7,922            8,898            12,110
</TABLE>
See accompanying notes to consolidated financial statements.
*    Total capital expenditures for fiscal years 1995, 1994 and
     1993 were $117,680, $84,694 and $41,960, of which $7,898,
     $27,448 and $2,633 were acquired under a deferred payment
     arrangement.
<PAGE>

Notes to Consolidated Financial Statements
February 3, 1996, January 28, 1995 and January 29, 1994
(In thousands, except share amounts and drug stores)

(1) Organization of Business
(a) Description of Business
        Eckerd Corporation (Company) operates the Eckerd Drug
store chain, which is one of the largest drug store chains in the
United States. The Company's stores are located primarily in the
Sunbelt, with the largest concentration of stores being in
Florida and Texas.
        During 1993, 1994 and 1995, the Company purchased 74 drug
stores in four transactions at an aggregate cost of $85,517. The
operations of such stores, which have been included in the
consolidated financial statements from dates of acquisition, are
not material to the Company and, accordingly, pro forma
comparative operating numbers are not presented.

(b) Initial and Secondary Public Offerings
        On August 12, 1993, the Company completed an initial
public offering (IPO) in which it issued and sold 10,350,000
shares of its Common Stock par value $.01 per share (Common
Stock) for $7.00 per share. In connection with the IPO, the
Company amended its Restated Certificate of Incorporation to 
effect, among other things: (i) the reclassification of its Class
A common stock and Class B common stock into Common Stock at
certain specified rates (Reclassification); (ii) a two-for-three
reverse stock split (Stock Split); (iii) the adoption of certain
provisions, such as a classified board of directors and the
prohibition of stockholder action by written consent, which 
could make non-negotiated acquisitions of the Company more
difficult; and (iv) the change of the Company's name from "Jack
Eckerd Corporation" to "Eckerd Corporation."
        On May 2, 1994, the Company completed an underwritten
secondary offering of 6,398,112 shares of its Common Stock for
$9.50 per share. The secondary offering only included shares
owned by certain institutional stockholders. The Company did not
receive any of the proceeds from the sale of shares of common
stock and was required to pay certain expenses of the secondary
offering.
        On August 3, 1995, the Company completed an underwritten
primary and secondary offering of 12,351,000 shares of its Common
Stock for $16.12 per share. The offering consisted of 5,350,000
shares sold by the Company and 7,001,000 shares sold by certain
institutional stockholders.
        On December 15, 1995, the Company completed an
underwritten secondary offering of 12,000,000 shares of its
Common Stock for $21.00 per share. The secondary offering only
included shares owned by certain institutional stockholders. The
Company did not receive any of the proceeds from the sale of
shares of common stock and was required to pay certain expenses
of the secondary offering.

(c) Sales of Subsidiaries
        On March 31, 1994, the Company closed on the sale        
of its Vision Group operations which were sold effective        
January 30, 1994 for an amount in cash and notes approximately
equal to the book value of the related assets. In 1993, Vision
Group sales were approximately $61,000 and earnings before
interest and taxes were approximately $3,000.
        On November 15, 1994, the Company closed on the sale of
its Insta-Care Pharmacy Services (Insta-Care) operations for a
total consideration of $112,000 in cash. The net proceeds after
certain closing adjustments were approximately $94,000.
Insta-Care operations are included in the consolidated financial
statements up to the closing date of the sale. In 1994,
Insta-Care sales were approximately $89,000 and earnings before 
interest and income taxes were approximately $4,000. The Company
recognized a gain on the sale of Insta-Care of $49,470, net of
income taxes of $4,655. The gain of $54,125 before income taxes
is reported in the consolidated statement of operations as part
of sales and other operating revenue.

(2) Summary of Significant Accounting Policies
(a) Use of Estimates
        The preparation of financial statements in conformity
with generally accepted accounting principles requires management
to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of
<PAGE>
contingent assets and liabilities at the date of the financial 
statements, and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from
those estimates.

(b) Principles of Consolidation
        The consolidated financial statements include the
accounts of the Company and its wholly owned subsidiaries. All
significant intercompany accounts have been eliminated in the
consolidation.

(c) Definition of Fiscal Year
        The Company's fiscal year ends on the Saturday nearest
January 31. Fiscal year 1995 ended February 3, 1996 and consisted
of 53 weeks. Fiscal years 1994 and 1993 ended January 28, 1995
and January 29, 1994, respectively, and consisted of 52 weeks.

(d) Merchandise Inventories
        Inventories consist principally of merchandise held for
resale and are based on physical inventories taken throughout the
year. Inventories are stated at the lower of cost (last-in,
first-out) or market. At February 3, 1996 and January 28, 1995,
inventories would have been higher than reported by approximately
$91,900 and $76,900, respectively, if the first-in, first-out
method of valuing inventories had been used by the Company.

(e) Income Taxes
        Effective January 31, 1993, the Company adopted Statement
of Financial Accounting Standards No. 109 (SFAS No. 109),
Accounting for Income Taxes. Under the asset and liability method
of SFAS No. 109, deferred tax assets and liabilities are
recognized for the future tax consequences attributable to
differences between the financial statement carrying amounts 
of existing assets and liabilities and their respective tax
bases. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the
years in which those temporary differences are expected to be
recovered or settled. Under SFAS No. 109, the effect of a 
change in tax rates on deferred tax assets or liabilities is
recognized in income in the period that includes the enactment
date.

(f) Depreciation Policy and Maintenance and Repairs
        Plant and equipment is depreciated principally by the
straight-line method over the estimated useful lives of such
assets. The principal lives used to compute depreciation are:
buildings, 16-45; furniture and equipment, 1-10; transportation
equipment, 1-8; and leasehold improvements, 2-20.
        Maintenance and repairs are charged to expense as
incurred. The Company's policy is to capitalize expenditures for
renewals and betterments and to reduce the asset accounts and the
related allowance for depreciation for the cost and accumulated
depreciation of items replaced, retired or fully depreciated.

(g) Favorable Lease Interests
        Favorable lease interests represent the present value of
the excess of current market rents at dates of acquisition over
the below market rents of leases acquired (principally store
locations). Such costs are amortized over the lives of the
favorable leases averaging approximately twenty years.

(h) Unamortized Debt Expenses
        Unamortized debt expenses represent underwriting
discounts, professional fees and other costs related to long-term
debt (see note 4) which are amortized over the life of the debt
instruments.

(i) Advertising Costs
        Net advertising costs are expensed when incurred and were
$24,752, $24,050 and $26,758 for the years ended February 3,
1996, January 28, 1995 and January 29, 1994, respectively.

(j) Reclassification
        Certain amounts have been reclassified in the 1993 and
1994 consolidated financial statements to conform to the 1995
consolidated financial statement presentation.

(k) Supplemental Cash Flow Information
        The Company considers all liquid investments with a
maturity of three months or less when purchased to be cash
equivalents.

<PAGE>
        During 1994, the Company issued $7,576 of Common Stock in
connection with the acquisition of certain drug stores.
        Cash paid for interest was $82,152, $86,821 and $120,329
for the years ended February 3, 1996, January 28, 1995 and
January 29, 1994, respectively.
        Cash paid for income taxes was $5,337, $7,294 and $1,273
for the years ended February 3, 1996, January 28, 1995 and
January 29, 1994, respectively.

(l) Earnings (Loss) Per Share and Stock Split
        Primary earnings per share have been computed based on
the weighted average number of shares of common stock outstanding
during each fiscal year (68,606,482 in 1995, 64,863,438 in 1994
and 58,785,610 in 1993). All share information in these
consolidated financial statements has been restated to reflect
the two-for-one stock split declared April 1, 1996 (payable May
13, 1996) and the August 12, 1993 Reclassification and Stock
Split.

(m) Recent Accounting Pronouncements
        The Company will adopt Statement of Financial Accounting
Standards No. 121 (SFAS No. 121), Accounting for the Impairment
of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of,
during the first quarter of fiscal year 1996. SFAS No. 121 is not
expected to have a material impact on the consolidated financial
statements of the Company.
        In October 1995, Statement of Financial Accounting
Standards No. 123 (SFAS No. 123), Accounting for Stock - Based
Compensation, was issued, which is effective for fiscal year
1996. Under SFAS No. 123, the Company can elect, but is not
required, to recognize compensation expense for all stock-based 
awards using a fair value method. The Company expects to
implement the disclosure-only provisions, as permitted by SFAS
No. 123, in fiscal year 1996.

(3) Employees' Benefit Plans
(a) Profit Sharing Plan
        The Company has in effect a noncontributory profit
sharing plan which covers all regular, full-time employees. The
Company makes annual contributions to the Plan at the discretion
of the Company's Board of Directors. All funds are held by a bank
as trustee under a trust agreement. Included in operating and
administrative expenses are charges accrued for contributions 
to the Plan of $11,231, $9,712 and $8,765 for February 3, 1996,
January 28, 1995 and January 29, 1994, respectively.
        Plan assets at fair value, consisting of fixed income
securities, the Company's stock and listed stocks, amounted to
approximately $256,800 for the plan year ended December 31, 1995.

(b) Pension Plans
        The Company has in effect a noncontributory pension plan
covering all full-time employees who qualify as to age and length
of service. Benefits are computed based on the average annual
compensation for the five consecutive years that produce the
highest average during the final ten years of creditable service.
The Company's policy is to fund the Plan in accordance with
minimum Internal Revenue Service (IRS) requirements.
        The Company accounts for pension costs in accordance with
Statement of Financial Accounting Standards No. 87, Employers'
Accounting for Pensions.
        The funded status of the Company's pension plan at
February 3, 1996 and January 28, 1995 was:

                                                1996       1995
                                            (Projected)
Accumulated benefit obligation (including 
 vested benefits of $40,743 and $34,792 at
 January 1, 1995 (most recent valuation
 date) and January 1,1994, respectively)      $(45,107)  (37,814)
Effect of anticipated future compensation 
 levels and other events                       (11,130)   (8,824)
Projected benefit obligation for service
 rendered to date                              (56,237)  (46,638)
Plan assets at fair value, consisting of 
 fixed income securities and listed stocks      44,751    34,602
   Plan assets less than projected benefit 
     obligation                                (11,486)  (12,036)
Unrecognized prior service cost                  2,245     2,436
Unrecognized net loss                            8,791    10,290
Unrecognized net transition asset at 
  January 1, 1987, which is 
  being amortized over 13 years                 (2,100)   (2,777)
    Accrued pension cost                       $(2,550)   (2,087)
<PAGE>

        Net periodic pension costs for the years ended        
February 3, 1996, January 28, 1995 and January 29, 1994 included
the following (income) expense components:

                                        1996      1995      1994
Service costs (benefits earned
    during the period)                 $3,606     3,552    2,818
Interest cost on projected 
    benefit obligation                  3,790     3,159    2,548
Return on assets                       (3,536)   (3,411)  (3,271)
Amortization of prior service cost        191      (204)    (161)
Amortization of net transition asset     (677)     (677)    (677)
Amortization of net loss                  101       461       --
    Net periodic pension cost          $3,475     2,880    1,257

    Assumptions used in determining the accumulated and projected
benefit obligations were:
Weighted average discount rate            7.5%     8.25%     7.5%
Weighted average long-term 
    rate of return on assets                9%        9%       9%
Rate of compensation increases              5%        5%       5%

        The Company has in effect an Executive Supplemental
Benefit Plan to provide additional income for its executives
after their retirement as well as pre-retirement death benefits
to beneficiaries of such executives. Annual benefits will
generally be no greater than 25 percent of the participant's 
salary mid-point on the date the participant retires or separates
from service with the Company.

(4) Long-Term Debt
        Long-term debt at February 3, 1996 and January 28, 1995
was:

                                              1996         1995
Term loan, due November 29, 2000 (a)        $230,000     434,373
Revolving credit and bankers 
  acceptances (a)                            230,000      21,000
9 1/4% Senior Subordinated Notes 
  due February 15, 2004, 
  $200,000 face amount (b)                   200,000     200,000
11 1/8% Subordinated Debentures 
  due May 1, 2001, $95,500 face amount,
  net of original issue discount of 
  $6,542 (c)                                      --      88,958
Variable rate demand industrial development 
  revenue refunding bonds, due $8,250 
  March 1, 2009 and $10,000 
  May 1, 2013 (d)                             18,250      18,250
Other (principally notes secured by 
  fixtures and equipment)                     24,568      24,432
      Total long-term debt                   702,818     787,013
Less amounts due within one year               1,020       1,452
      Amounts due after one year            $701,798     785,561

        The aggregate minimum annual maturities of long-term debt
for the next five fiscal years are: 1996 - $31,020; 1997 -
$50,729; 1998 - $50,667; 1999 - $50,605; and 2000 - $280,548.
Although the term loan commitment requires a repayment of $30,000
during fiscal year 1996, the Company has excess availability
under the revolving credit commitment, and accordingly, has not
treated the 1996 required repayment as current.
        (a) On June 15, 1993, the Company entered into a Credit
Agreement which was subsequently revised on August 3, 1994. The
original agreement was for a total of $950,000. The revised
agreement provided for a total loan facility of $850,000. The 
revised loan facility did not provide any additional proceeds to
the Company, but it provided improved pricing and increased
operating flexibility with respect to acquisitions, capital
expenditures and lease payments. The revolving loan facility was
extended a year and increased to $350,000 (with $30,000 available
as a bank swingline loan facility and $155,000 available as 
a letter of credit and bankers' acceptance facility) (Revolving
Loan), and a five-year amortizing term loan facility (Term Loan)
was reduced to $500,000.
        On November 29, 1995, the Company entered into another
significant revision of the Credit Agreement. The new agreement
provides for a total loan facility of $750,000. The new loan
facility did not provide any additional proceeds to the Company,
but it does provide improved pricing and increased operating
flexibility through reduced annual term loan amortization. The 
Revolving Loan facility matures on November 29, 2000 and was
increased to $500,000 (including the bank swingline loan facility
and the letter of credit and bankers' acceptance facility), and
the Term Loan facility maturity was extended to November 29,
2000, and was reduced to $250,000.
<PAGE>

        The Term Loan and the Revolving Loan bear interest at
various rates approximating, at the Company's option (i)
Alternate Base Rate (ABR) (as defined) or (ii) adjusted LIBOR 
plus 5/8%. The spread above LIBOR may decrease or increase by
1/8% in two separate instances if certain ratios of cash flow to
interest expense are achieved by the Company. The spread above
LIBOR may also decrease by an additional 1/8% if a certain ratio
of cash flow to interest expense is achieved and the bank
facility receives an investment grade rating by both major rating
agencies.
        Interest on ABR borrowings is payable quarterly. Interest
on LIBOR borrowings is payable at the end of the relevant
interest period (one, two, three or six month periods, except
that with respect to six month periods, interest shall be payable
every three months). The Company is required to pay a commitment
fee of 1/4% per annum on the undrawn amount of the Revolving 
Loan facility and it may decrease or increase by 1/16% in two
separate instances if certain ratios of cash flows to interest
expense are achieved by the Company. The Company is also required
to pay letter of credit fees and bankers' acceptance fees.
        The Company has entered into interest rate cap agreements
relating to the Credit Agreement. The cap agreements are for
$200,000 and mature at various dates in 1996. The cap agreements
have an approximate 6% interest rate. At February 3, 1996, these
agreements had a value to the Company of approximately $164 below
their carrying values.
        Principal of the Term Loan will be amortized in quarterly
payments and mature in full on November 29, 2000. Required annual
principal payments are $30,000 in 1996 and $50,000 in 1997
through 2000. The Company has the right to prepay any borrowings
under the Credit Agreement in whole or in part at any time.
        The Company is required to prepay borrowings under the
Credit Agreement with (i) in any fiscal year, the excess of the
aggregate net proceeds of dispositions of assets of the Company
and its subsidiaries over $10,000; (ii) in any fiscal year, the
net proceeds of any incurrence of debt (other than indebtedness
permitted under the Credit Agreement); and (iii) the net proceeds
of the sale and leaseback of any asset. Prepayments are to be 
applied pro rata against the remaining scheduled payments due in
respect to the Term Loan and, after such loan is paid in full, to
the swingline loans and then the Revolving Loan.
        The borrowings under the Credit Agreement are secured by
a pledge of all capital stock of the Company's subsidiaries, as
well as substantially all personal property, including inventory
and accounts receivable and certain real property (as defined),
contain certain restrictive covenants which provide limitations
on the Company with respect to incurring debt, the incurring of
liens, making investments in excess of $7,000, payment of 
dividends and purchase of shares of stock of the Company,
consolidations and mergers, sale of assets, acquisitions, and
transactions with affiliates. The Credit Agreement also requires
the Company to satisfy certain financial ratios. At February 3,
1996, the Company was in compliance with these covenants.
        (b) On November 2, 1993, the Company issued $200,000
aggregate principal amount of 91/4% Senior Subordinated Notes
(Notes) due February 15, 2004. The Notes are unsecured and
subordinated to all existing and future senior debt (as defined)
of the Company and are redeemable at the option of the Company,
in whole or in part, at any time after February 15, 1999 at 
various redemption prices (as defined) plus accrued interest to
the date of redemption. Interest is payable semi-annually on
February 15 and August 15 of each year.
        (c) The 11 1/8% Subordinated Debentures were subordinated
to all existing and future senior debt (as defined) of the
Company, and were redeemable at the option of the Company, in
whole or in part, at any time at 100% of their principal amount
plus accrued interest to the date of redemption. During 1994 and
1995, $50,000 face amount and the remaining $95,500 face amount,
respectively, of these subordinated debentures were redeemed by
the Company.
        (d) The variable rate demand industrial development
revenue refunding bonds currently have an interest rate which is
a daily rate established by First National Bank of Chicago and is
indicative of current bid-side yields of high grade tax-exempt
securities. At the Company's option, and under certain
conditions, the interest rate may be changed to a monthly rate or
a fixed rate. The bonds are secured by the related buildings,
leases and letters of credit.
        (e) An extraordinary charge of $30,523 (net of tax
benefit of $1,607) was recognized during the year ended January
28, 1995, primarily from the write-off of unamortized debt
expenses related to the significant revision of the Credit
Agreement, as well as the early repayment of debt from a portion 
of the net proceeds from the sale of Insta-Care.
        An extraordinary charge of $9,306 (net of tax benefit of
$1,907) was recognized during the year ended February 3, 1996,
primarily from the write-off of original issue discount and
unamortized debt expenses on the redemption of the 11 1/8%
Subordinated Debentures and from the write-off of unamortized 
debt expenses related to the significant revision of the Credit
Agreement.
<PAGE>
        (f ) The fair value of the Term Loan, Revolving Loan and
the variable rate demand industrial development revenue refunding
bonds approximate their carrying value, based on the frequency of
the interest rate reset periods. The fair value of the Notes is
approximately $215,250, based on its quoted market price. The
fair value of the other long-term debt approximates its 
carrying value, based on the relatively short remaining maturity
of the debt.

(5) Income Taxes
        Income tax expense before extraordinary  items for the
years ended February 3, 1996, January 28, 1995 and January 29,
1994 was:

                                    1996       1995     1994
Current: 
    Federal                       $19,309     5,278     2,232
    State                           1,291     3,475     2,324 
      Total                       $20,600     8,753     2,556

        For fiscal years 1995, 1994 and 1993, the income tax
expense differs from amounts computed by applying the Federal
statutory rate of 35% to earnings before income taxes and
extraordinary items. The actual tax differs from the expected tax
for the years ended February 3, 1996, January 28, 1995 
and January 29, 1994 as follows:

                                        1996      1995     1994
Expected tax                          $43,184    30,479   15,389
State taxes, net of Federal benefit       839     2,259      211
Changes in valuation allowance
    through the use of loss 
    carryforwards                     (42,239)  (29,263) (15,276)
Other                                  18,816     5,278    2,232
                                      $20,600     8,753    2,556

"Other" consists principally of alternative minimum tax.
        In addition to alternative minimum tax credit
carryforwards of approximately $21,000, the Company has Federal
income tax loss carryforwards of approximately $177,000, which
are available to offset future taxable income, if any, through
2008.
        The Company's Federal income tax returns have been
examined through April 30, 1986 and any assessments have been
paid or accrued. The Federal income tax returns for the fiscal
periods ended January 31, 1987 and January 30, 1988 are currently
being examined. The Company has established a valuation allowance
for the full amount of its loss carryforward. The valuation
allowance will be reviewed in the future, based on management's 
estimates of the expected outcome of these examinations.
        Temporary differences and carryforwards which give rise
to deferred tax assets and liabilities as of February 3, 1996 and
January 28, 1995 are as follows:

                                               1996       1995
Deferred tax assets:
    Reserves and other liabilities           $13,620     23,880
    Amortization                               7,452      7,804
    Other                                      6,351      7,613
    Loss carryforwards                        67,111     82,745
    Credit carryforwards                      25,803      8,364
      Gross deferred tax assets              120,337    130,406
    Less valuation allowance                 (67,111)   (94,176)
      Net deferred tax assets                $53,226     36,230
Deferred tax liabilities:
    Inventory                                $37,698     23,481
    Fixed assets                              15,528     12,749
      Gross deferred tax liabilities         $53,226     36,230

(6) Stockholders' Equity
(a) Common Stock
        The Company's authorized common stock consists of
100,000,000 shares of Common Stock, par value $.01 per share (of
which 3,518,728 shares are Nonvoting Common Stock (Series I), par
value $.01 per share).

(b) Preferred Stock
        The Company's authorized preferred stock consists of
20,000,000 shares. The preferred stock is issuable in series with
terms as fixed by the Board of Directors. No preferred stock has
been issued.

(c) Stock Options
        The Company has reserved 6,782,406 shares of its Common
Stock for the granting of stock options and other incentive
awards to officers, directors and key employees under the 1993
and 1995 Stock Option and Incentive Plans of Eckerd Corporation.
Options are granted at prices which are not less than the 
fair market value of a share of common stock on the date of
grant. Commencing three years after the date of grant, all
options are exercisable to the extent of 50%, with an additional
<PAGE>

25%  exercisable  after  each of the next two  successive  years.
Unexercised  options  expire  ten years  after the date of grant.
Options  granted under prior plans were  surrendered  and granted
under the terms of the 1993 plan.  Shares under option and option
prices have been adjusted to reflect the Reclassification and the
Stock  Split (note  1(b)) and the  two-for-one  stock split (note
2(l)).
        As of February 3, 1996, January 28, 1995 and January 29,
1994, 3,531,658, 458,354 and 445,336 shares of Common Stock were
available for grant. At February 3, 1996, options for 758,308
shares of Common Stock were exercisable at $2.59 to $7.00 per
share. At January 28, 1995, options for 699,720 shares of Common
Stock were exercisable at $.28 to $7.00 per share. At January 29,
1994, options for 900,786 shares of Common Stock were exercisable
at $.28 to $7.00 per share.
        A summary of changes during the years ended February 3,
1996, January 28, 1995 and January 29, 1994 is set forth below:


                                   Shares under         Option
                                      option            prices
Outstanding January 30, 1993         1,373,920      $  .28 - $18.75
    Granted                          1,711,830      $ 5.00 - $ 7.00
    Exercised                         (148,790)     $ 2.82 - $ 4.62
    Cancelled                         (122,952)     $ 2.82 - $18.00

Outstanding January 29, 1994         2,814,008      $  .28 - $ 7.00
    Granted                            171,000      $ 7.00 - $14.63
    Exercised                         (248,998)     $  .28 - $ 7.00
    Cancelled                         (184,018)     $  .28 - $12.32

Outstanding January 28, 1995         2,551,992      $  .28 - $14.63
    Granted                          1,059,134      $12.81 - $22.00
    Exercised                         (227,940)     $  .28 - $ 7.00
    Cancelled                         (132,438)     $ 7.00 - $19.31

Outstanding at February 3, 1996      3,250,748      $ 2.59 - $22.00

        Options previously granted at prices greater than $7.00
per share were modified to $7.00 per share at the date of the
IPO.

(7) Commitments
        The Company conducts the major portion of its retail
operations from leased store premises under leases that will
expire within the next 20 years. Such leases generally contain
renewal options exercisable at the option of the Company. In
addition to minimum rental payments, certain leases provide     
for payment of taxes, maintenance and percentage rentals based
upon sales in excess of stipulated amounts.
        Rental expense for the years ended February 3, 1996,
January 28, 1995 and January 29, 1994 was:

                                1996         1995          1994
    Minimum rentals           $118,797      111,845      111,072
    Percentage rentals          25,651       20,971       18,369
                              $144,448      132,816      129,441

        At February 3, 1996, minimum rental commitments for the
next five fiscal years and thereafter under noncancelable leases
were as follows: 1996 - $110,423; 1997 - $103,451; 1998 -
$90,791; 1999 - $82,881; 2000, - $75,030; and thereafter -
$529,864. These amounts include any rental commitments for 
under-performing stores closed or to be closed (note 9).
        In 1987, the Company entered into an operating lease
agreement for 72 stores with a third-party lessor established by
an affiliate of Merrill Lynch & Co. (which, through affiliated
entities, controls approximately 6% of the Company's common
stock). The lease agreement has certain restrictive covenants,
which, upon violation by the Company, give the lessor the right
to require the lessee to purchase the leased stores at the
remaining balance of the lease contract. At February 3, 1996, the
balance subject to the repurchase terms is $35,774. At February
3, 1996, the Company was in compliance with these covenants.
        During 1995, 1994 and 1993, the Company sold certain
photo processing equipment to an unrelated third party for
approximately $4,900, $14,800 and $35,000, respectively, and
entered into five-year leases with respect to such equipment. No
gain or loss was recorded in connection with these transactions.
Annual lease payments by the Company of $6,801 are required 
over the term of the leases.
        During 1993, the Company and Integrated Systems Solutions
Corporation (ISSC) entered into a Systems Operations Service
Agreement (Service Agreement) pursuant to which ISSC will manage
the Company's entire information systems operation, including the
implementation of a new point-of-sale system with scanning
capabilities. The Service Agreement has a ten year term, and the
total payments to be
<PAGE> 
made by the Company are expected to be $480,000 over such term,
based on currently anticipated services. A portion of these
payments is being accounted for as capital expenditures. As of
February 3, 1996, the Company has acquired $83,711 of equipment,
of which $37,979 has been acquired under a deferred payment
arrangement.

(8) Transactions with Related Parties
        In April 1989, the Company entered into a "Master Lease"
agreement with a third-party lessor established by an affiliate
of Merrill Lynch & Co. (which, through affiliated entities,
controls approximately 6% of the Company's common stock) whereby
such lessor would finance the acquisition of store sites and the
construction of buildings and acquisition of equipment. As of
February 3, 1996, there were 12 stores leased under the agreement
with an aggregate cost of approximately $18,400. The Company pays
the Merrill Lynch affiliate a structure fee of 1% of the cost of
land, buildings and equipment financed under the Master Lease
plus an administration fee. The Company paid the Merrill Lynch
affiliate fees aggregating $43, $43 and $44 for the years ended
February 3, 1996, January 28, 1995 and January 29, 1994,
respectively.
        During 1993, Merrill Lynch & Co., as one of the
representatives of the underwriters in the IPO, received
underwriting commissions and related fees of $1,847. In addition,
as sole underwriter in the issuance of the Notes, Merrill Lynch &
Co. received approximately $4,000 in underwriting discounts from
the Company. During 1995, Merrill Lynch & Co., as one of the 
representatives of the underwriters in the August offering,
received underwriting commissions and related fees of $3,000.
        During 1994, Merrill Lynch & Co. acted as financial
advisors to the Company in connection with the sale of Insta-Care
and received a fee of $1,417 for its services.


(9) Store Closing Charges
        In 1994, the Company changed its accounting policy for
closed stores to record the loss at the time the decision is made
to close the store, in accordance with Emerging Issues Task Force
Issue No. 94-3. In the fourth quarter of 1994, the Company
established a $48,988 provision for future drug store closings.
In addition to the small number of stores the Company would 
close in the normal course of business, the Company accelerated
the closing of approximately 90 geographically dispersed
under-performing stores. At February 3, 1996, 84 of the
approximately 90 under-performing stores had been 
closed. The total charge of $48,988 was included in operating and 
administrative expenses on the 1994 consolidated statement of
operations. Of the total charge, approximately $31,000 related to
lease settlements and obligations and other expenses to be
incurred in connection with the store closings. The remaining
charge of approximately $18,000 was for the write-off of impaired
assets which included inventory liquidation and the write-off of 
intangible and fixed assets. The effect of this accounting change
on prior periods was immaterial.
        In 1995, approximately $20,400 of the provision was
utilized for lease obligations, settlements and asset write-offs.
Remaining expenses are anticipated to be less than the balance of
the provision; therefore, approximately $10,800 of the provision
is available for the 1996 store closings primarily related to
relocation of existing stores.
<PAGE>

Independent Auditors' Report


The Board of Directors
Eckerd Corporation and Subsidiaries:


        We have audited the accompanying consolidated balance
sheets of Eckerd Corporation and subsidiaries as of February 3,
1996 and January 28, 1995, and the related consolidated
statements of operations, stockholders' equity (deficit), and
cash flows for each of the years in the three-year period ended
February 3, 1996. These consolidated financial statements are 
the responsibility of the Company's management. Our
responsibility is to express an opinion on these consolidated
financial statements based on our audits.
        We conducted our audits in accordance with generally
accepted auditing standards. Those standards require that we plan
and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial 
statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our
opinion.
        In our opinion, the consolidated financial statements
referred to above present fairly, in all material respects, the
financial position of Eckerd Corporation and subsidiaries at
February 3, 1996 and January 28, 1995, and the results of their
operations and their cash flows for each of the years in the
three-year period ended February 3, 1996, in conformity with 
generally accepted accounting principles.
        As described in note 9, the Company changed its
accounting policy in fiscal year 1994 related to the timing of
the recognition of closed store obligations.





/s/KPMG Peat Marwick LLP
KPMG Peat Marwick LLP
Tampa, Florida
March 26, 1996
<PAGE>
<TABLE>
Quarterly Information (Unaudited)
(In thousands, except per share amounts)                                                     Fiscal 1995 Quarters Ended
                                                                   4/29/95     7/29/95      10/28/95      2/3/96
<S>                                                             <C>          <C>            <C>          <C>
Financial Information
 Sales and other operating revenue                              $1,219,594   1,138,724      1,164,907    1,473,848
 Cost of sales, including store occupancy,
   warehousing and delivery expense                                939,488     885,108        915,137    1,134,990
 Operating and administrative expenses                             220,591     221,832        224,301      255,407
 Interest expense                                                   20,356      19,593         18,720       18,167
 Earnings before income taxes
   and extraordinary item                                           39,159      12,191          6,749       65,284
 Income taxes                                                        8,615         115          1,147       10,723
 Earnings before extraordinary item                                 30,544      12,076          5,602       54,561
 Extraordinary item-early retirement
   of debt, net of tax benefit                                          --      (1,021)        (5,012)      (3,273)
 Net earnings                                                   $   30,544      11,055            590       51,288
 Earnings before extraordinary
   item per common share                                        $      .47         .18            .08          .76
 Net earnings per common share                                  $      .47         .17            .01          .71
 Weighted average common shares outstanding                         65,626      65,794         71,242       71,764
          
Market Price Per Share Information
 High                                                           $       15-1/8      17-5/16        21           22-3/8
 Low                                                                    12-1/4      14-3/16        16-5/16      19-1/16

(In thousands, except per share amounts)                                                     Fiscal 1994 Quarters Ended
                                                                   4/30/94     7/30/94       10/29/94      1/28/95
Financial Information
 Sales and other operating revenue                              $1,136,195   1,066,890      1,071,036    1,315,396
 Cost of sales, including store occupancy,
   warehousing and delivery expense                                866,083     820,281        831,513      966,750
 Operating and administrative expenses                             217,846     215,767        215,476      274,982
 Interest expense                                                   23,901      24,491         23,410       21,933
 Earnings before income taxes
   and extraordinary item                                           28,365       6,351            637       51,731
 Income taxes                                                        1,420         330             32        6,971
 Earnings before extraordinary item                                 26,945       6,021            605       44,760
 Extraordinary item - early retirement
   of debt, net of tax benefit                                          --          --        (26,620)      (3,903)
 Net earnings (loss)                                            $   26,945       6,021        (26,015)      40,857
 Earnings before extraordinary
   item per common share                                        $      .42         .09            .01          .68
 Net earnings (loss) per common share                           $      .42         .09           (.40)         .62
 Weighted average common shares outstanding                         64,448      64,492         64,844       65,670

Market Price Per Share Information
 High                                                           $       12          12-5/8         15-3/4       16
 Low                                                                     9-1/4       9-1/16        11-5/8       12-11/16
</TABLE>
    The Company's stock is listed on the New York Stock Exchange
(Symbol: ECK). The approximate number of shareholders of record
on March 29, 1996 was 965.
    The Company is subject to restrictive covenants under its
bank credit agreement and its 91/4% senior subordinated notes
which restrict the payment of dividends. The Company has not paid
or declared any dividend distributions on its common stock.
    Earnings (loss) per common share are computed independently
for each of the quarters. Therefore, the sum of the quarterly
earnings (loss) per share may not equal the annual earnings per
common share.
    All quarters have been restated to reflect a two-for-one
stock split effected in the form of a stock dividend declared
April 1, 1996 (payable May 13, 1996).


                                                                   Exhibit 21.1



                               ECKERD CORPORATION
                           Subsidiaries of the Company


         At February 3, 1996, Eckerd  Corporation,  incorporated in the State of
Delaware,  had  eight  wholly-owned  subsidiaries,  which  are  included  in the
consolidated  financial  statements  of the  Company.  The  names  of the  eight
subsidiaries have been omitted because these unnamed subsidiaries, considered in
the  aggregate  as  a  single  subsidiary,   do  not  constitute  a  significant
subsidiary.



                                                                   Exhibit 23.1




The Board of Directors
Eckerd Corporation and Subsidiaries


Re:      Registration Statement on Form S-3 (No. 33-50223)
         Registration Statement on Form S-8 (No. 33-49977)
         Registration Statement on Form S-8 (No. 33-50755)
         Registration Statement on Form S-3 (No. 33-56261)
         Registration Statement on Form S-8 (No. 33-60175)



We  consent  to  the   incorporation   by  reference  in  the  above  referenced
registration  statements of Eckerd  Corporation  and  subsidiaries of our report
dated March 26,  1996,  relating to the  consolidated  balance  sheets of Eckerd
Corporation  and  subsidiaries  as of February 3, 1996 and January 28, 1995, and
the  related  consolidated   statements  of  operations,   stockholders'  equity
(deficit),  and cash flows,  and related  schedules for each of the years in the
three-year  period ended February 3, 1996,  which report appears in the February
3, 1996 Annual Report on Form 10-K of Eckerd Corporation and subsidiaries.

                                                     KPMG Peat Marwick LLP



Tampa, Florida
April 25, 1996


<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000031364
<NAME> ECKERD CORPORATION
<MULTIPLIER> 1,000
       
<S>                                      <C>            
<PERIOD-TYPE>                            YEAR          
<FISCAL-YEAR-END>                        FEB-03-1996    
<PERIOD-END>                             FEB-03-1996   
<CASH>                                         7,922        
<SECURITIES>                                       0             
<RECEIVABLES>                                 73,137    
<ALLOWANCES>                                   3,000    
<INVENTORY>                                  835,551    
<CURRENT-ASSETS>                             918,006   
<PP&E>                                       634,023    
<DEPRECIATION>                               282,974    
<TOTAL-ASSETS>                             1,490,699     
<CURRENT-LIABILITIES>                        597,388     
<BONDS>                                      701,798      
<COMMON>                                         700           
                              0             
                                        0             
<OTHER-SE>                                    54,041      
<TOTAL-LIABILITY-AND-EQUITY>               1,490,699    
<SALES>                                    4,997,073    
<TOTAL-REVENUES>                           4,997,073     
<CGS>                                      3,874,723    
<TOTAL-COSTS>                              3,874,723     
<OTHER-EXPENSES>                             917,567       
<LOSS-PROVISION>                               4,564      
<INTEREST-EXPENSE>                            76,836   
<INCOME-PRETAX>                              123,383     
<INCOME-TAX>                                  20,600         
<INCOME-CONTINUING>                          102,783     
<DISCONTINUED>                                     0             
<EXTRAORDINARY>                               (9,306)      
<CHANGES>                                          0             
<NET-INCOME>                                  93,477    
<EPS-PRIMARY>                                   1.36  <F1>           
<EPS-DILUTED>                                   1.36  <F1>        
<FN>
<F1>EPS PRIMARY AND DILUTED REFLECTS THE TWO-FOR-ONE STOCK SPLIT EFFECTED IN THE
    FORM OF A STOCK DIVIDEND DECLARED APRIL 1, 1996 AND PAYABLE ON OR ABOUT MAY
    13, 1996. EPS PRIMARY AND DILUTED FOR PREVIOUSLY FILED FINANCIAL DATA 
    SCHEDULES HAVE NOT BEEN RESTATED FOR THE STOCK SPLIT.
</FN>
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission